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Foreword 
This is the fourth Annual report prepared under the auspices of COST820 and it serves to highlight 
some of our scientific activities and laboratory visits during the past 12 months. At one time I 
anticipated that this report would be the last annual description of our work but COST820 was 
granted an extra one year to contine with its work. Naturally the membership of COST820 are 
delighted that that our hard efforts have been recognised in Brussels. The COST820 action will now 
close in June 2000. 
Looking back over the life of COST820, I think that we are proof for the success of the COST 
scheme. Certainly our model has been looked at enviously by our colleagues in, for example, the 
USA and as I pointed out in an introduction to the 1998 Annual Workshop -
At the end of September I participated in meeting in London that was organised by the UK Ministry 
of Agriculture Fisheries and Food and which considered the value of COST actions in agriculture 
and biotechnology to the UK scene. My task of both defending and promoting our COST820 action 
was incredibly easy as I was able to illustrate my presentation with many references to the 
substantial networking that now exists across most of Europe (and not just those countries within 
the EU). As an example, I used the links involving the UK scientists that have been established 
because of COST but, equally, I could have shown the links emanating from other countries. Any 
one network that has arisen because of our participation in COST820 is proof that the concept 
works but within COST820 a substantial number of new links have been forged since 1994. 
In the context of the 1998 Annual meeting, I would like to thank Professor Luis Ortega-Mora and 
his colleagues for their efforts in making the local arrangements and, with Dr Astrid Tenter, for 
preparing the scientific programme and liasing with all delegates. Also, I would again like to thank all 
those members of COST820 who have contributed towards the preparation of this document (with 
their accounts of Working Groups, scientific activities, etc.), Professor M. Rommel for editorial help 
and senior colleagues within COST820 who promote and direct the activities of our action. 
Martin W. Shirley 
Chairman 
June, 1999 
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1. SUMMARY OF OBJECTIVES OF THE COST820 ACTION 
COST820 Action began formally in July 1994 following the signing of a "Memorandum of 
Understanding" by at least seven countries. The main objectives are the: 
• Evaluation of new vaccination strategies 
• Development of new vaccines, with the emphasis on recombinant vaccines 
• Study of innovative ways for vaccine production 
• Preparation of recommendations for industrial production and efficacy and safety evaluations of 
vaccines 
• Development of biomathematical models for evaluating the potential impact of immunisations on 
the epidemiology of infections with coccidia 
For these objectives, it was anticipated that high priorities will be given to three areas loosely defined 
as: 
Basic Studies: to include aspects of the molecular biology and immunology of the coccidial parasites 
that have potential relevance for vaccine development. Such studies might include the development 
of strategies to identify protective antigens, the isolation and characterisation of antigens and 
fundamental molecular analyses of the parasites, etc. 
Intermediate Studies: to include evaluations of eucaryotic expression systems to produce modified 
parasite proteins, investigations of the abilities of different viral and bacterial vectors to present 
antigens in different sites, examinations of different adjuvants and the initial small-scale evaluation of 
potential vaccine candidates. 
Vaccination: to include the more practical aspects of vaccinations and larger scale trials of any 
outstanding recombinant vaccine candidates will be required. 
2. CURRENT STATUS OF COST820 
The status of the action as at 1st January 1998, is that the following European countries are listed as 
participants in COST820. Austria*, Belgium, Czech Republic, Denmark, Germany, Hungary, Italy, 
Ireland, The Netherlands, Poland, Spain, Sweden, Switzerland and United Kingdom. 
• Note that Austria has observer status in the Management Committee. 
3. LIST OF MEMBERS OF THE MANAGEMENT COMMITTEE 
Chairman/President/ 
Vorsitzender 
Dr. M. W. Shirley 
Institute for Animal Health, 
Compton Laboratory, Compton, Newbury, 
Berkshire, England, RG20 7NN. 
Tel: 0044 1635 577275 
Fax 0044 1635 577263 
e­mail: shirley @bbsrc. ac.uk 
Vice-Chairman/ Professor Dr. M. Rommel Tel: 0049 511 953 8790 
Vice-President/ Tierärztliche Hochschule, Institut fur Fax: 0049 511 953 8870 
stellvertretender Parasitologic, Bünteweg 17, D­30 559 
Vorsitzender Hannover, Germany 
Vice-Chairman/ 
Vice-President/ 
stellvertretender 
Vorsitzender 
Dr. P. Coudert 
INRA, Laboratoire de Pathologie du Lapin, 
F­37380, Monnaie, France 
Tel: 0033 47 42 7752 
Fax: 0033 47 42 7774 
Secretary/Secretaire/ 
Sekretär 
Belgium/Belgique 
Belgien 
Czech 
Republic/République 
Tchèque/Tschechien 
Denmark/Danemark/ 
Dänemark 
Dr Françoise Coudert 
COST Cooperation, CCE, DGX11 / Β / 1 
200 rue de la Loi, SDME 1/10, 
B­1049 Brussels, Belgium 
Dr. Dirk C. de Graaf 
Nationaal Instituut voor 
Diergeneeskundig Onderzoek 
Groeselenberg 99, B­l 180 Brussel 
Tel: 0032 2 296 55 07 
Fax: 0032 2 296 42 89 
Tel. + 32­2­375 44 55 
Fax.+ 32­2­375 09 79 
Dr. P. Bedrnik Tel: 0042 2 995 1668 
Biopharm, Research Institute of Fax: 0042 2 995 133 
Biopharmacy and Veterinary Drugs, 254 49 
Jilove near Prague, Czech Republic 
Dr. Heidi L. Enemark 
Danish Veterinary Laboratory, Department 
of Parasitology, 27 Bülowsvej, DK­1790 
Copenhagen V, Denmark 
Professor P. Lind 
Danish Veterinary Laboratory, 27 
Bülowsvej, 
DK­1790 Copenhagen V, Denmark 
Tel: 0045 35 4544 
Fax: 0045 35 3737 
Tel: 0045 35 30 0232 
Fax: 0045 35 30 0230 
France/France/ 
Frankreich 
Germany/République 
Fédérale d'Allemagne/ 
Deutschland 
Hu ngary/Ho ngrie/ 
Ungarn 
Italy/Italie/Italien 
Dr. P. Coudert 
LNRA, Laboratoire de Pathologie du Lapin, 
F-37380 Monnaie, France 
Dr. P. Pery 
Unité de Virologie et Immunologie 
Moléculaires, INRA, 
F-78352 Jouy-en-Josas Cedex, France 
Professor Dr. M. Rommel 
Tierärztliche Hochschule, Institut für 
Parasitologic, Bünteweg 17, D-30 559 
Hannover, Germany 
Dr. F. J. Conraths 
Bundesforschungsanstalt für Viruskranheiten 
der Tiere, Institut für Epidemiologische 
Diagnostik, Seestrasse 55, 
D-16868 Wusterhausen/Dosse, Germany 
Professor Istvan Varga 
Department of Pathology and Zoology, 
University of Veterinary Science, 
H-1078 Budapest, Istvan út 2, 
H-1400 Budapest, P.O. Box 2, Hungary 
Dr. G. Santini 
Istituto Zooprilattico Sperimentale 
Dell'Abruzzo e Molise, Via Campo Boario 
64100 Teramo, ITALY 
Tel: 0033 47 42 7752 
Fax: 0033 47 42 7774 
Tel: 0033 1 34 652623 
Fax: 0033 1 34 652273 
Tel: 0049 511 953 8790 
Fax: 0049 511 953 8870 
Tel: 0049 33 979 8010 
Fax: 0049 33 979 
80200 
Tel: 0036 1 342 7701 
Fax: 0036 1342 6518 
Tel: 0039 861 332287 
Fax: 0039 861 332251 
Ireland/Irlande/ 
Irland 
Dr. Grace Mulcahy 
Dept. of Veterinary Microbiology and 
Parasitology, University College Dublin, 
Faculty of Veterinary Medicine, 
Ballsbridge, Dublin 4, Ireland 
Tel: 353-1-6687 988 
Fax: 353-1-6608656 
Netherlands/ 
Hollandie/ 
Niederlande 
Professor Dr. A. C. W. A. Cornelissen 
Faculty of Vet. Medicine, 
Dept. of Parasitology and Tropical 
Medicine, Yalelaan 1, P.O. Box 80.165, 
NL-3508 TD Utrecht, The Netherlands 
Tel: 003130 53 4882 
Fax: 0031 30 54 0784 
Vet. 
Dr. M. H. Vertommen 
Zeelandia 4, 3901 G2 
Netherlands 
Tel: 0031 318 540479 
Veenendaal, The 
Poland/Pologne/Polen K. Gaca-Lagodzinska 
Olsztyn University of Agriculture and 
Technology, Faculty of Vet. Medicine, 
ul. Oczapowskiego 14, PL-10 957 Olsztyn-
Kortowo, Poland 
Tel: 0048 89 23 4730 
Fax. 0048 89 23 3430 
Spain/Espagne/ 
Spanien 
Professor L. M. Ortega Mora 
Universidad Complutense de Madrid, 
Facultad de Veterinaria, Depto Patologia 
Animal 1 (Sanidad Animal), Avda. Puerto 
de Hierro, s/n 28040, Madrid, Spain 
Sweden/Suèd e/ 
Schweden 
Professor A. Uggla 
Department of Parasitology, 
National Veterinary Institute and Swedish 
University of Agricultural Sciences, 
P.O. Box 7073, S-75007 Uppsala, Sweden 
Tel: 0046 18 67 4137 
Fax: 0046 18 30 9162 
Dr. A. Lunden 
The National Veterinary Institute Laboratory 
of Parasitology, 
P.O. Box 7073, S-75007 Uppsala, Sweden 
Tel: 0046 18 67 4120 
Fax: 0046 18 30 9162 
Switzerland/Suisse/ 
Schweiz 
Professor B. Gottstein 
Institute of Parasitology, 
University of Berne, 
Längass-Strasse 122, P. O. Box 8466 
CH-3001 Berne, 
Switzerland 
United Kingdom/ 
Grande Bretagne/ 
Grossbritannien 
Dr. M. W. Shirley 
Institute for Animal Health, Compton 
Laboratory, Compton, Nr Newbury, 
Berkshire, RG20 7NN, United Kingdom 
Tel: 0044 635 577275 
Fax: 0044 1635 577263 
J. Catchpole 
Department of Parasitology, 
Veterinary Laboratories Agency, 
New Haw, Weybridge, Surrey, KT 15 3NB, 
United Kingdom 
Tel: 0044 1932 357766 
Fax: 0044 1932 357445 
Observer - Austria 
Observateur 
Austriche 
Beobachter 
Österreich 
Dr. H. Steinkellner 
Institute of Applied Genetics, 
Universität für Bodenkultur, 
Gregor Mendelstrasse 33, 
A-l 180 Wien, Austria 
Tel: 0043 1 369 29 24 
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4. WORKING GROUPS 
To facilitate the objectives of the Action, six Working Groups were established at the outset of 
the COST820 Action to provide a focus for specific areas of interest: 
WG1 Avian coccidiosis 
WG2 Mammalian coccidiosis 
WG3 Cryptosporidiosis and cyclosporosis 
WG4 Sarcocystiosis, toxoplasmosis and neosporosis 
WG5 Biomathematical modelling 
WG6 Immunology and cell biology 
5. REPORTS OF THE WORKING GROUPS 
5.1 WG1 and WG6 Avian coccidiosis and immunology and cell biology 
Co-ordinators: Drs Martin W. Shirley and Fiona M. Tomley 
A highly successful meeting, entitled "Transfection and whole genome approaches to gene 
discovery and function: the way forward for vaccine research in coccidians?" was held jointly 
between the two Working Groups at Grottaferrata, Rome, Italy on 19th -21 s t June, 1998. 
The scientific programme was organised by Drs Fiona M. Tomley and Martin W. Shirley with 
help from Dr Furio Spano. 
Dr Furio Spano and Dr Andrea Cri santi were the local hosts and provided an excellent venue 
The programme for the joint meeting and abstracts of the papers presented are included in the 
Appendix. 
A meeting of WG1 was also held on 27th February 1998 at the Veterinary Laboratories 
Agency, Weybridge on "Identification of avian species of Eimeria, further experiments and the 
impact that the new work may have for vaccination strategies". The primary purpose of the 
meeting was to discuss the work of Dr Beate Schnitzler (Sweden) who had recently developed 
a PCR diagnostic test based on the amplification of the ITS1 region of the genome. 
5.2 WG2 Mammalian coccidiosis 
Co-ordinator: Janet Catchpole 
A well attended and successful meeting was held on 27th February 1998 at the veterinary 
Laboratories Agency, Weybridge on the topic "Coccidiosis in Pigs". A copy of the proceedings 
is included in the Appendix 
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5.3 WG3 Cryptosporidiosis and cyclosporosis 
Co-ordinators: Dirk C. de Graaf & Alain Bonnin 
Background 
Organisms of the genus Cryptosporidium are Apicomplexan protozoans that infect several 
groups of vertebrates. Six Cryptosporidium species are currently considered valid: C. parvum 
and C. muris in mammals, C. meleagridis and C. baileyi in birds, C. serpentis in reptiles and C. 
nasorum in fish. 
Among these species, C. parvum, that is infective for mammals, has the most important 
economic impact. In calves and sheep C. parvum has been identified as the most common 
infectious agent in outbreaks of diarrhoea. Large numbers of cryptosporidial oocysts produced 
during commercial calf production contaminate drinking water resources and contribute to 
human cryptosporidiosis. Only ozone is effective in disinfecting drinking water from C. 
parvum. Few drugs are active against the parasite, and even less are commercially available. 
Moreover, public opinion is more and more opposed against systematic chemoprevention of 
parasitic diseases. Therefore, immuno-prophylactics should be considered. 
The prevention of cryptosporidiosis is difficult. Whereas most other species of coccidia are 
incapable of recycling within the host, C. parvum has two stages that initiate auto-infectivity : 
type I merozoites and sporozoites derived from thin-walled oocysts. These characteristics 
allow C. parvum to develop severe infections in hosts exposed to small numbers of thick-
walled oocysts, and development of an effective immune response seems to be the only way to 
control infection. 
Little is known about the immunobiology C. panmm. In immunocompetent hosts 
cryptosporidiosis is self-limiting. Calves that recover from infection are resistant to a second 
challenge with the same strain. So recovery depends on a specific, acquired immune response, 
although the exact mechanisms responsible for resistance have not been defined yet. 
Colostrum plays a limited role. Although neonatal calves can be partially protected by 
hyperimmune colostrum, normal colostrum does not protect ruminants from infection. This 
may be due to the fact that the time of exposure of parasitic stages to colostral antibodies is 
too short to protect neonates. In humans passive lacteal immunity against C. parvum in breast­
fed children has been described. No lactogenic immunity seems present in cattle, as most calves 
will experience cryptosporidiosis while they are nursing from immune cows. 
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The role of immunoglobulins in the elimination of the parasite is controversial. Some evidences 
support the involvement of antibodies in the clearance of the infection, such as i) the 
persistency of cryptosporidiosis in congenitally hypogammaglobulinemic individuals, ii) the 
good temporal association between C. parvum oocyst excretion and the amount of specific 
IgA in the faeces of calves and lambs and iii) the protective role of neutralising antibodies as 
demonstrated by their ability to inhibit invasion both in vivo and in vitro. On the other hand, 
there are observations arguing against the importance of the antibody response: i) oocyst 
shedding patterns do not differ between B-cell-depleted neonatal mice or bursectomised 
chickens and their controls, ii) challenged immune calves do not show a secondary mucosal 
antibody response and iii) AIDS patients with persistent cryptosporidiosis produce C parvum 
specific serum and/or mucosal IgG, IgM and IgA. 
Whitmire & Harp showed that peripheral lymphocytes recovered on the second day post­
infection recognise antigens in a lysate of C. panmm oocysts. Natural Killer cells and tumour 
necrosis factor seem to have no influence on the progress of infection in BALB/c mice. This 
was confirmed by the fact that severe combined immunodeficient mice - who have natural killer 
cells but no Τ and Β cells - develop a persistent infection and die within 12 weeks after 
infection. However, when their immune system is reconstituted by injection of spleen cells 
from normal donors they can reduce the infection level. This reconstitution seems to be CD4+ 
Τ cell dependent, as was seen by depletion of different Τ cell subsets of the samples to be 
transferred. Similarly, administration of neutralising anti- CD4+ Τ cells and anti-INFy 
monoclonals prevented the recovery from infection after adoptive transfer with spleen cells. 
Interferon-gamma seems to be of major importance in the development of protection against 
C. parvum infection. Daily administration of INFy to immunosuppressed rats reduced the 
intensity of subsequent ileal infection. And administration of IL12 to immunocompetent and 
immunosuppressed mice reduced the severity of infection by a INFy dependent mechanism. 
Recently a specific INFy response was found after Cryptosporidium infection of neonatal 
calves. The antigens that provoke this cellular response might be interesting vaccine 
compounds. 
In chickens disease associated with C. baileyi manifests itself most often as a respiratory 
disease in immunosuppressed birds. Only occasionally the parasite causes intestinal or renal 
disease although combinations with tracheitis may be observed. 
Cyclospora may cause diarrhoea and weight loss in humans. The infection is felt to be a 
waterborne disease. The economic impact in animals is unknown. 
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Activities of WG 3 in 1998 
A Working Group 3 Meeting was held on Saturday, 24th October 1998, during the Annual 
Workshop in Toledo, Spain. This meeting was entitled: "A vaccine against cryptosporidiosis: 
reality or fantasy?". 
The programme was as follows: 
D.C. de Graaf: General introduction. 
D.C. de Graaf: Is a vaccine necessary in veterinary medicine? 
A. Bonnin: Is a vaccine necessary in human medicine? 
S. Sagodira: The answers currently available. 
F. Petry: Mechanisms of the immune response to cryptosporidiosis relevant to vaccination. 
F. Spano: Possible targets offered by the molecular biology. 
A. Bonnin: Priorities for the future and conclusion. 
Based on this WG3 meeting a new list of points of action for the near future was derived: 
i) a clinico-epidemiological analysis to confirm the impact of cryptosporidiosis on the 
nutritional status and development of young children 
ii) a study of the consequences of combined antiviral chemotherapy on AIDS 
cryptosporidiosis 
iii) the study of the immune effector mechanisms involved in the clearance of the infection 
iv) the identification οι Cryptosporidium T-cell antigens 
v) the understanding of the mechanism involved in the passive immunisation of neonatal 
ruminants by colostral transfer 
vi) the identification and complete characterisation of new targets offered by the molecular 
biology 
vii) the confirmation of the protective potential of candidate vaccine antigens in vaccination 
trials 
viii) the study of the genetic structure of C parvum and the characterisation of the 
pathogenicity of different genotypes to ensure the choice of the most appropriate 
target. 
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Representation of WG 3 at the Annual Workshop: 
At the 1998 Annual Workshop of the COST 820 Action in Toledo, the following oral 
presentations were given by WG 3 members: 
S. Sagodira, D. Buzoni-Gatel, S. Iochmann, M. Naciri and D. Bout: Protection of 
neonates against cryptosporidiosis after genetic vaccination of dams. 
F. Petry and V. McDonald: Further characterisation of recombinant antigens of 
Cryptosporidium parvum. 
A. Bonnin, J.F. Dubremetz, J. Lopez, S. Robine, C. Chaponnier and G. Gabbiani: 
Detection of microvillous cytoskeletal components in the parasitophorous vacuole wall of 
Cryptosporidium parvum. 
M. Giles, K.A. Webster, J.A. Green, J. Catchpole, C. Dawson, S. Pedraza-Diaz and J. 
McLauchlin: Host specificity, pathogenesis and molecular classification of Cryptosporidium 
species 
S. Patel, J. McLauchlin, S. Pedraza-Diaz and D. Casemore: Seroepidemiology and 
molecular characterisation of cryptosporidiosis. 
D.C. de Graaf, E. Vanopdenbosch and J.E. Peeters: Introduction to the debate on the 
epidemiology and economic importance of Cryptosporidium spp. 
C.A. Vergara-Castiblanco, S. Santos-Nunez, F. Freire-Santos and E. Ares-Mazas: 
Cryptosporidium parvum in two Colombian populations: immunoblot analysis of specific 
serum response (IgA, IgG and IgM). 
The following poster presentations were given by WG 3 members: 
F. Petry and J. R. Harris: Ultrastructure and molecular analysis of the extracellular stages of 
Cryptosporidium parvum. 
S. Pedraza-Diaz, S. Patel and J. McLauchlin: Molecular typing of Cryptosporidium from 
human water-borne outbreaks. 
D. Champliaud, P. Gobet, M. Naciri, O. Vagner, J. Lopez, Y. Varga, G. Harly, R. 
Mancassola and A. Bonnin: Failure to differentiate Cryptosporidium parvum from C 
meleagridis based on PCR amplification of eight DNA sequences 
F. Freire-Santos, C.A. Vergara-Castiblanco and E. Ares-Mazas: An attempt of 
experimental infection by Cryptosporidium parvum in rainbow trout. 
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H. Abbassi, F. Coudert, Y. Chérel, J. Brugère-Picoux and M. Naciri: Effect of pathogenic 
virus of Infectious Bursal Disease (IBD) on the pathogenicity οι Cryptosporidium baileyi and 
the development of acquired immunity to parasite. 
S. Hornok, Z. Széll, J. Nieuwenhuijs, M.G.B. Nieuwland, A.W.C.A. Cornelissen and I. 
Varga: Immunogenicity of three oocyst extracts of Cryptosporidium baileyi in experimentally 
infected chickens. 
S. Hornok, Z. Bitay, Z. Széll and I. Varga: Assessment of maternal immunity to 
Cryptosporidium baileyi in chickens. 
Representation of WG 3 at the Joint Meeting of WG 1 and WG 6: 
At the Joint Meeting of WG 1 and WG 6 in Rome, Italy, the following oral presentations were 
given by WG 3 members: 
M. Piper: Happy mapping in Cryptosporidium. 
S. Caccio: Establishment of the molecular karyotype οι Cryptosporidium parvum. 
F. Spano: Gene discovery and genetic variation in Cryptosporidium and Toxoplasma. 
D.C. de Graaf, P.T. Hoff, F. Petry and J.E. Peeters: First attempts to isolate recombinant 
Cryptosporidium Τ cell antigens. 
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Members of WG 3 
Belgium 
Dr. Dirk C. de GRAAF 
Nationaal Instituut voor Diergeneeskundig 
Onderzoek 
Groeselenberg 99 
B-l 180 Brussel 
Dr. Johan E. PEETERS 
Nationaal Instituut Diergeneeskundig Onderzoek 
Groeselenberg 99 
B-l 180 Brussel 
Dr. Béatrice ROBERT 
Centre d'Economie Rurale 
Rue du Carmel 1 
B-6900 Marloie 
Czech Republic 
Dr. Oleg DITRICH 
Institute of Parasitology 
Czech Academy of Sciences 
Branisovska 31, CZ-370 05 Ceské Budejovice 
Dr. Slávomír KOUDELA 
Institute of Parasitology 
Czech Academy of Sciences 
Branisovska 31, CZ-370 05 Ceské Budejovice 
Denmark 
Dr. Svend Aage HENRIKSEN 
Danish Veterinary Laboratory 
Bülowsvej, 27 
PO Box 373, DK-1790 Copenhagen V 
Dr. Heidi Larsen ENEMARK 
Danish Veterinary Laboratory 
Bülowsvej 27, DK-1790 Copenhagen V 
France 
Dr. Alain BONNIN 
Laboratoire de Parasitologie et Mycologie 
Hôpital du Bocage, F-21034 Dijon Cedex 
Tel. + 32-2-375 44 55 
Fax.+ 32-2-375 09 79 
Tel. + 32-2-375 44 55 
Fax.+ 32-2-375 09 79 
Tel. + 32-84-22 02 11 
Tel. + 45-31-35 45 44 
Fax.+45-35-30 01 20 
E-mail: saah@svs.dk 
Fax.+45-35-30 01 20 
E-mail: hle@svs.dk 
Tel. + 33-3-80 29 36 03 
Fax.+ 33-3-80 29 32 80 
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Dr. Daniel BOUT Tel. + 33-80 29 35 23 
Université de Tours/INRA 
UFR des Sciences Pharmaceutiques 
31, Avenue Monge, F-37200 Tours 
Dr. Muriel NACIRI Tel. + 33-47 42 77 67 
INRA 
Station de Pathologie Aviaire et de Parasitologie 
F-37380Nouzilly 
Fax.+ 33-47 42 77 74 
Serge SAGODIRA Tel. + 33-2-47 36 72 44 
CJF9309 INSERM d'Immunologie des Maladies _ 
T - . Fax. + 33-2-47 36 72 52 Infectieuses 
UFR Pharmacie, Immunologie Parasitaire E-mail: sagodira@univ-tours.fr 
31, avenu Monge, F-37200 Tours 
Germany 
Dr. P. KARANIS 
Institut für Medizinische Parasitologie 
Sigmund-Freud-Straße 25, D-53127 Bonn 
Prof. WA. MAJER 
Institut für Medizinische Parasitologie 
Sigmund-Freud-Straße 25, D-53127 Bonn 
Prof. H.M. SEITZ 
Institut für Medizinische Parasitologie 
Sigmund-Freud-Straße 25, D-53127 Bonn 
Dr. Franz PETRY Tel. + 49-6131 -173 144 
Johannes Gutenberg - Universität Mainz 
Fachbereich Medezin 
Institut für Medizinische Mikrobiologie und Hygiene E-mail: 
Augustusplatz/Hochhaus, D-55101 Mainz 
Fax.+49-6131-173 439 
petrfOOO@goofy.zdv.uni-mainz.de 
Hungary 
Dr. István VARGA Tel. +36-1-342 7701 
Department of Parasitology and Zoology 
University of Veterinary Science 
István u. 2, H-1078 Budapest 
Fax.+ 36-1-342 6518 
Dr. Tamas SRETER Tel. + 36-1 -342 7701 
Department of Parasitology and Zoology 
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5.4 WG 4, Sarcocystiosis, toxoplasmosis and neosporosis 
Co-ordinators: Dr D. Buxton and Prof. M. Rommel 
1998 has been a particularly productive year for COST 820 Working Group 4. Apart from numerous 
informal links between laboratories that it has created, more formal meetings funded by the EU have 
been very successful. 
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At the COST 820 meeting held to discuss "Vaccines Against Animal Coccidioses" in Toledo 22-25 
October, members of Working Group 4 were seen to have been particularly active. Of 40 oral 
presentations 19 (47.5%) were by members of WG4. 
Under the umbrella title "Recombinant antigens and other tools for the development of molecular-
engineered vaccines against coccidial parasites" six papers from WG4 demonstrated the very 
significant advances in our understanding of protective immunity to Toxoplasma gondii and three 
were presented on the very much more recently recognised Neospora caninum. 
Oral sessions. 
Within the first session, "DNA Vaccines and Recombinant Antigens", one was on vaccinating mice 
with recombinant proteins derived from Neospora caninum (presented by Simone Eperon, 1 below) 
and the other on the use of recombinant surface antigen,SAGl, to vaccinate mice against 
Toxoplasma gondii (presented by Henrik Vedel-Nielsen, 2 below). 
In the second session "Identification of New Vaccine Candidates" there was a further paper on the 
potential of SAG from T. gondii to induce protective immunity (presented by Furio Spano, 3 below) 
and two on specific surface antigens ofN. caninum (presented by Simone Sonda, 4, and Nicole 
Fuchs, 5). 
In the "Transfection" session the three papers concerned with T. gondii presented data on how the 
parasite could now be engineered to meet specific experimental needs which in turn could lead to the 
production of a successful vaccine (Adrian Hehl, 6). Jens Mattsson then spoke on the use of 
transfection to investigate and characterise the genetic background of certain phenotypes (7) and 
Martine Soete on the bradyzoite-specific surface antigen SAG4 in the temperature sensitive (Ts-4) 
vaccine strain (8). Bruno Gottstein then presented data from original research using knockout mice 
and wild-type mice as models for Neospora infection and showed the importance of both cellular and 
humoral immunity to this parasite (9). 
These sessions were then followed by a very focussed and relevant examination of the 
"Epidemiology and Economic Impact of Coccidiosis In Animal Production" starting with a scientific 
session followed by a round table discussion. 
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In the scientific session speakers examined the incidence of protozoan cysts in bovine, ovine and 
caprine abortions in Italy (Gabriella Di Francesco, 10). Five of the following six papers from 
members of WG4 then highlighted the very rapid progress being made in piecing together our 
understanding of bovine neosporosis. These covered its seroprevalence in England and Wales (Helen 
Davison, 11) and Spain (Enrique Tabares, 12) and then Jonathan Wastling emphasised the value of 
being able to accurately distinguish between different isolates of N. caninum by genetic typing to 
allow an accurate analysis of field data (13). 
As well as molecular techniques it is crucial that we have, and understand, what serology can do to 
help. In this respect Peter Lind moved the discussion significantly further forward in his paper (14) 
and then Jo Marks, summarising her studies into bovine immunity to N caninum, also demonstrated 
the importance of cell-mediated mechanisms and highlighted the role of interferon gamma (15). 
While these studies were in non-pregnant cattle the following paper by Catherine Guy examined 
immunological responses in pregnant cattle (16). The importance of cell-mediated immunity in 
protecting animals against the protozoa worked on by members of WG4 was further emphasised 
when the session ended with a paper on the role of immunological memory in Sarcocystis infection, 
by Thomas-Erich Jekel (17). 
In the round table that followed papers, by David Buxton, Jonathan Wastling and Astrid Tenter 
attempted to estimate how much T. gondii, ΛΓ. caninum and Sarcocystis spp. respectively cost the 
EU in terms of inefficiency and lost production (18, 19, 20). 
The overarching conclusion from all three presentations was a) how important these parasites are in 
causing considerable losses in EU agriculture (as well as, in the case of T. gondii, causing human 
disease) and b) how these figures were essentially honest but crude estimates, as much work remains 
to be done in gathering more accurate data. 
Poster session. 
Eight of the 18 posters (44%) were presented by members of WG4. 
While one addressed the problem of toxoplasmosis in pigs (G. Jungersen et al, 21) the other 7 all 
presented research into neosporosis. Four tackled epidemiological aspects and incidence in cattle (A. 
Schock et al, 22; W. Wouda et al, 23; H.C. Slotved et al, 24; A. Uggia et al, 25) and one examined 
the potential role that foxes might play (S. Wright et al, 26). Two others looked at immunity to 
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Neospora in mice (A. Lunden et al, 27) and a comparison between bovine and canine Neospora 
isolates in a mouse model (R. Atkinson et al, 28). 
46.5% of this very successful conference was devoted specifically to Working Group 4 with many of 
the other presentations also being of very great relevance to the group. 
A business meeting of COST 820, working group 4 was also held (at 21.00h on 22/9/98 at 
the Beatriz Hotel, Toledo Spain). The object of the meeting was to take advantage of 
having "so many members of WG4 under the same roof at the same time" to discuss 
the way forward. 
Those present were:­
C. Björkman (S). 
B. Gottstein (CH). 
J. Mattsson (S). 
J. Pereira Bueno (Es). 
A. M. Tenter (D). 
W. Wouda (N). 
D. Buxton (UK) ­ in the chair, 
P. Lind (DK). 
Ν. Müller (CH). 
G. Savini (I). 
A. Vermeulen (Ν). 
F. J. Conraths (D). 
A Lundén (S). 
L. M. Ortega Mora (Es). 
S. Stenlund (S). 
J. M. Wastling (UK). 
The meeting was convened to discuss two matters. 
1. The proposal to run a joint meeting between COST 820 WG 4 (Sarcocystiosis, Toxoplasmosis 
and Neosporosis) and WG 5 (Epidemiology). 
2. 2. Future funding for WG 4. 
1. Neoporosis is now recognised as being of very great importance in European and World 
agriculture. Very recent data from members of WG 4 and scientists in other countries in the world 
variously indicate levels of calf abortion attributable to N. caninum being at 10 to 40% (with some 
estimates as high as 50%). The full life cycle of the parasite was shown to take place in the dog in the 
summer of 1998. 
In view of the importance of bovine neosporosis the meeting discussed the proposal that WG 4 hold 
a joint meeting with WG 5 and focus on epidemiological aspects of neosporosis in cattle. The recent 
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discovery that the dog is the definitive host for N caninum would make such a meeting very timely. 
All those present felt that it was vital that such a meeting should be held. It was unanimously agreed 
that we would ask Professor A. W. C. A. Cornelissen of Utrecht University (WG 5) and Dr W. 
Wouda (WG 4) to explore the possibility of holding such a meeting in Amsterdam either in January 
1999 or around the end of April 1999. It was felt that the latter date was more realistic. 
2. The meeting then discussed the possibility of seeking funding to permit the activities of WG 4 to 
continue after the demise of COST 820. It was agreed unanimously that in view of the important and 
very exciting progress in Neospora research that we would work to this end. It was also universally 
recognised that a very considerable amount of research into the parasite as well as pathogenesis and 
immunity in the host and epidemiology was required if the real losses caused by neosporosis were to 
be tackled in a meaningful way. It was felt that a provisional working title of "The Economic Impact 
of Bovine Neosporosis" could be adopted for the time being. 
COST 820 funded visits between WG4 laboratories. 
Dr Anja Heckeroth from the Institute for Parasitology, Hannover Veterinary School, Germany, 
visited the Moredun Research Institute, Edinburgh, Scotland in the summer in an exchange which 
successfully transferred the technologies for the detection of Sarcocystis spp and Neospora by PCR 
between the two laboratories. In addition transfer serological methods for detecting infection by both 
parasites was also achieved. . 
6 SHORT-TERM SCIENTIFIC MISSIONS 
6.1 Anja Heckeroth 
Institut für Parasitologie 
Tierärztliche Hochschule Hannover 
Bünteweg 17 
D-3 05 5 9 Hannover 
Germany 
Visit to Moredun Research Institute, Edinburgh, United Kingdom, September 1998 
In September 1998,1 spent 18 days at the Moredun Research Institute, Edinburgh, United 
Kingdom. The aim of the STSM was to standardise methods for in vitro cultivation and diagnosis 
of Neospora caninum, Toxoplasma gondii, Sarcocystis tenella and Sarcocystis arieticanis between 
the two laboratories. 
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Firstly, I was introduced to cell culture techniques for N caninum and T. gondii. I learned different 
methods to test new cell culture reagents and to optimise the culture conditions. In addition, I 
learned a method for the isolation of N caninum from infected tissue and the start of a cell culture 
using this material. After I learned the routine maintenance of Vero cells and parasites I expanded 
one strain of each parasite, N caninum and T. gondii, and harvested the tachyzoites. Subsequently, 
the parasites were purified from Vero cells and other culture material. Most of the parasites were 
frozen and shipped to the Tierärztliche Hochschule Hannover where two­dimensional 
electrophoretic analysis and comparison of protein profiles will now be carried out. A portion of 
the parasites were used to prepare antigen for serological tests, the enzyme­linked immunosorbent 
assay (ELISA) and indirect immunofluorescence antibody test (IFAT). 
Secondly, I was trained in the methodology of an ELISA and IF AT for the diagnosis ofN. caninum 
in cattle sera. Evaluation of the tests with the newly prepared antigen was intensively discussed. In 
addition, sera from a German dairy herd were examined with both tests. The results of the two tests 
were compared with those obtained by a different ELISA which was carried out in Hannover 
earlier. Furthermore, I established an ELISA for the diagnosis of S. tenella and S. arieticanis 
infections in sheep and trained the staffai the Moredun Research Institute in the methodology of 
this test. The antigen, reference sera and conjugate for this ELISA originated from the Tierärztliche 
Hochschule Hannover. 
Thirdly, different PCR methods developed at both laboratories for the diagnosis of different cyst­
forming coccidia were compared. I introduced a Nested­PCR for the species­specific diagnosis of 
S. tenella as well as S. arieticanis at the Moredun Research Institute. Primers for this tests were 
previously developed at the Tierärztliche Hochschule Hannover. In return, I learned the Nested­
PCR methods for the diagnosis οι N caninum or Τ gondii currently carried out at the Moredun 
Research Institute. These methods will now be established as diagnostic tools at the Tierärztliche 
Hochschule Hannover. In addition, blood samples from a German dairy herd and a German sheep 
herd as well as samples from tissue sections were examined by the PCRs. 
I wish to thank Dr. David Buxton and all the members of his group at the Moredun Research 
Institute for their kindness and helpfulness during my stay in Edinburgh. 
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6.2 Beate E. Schnitzler 
Department of Parasitology, 
National Veterinary Institute 
P.O. Box 7073, 
S-750 07, Uppsala 
Sweden 
Visit to Animal Health in Compton, Newbury, United Kingdom, November/December, 1998 
From 16th November to 18th December 1998,1 spent several weeks working at the Institute for 
Animal Health in Compton, Newbury, UK. During this period I learned some basic as well as some 
more advanced techniques applicable to research on Poultry Eimeria. 
Am of this Short Term Scientific Mission was to plan several different experiments which are part 
of a big 3-year collaborative project between the Swedish University of Agricultural Sciences in 
Uppsala, Sweden and the Institute for Animal Health in Compton, UK. These experiments had to 
be planed and divided between the two locations. Additionally I had the opportunity to learn and 
understand the basic techniques that should enable me to proceed with the part of the experiments 
taking place in Uppsala. 
Basic techniques I learned and commonly used, at the Institute for Animal Health include large 
scale preparations of faecal samples, flotations, harvesting and counting of oocysts, preparation for 
DNA extractions and different methods for DNA extractions (extractions from oocysts and from 
sporocysts), different techniques for inoculations of chickens (single sporocyst inoculation). 
Furthermore I was introduced to a new technique which implies the use of Amplified Fragment 
Length Polymorphism markers (AFLP's). This is a popular new technique based on a molecular 
marker system and helpful for the construction of a genetic linkage map. 
I would like to thank Drs Fiona Tomley and Martin Shirley and all the members of the Parasitology 
Department at the Institute for Animal Health for their kindness and helpfulness during my stay in 
Compton. The introduction to the techniques will certainly help me not only with the experiments 
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planed in the near future which are based on a long cooperation between the two institutes but also 
contribute substantially to my general knowledge of Coccidiosis. 
Furthermore I would like to thank COST 820 for the financial support that made this short 
scientific visit possible. 
6.3 Enrique Tabares 
Departamento de Patologia Animal I 
(Sanidad Animal) 
Facultad de Veterinaria 
Universidad Complutense de Madrid 
Visit to Animal Health in Compton, Newbury, United Kingdom, November/December, 1998 
My visit to the Institute for Animal Health (IAH) took place from November 30th to December 
18th 1998 (3 weeks). The aim of this visit was to construct a Cryptosporidium parvum cDNA 
library in order to identify parasite genes of interest. Contacts with Dr. Fiona Tomley and Dr. 
Martin W. Shirley at the IAH were established because of their expertise developing cDNA 
libraries for the close related protozoa Eimeria tenella. 
During this three weeks, two different cDNA libraries were developed. The first was from a cattle 
isolate (passage in sheep) from Spain (CUCM-1) and the second from a cattle isolate from U.S.A. 
(CUSA-1). C. parvum mRNA was extracted from 1010 sheep oocysts or 2xl09 cattle oocysts using 
the Fast Track 2.0 Kit (Invitrogen). For the development of the cDNA libraries the 1-ZAP cDNA 
Synthesis Kit (Stratagene) was used. Synthesis of the first and second cDNA strands was followed 
using label dNTPs. The cDNA obtained was fractionated in sepharose CL-2B columns and 1 and 3 
high molecular weight fractions were recovered from the CUCM-1 and CUSA-1 isolates 
respectively. Approximately, 70 mg of each fraction were ligated into Uni-Zap XR vector and 1 ml 
of each ligation was packaged using the Gigapack III Gold Cloning Kit. Finally, phages were 
growth into XL1-BLUE cells. 
Titres of primary cDNA libraries were around 2x106 with a ratio of and recombinant and non 
recombinant colonies was greater than 100:1. The length of the inserted DNA fragments was 
determined in 9 random colonies for each library by PCR (Polymerase Chain Reaction) using the 
T3 and T7 promoter sequences as primers and was found to be between 800 and 4,000 base pairs. 
Primary libraries were amplified and number of the titres were between 2xl09 and 1.6xl010 pfii/ml. 
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This is the first 1-ZAP C. parvum cDNA library developed in Europe and has been possible due to 
COST action 820. The expertise of Dr. Fiona Tomley was central to the successful end of the 
experiment and the work has opened the possibilities for future collaborations between our 
laboratories. 
7. ACTIVITY REPORTS 
7.1. DENMARK 
REPORTERS 
Peter Lind, Lene Jensen, Gregers Jungersen, Hans-Christian Slotved 
Danish Veterinary Laboratory, 27, Bülowsvej, DK-1790 Copenhagen V, Denmark 
Toxoplasma gondii 
A 5-year study on identification of genetic markers for T. gondii subpopulations and virulence 
properties were completed in earlyl999. More than 40 isolates, collected from swine, sheep, cats 
and foxes in DK after 1992 have been typed using monoclonal antibodies. A more discriminatory 
typing system, based on a repetitive non-coding element was recently developed by the project 
partner at the Statens Serum Institute, Copenhagen, and will be used to study a possible clustering 
of the Danish isolates according to host species of origin and already established virulence 
characteristics after inoculations to mice, young pigs and pregnant mini-gilts. 
Neospora caninum 
Studies on N caninum infection in cattle herds have been a major activity during the last couple of 
years in cooperation with Swedish colleagues in Uppsala and the Danish Agricultural Advisory 
Centre. Longitudinal blood samplings of cows from moderately to heavily infected herds over an 18 
mo. period have shown a reasonable constancy in serological status (specific IgGl in ISCOM-
ELISA) over the cows' gestation, with 90% maintaining either positive or negative status, 8% 
showing apparent seroconversion and 2.5% with fluctuating status. The IgGl/IgG2 ratio for 
Neospora-specific antibodies showed a drop at the time of calving/abortion, which may reflect 
changes in Thl/Th2 stimulation during gestation. A number of cows in two heavily infected dairy 
herds were subsequently sampled with monthly intervals during 1998 to study changes in IgG 
subclass profiles, phagocytosis and killing ability towards intracellular agents as well as cytokine 
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mRNA expression during gestation. The data is presently under analysis in order to find prognostic 
parameters for transplacental transmission of neosporosis in the individual cows. 
A swine antiserum with specificity for N caninum, obtained from experimentally infected gilts has 
been distributed as a positive control reagent to several partners within the COST 820 action. No 
indications of naturally prevailing infections with N caninum in European pig populations have so 
far been reported. 
Publications: 
• Jensen, L., Jensen, T.K., Lind, P., Henriksen, S. Α., Uggla, Α. & Bille­Hansen, V. Experimental 
porcine neosporosis. APMIS, 106, 475­482, 1998. 
• Jensen, L., Heegaard, P.M.H. & Lind, P.: A study of virulence parameters for Toxoplasma 
gondii infections in mice. Parasitology Research, 84, 382­87, 1998 . 
• Jensen, L., Petersen, E., Henriksen, S.Aa., Dietz, H.H. & Lind, P. 1998: Monoclonal antibodies 
to Toxoplasma gondii strain 119 identify recently isolated Danish strains as one group. 
International Journal for Parasitology, 28, 1305­1313. 
• Jensen, A.M., Björkman, C , Kjeldsen, A.M., Wedderkopp, Α., Willadsen, C , Uggla, A & 
Lind, P.: Sero­epidemiological aspects of Neospora caninum infection in Danish dairy herds. 
Preventive Veterinary Medicine (submitted). 
• Petersen, E., Lebech, M., Jensen, L., Lind, P., Rask, M, Bagger, P., Björkman, C. & Uggla, Α.: 
Infection with Neospora caninum is not a major cause of habitual abortion in humans. 
Emerging Infectious Diseases (accepted for publication). 
• Slotved, H.C., Jensen, L. & Lind, P.: Antibody response in bovine fetuses with Neospora 
caninum infection. International Journal for Parasitology (submitted). 
• Jungersen, G , Jensen, L., Riber, U , Heegaard, P., Petersen, E. & Lind, P.: Pathogenicity of 
selected Toxoplasma gondii isolates after intravenous inoculation in pigs. International Journal 
for Parasitology (submitted). 
• Jungersen, G , Jensen, L., Rask, M.R. & Lind, P.: Differences in virulence of selected Danish 
Toxoplasma gondii isolates in mice. Parasitology Research (submitted). 
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7.2. FRANCE 
REPORTER: Alain Bonnin 
Laboratoire de Microbiologie 
Médicale et Moléculaire 
Faculté de Médecine 
7, boulevard Jeanne d Arc 
21033 Dijon Cedex, France 
Mailing address 
Laboratoire de Parasitologie et Mycologie 
Hôpital du Bocage 
21034 Dijon Cedex, France 
Tel. 33 3 80 29 36 03 
Fax.33 3 80 29 32 80 
E mail : abonnin@chu-dijon.fr 
Following ongoing programs, our 1998 efforts focused on the molecular characterisation of 
Cryptosporidium isolates, and the study of interactions between Cryptosporidium life cycle stages 
and the apical region of enterocytes. 
1. Genotyping Cryptosporidium isolates 
la. As part of a project aimed at understanding the population structure of C.parvum, we 
characterised a new polymorphic DNA region of the C.parvum genome, 8G26. This DNA region 
had been cloned following a previously described procedure (FEMS Microbiology Letters 1996, 
137 : 207-211). Direct sequencing of PCR products obtained from the central region of this clone 
identified 6 polymorphic nucleotide positions that determined 2 distinct genotypes. This new typing 
system was applied to human, calf, and goat isolates of Cryptosporidium, and the distribution 
observed at the 8G26 locus was compared to the distribution of the same isolates obtained with the 
5C12 PCR-RFLP assay we described previously (FEMS Microbiology Letters 1996, 137 : 207-
211) (manuscript in preparation) 
lb . We further characterised a bird isolate of'Cryptosporidium that had been identified as C. 
meleagridis on the basis of its host specificity and site of infection, but gave positive reactions with 
PCR reactions aimed at identifying C.parvum (Applied and Environmental Microbiology 1998, 64: 
1454-1458; Parasitology Today 1999, 15: 80-81). 
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2. Interactions between C. parvum and the apical region of enterocytes 
In order to understand the molecular basis of the Cryptosporidium-enterocytc interaction, we 
analysed the organisation of cytoskeletal components of the microvilli during invasion and 
intracellular development of enterocytes by C. parvum. To do so, we used immunoelectron 
microscopy and antibodies to villin, ezrin and actin, 3 of the microvillus cytoskeleton components, 
to study the Localization of these molecules in C. parvum infected enterocytes. These experiments 
showed that the vacuolar wall surrounding C. parvum contains 2 microvillar derived components, 
villin and ezrin (manuscript in preparation). 
REPORTER: Dr Pierre Pery 
Unité de Virologie et Immunologie Moléculaires, INRA 
F-78352 Jouy-en-Josas Cedex, France 
1) Amplification of immune responses against recombinant proteins 
In order to provoke and improve a local immune response against Eimeria recombinant proteins, 
the effect of cholera toxin (CT) was investigated. 
CT alone was shown to be very immunogenic in chickens when given by the oral route and to 
evoke both a local and systemic antibody production. When a recombinant protein,lpel was mixed 
with CT and given, by this same route, an increase of the anti lpel IgA production was noted in 
the duodenum 3 weeks post immunisation together with an increase of specific IgG production 
both in duodenum and caecum. 
This effect was however too moderate to be used in further trials, perhaps due to the paucity of 
Peyer's patches in the chicken intestine. 
ISCOMs were then used with the same goal and since it was expressed, purified and renatured, Ea 
HSP 70 was the incorporated antigen. When tested by the oral route, these ISCOMs were unable 
to evoke an immune response either at the local level or in the serum although they were given 
several times to each birds. 
On the contrary, when given by parenteral routes, this ISCOMs formulation was very immunogenic 
both in antibody production and spleen cell priming, whereas HSP 70 alone in the same conditions 
did not induce these responses at all. 
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A protection trial was then performed with these immunised chickens and a slight protection was 
obtained both at the oocyst output level (38% for the first day of oocyst secretion ) and at the body 
weight loss level. However, when the total oocyst number were compared this significant decrease 
was no longer observed. We did no find explanation for this delaying effect on the life cycle and 
such an experiment must be reproduced before we can conclude 
The carrier effect of the HSP 70 from mycobacterium tuberculosis is well know and was studied 
with a peptide repeat from the circumsporozoite protein from Plasmodium falciparum and as 
fusion protein with protein from the HIV virus . 
We are then trying to express fusion proteins with the Ea HSP70 in order to study this carrier 
effect. Ea aspartyl protease or peptides thereof were then tentatively fused at the plasmid level. 
Until now we were unable to obtain expression of such constructs and we are study other 
constructs and other expression conditions. 
2) Identification and characterisation of proteins from primary schizonts. 
this project continued through 1998 and certainly 1999 and after, being now our most important 
project. Several new genes were identified and their expression compared between sporozoites and 
primary schizonts. When isolated, the gene coding for such proteins are expressed, and 
antibodies obtained against the recombinant proteins. These antibodies will be used to localise the 
relevant antigens and to check an effect in inhibition of parasite development in in vitro culture of 
Eimeria tenella and finally to study and understand the cellular biology of the primary schizont. 
3)Aspartyl-proteinase 
This project has continued in collaboration with Fiona Tomley in Compton were L. Jean is 
performing her PhD on this topics. In Jouy, because we were unable to activate bacterial 
recombinant Ea prepro aspartyl proteinase after renaturation, all the genes related to the 
proteinases were successfully transferred in the yeast Pichia pastoris and expression after methanol 
induction is now under study 
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7.3. GERMANY 
REPORTER: Professor H. Zahner 
Institute for Parasitology 
Justus Liebig University 
Giessen 
Changes of epithelial ion transport by intracellular coccidia stages (S. Kowalik et al.) 
Coccidia rely on their host cells for energy supply and nutrition and cause clinical signs as 
diarrhoea. Changes of ion transport systems in the host cells may be involved in these processes. 
An in vitro system was therefore established to study the effects of coccidian parasites on ion 
transport systems in epithelial tissues. It used HT29/B6, a human colon carcinoma cell line, which 
builds a polarised monolayer like an epithelium. Toxoplasma gondii served as a model parasite as 
tachyzoites invade HT29/B6 and replicate rapidly. Mature schizonts are formed within 20 h and 
merozoites are released after 24 - 30 h. Ion transport was measured in a special perfusion 
chamber (ussing system). Parameters determined were: short circuit current and conductance to 
record the electrogenic ion transport, chloride fluxes with 36C1 (mucoserosal, seromucosal) and 
the paracellular water transport with 3H-mannitol. Measurement was performed 5 h, 10 h and 15 
h post infection using monolayers in which approximately 30% of the cells were parasitised. The 
infection had rapid effects on the conductance of infected monolayers , which was two to three 
times higher than that of uninfected HT29/B6 monolayers throughout the observation period. 
Chloride fluxes of both directions were also increased two to three times when compared to 
uninfected cells, independent of the time after infection. However, the chloride netto fluxes and 
short circuit currents were unaffected by the parasites. Data on the paracellular water transport 
will show whether the increased chloride fluxes and conductances are due to a higher chloride 
transport through the cells or through paracellular pathways. 
Immunity in rats against Eimeria separata, a coccidial parasite of the large intestine (M. Q. 
Shi et al. ) 
The study aimed to characterise the local reactions in the caecum of naive rats and rats immune 
against E. separata to a primary and a challenge infection, respectively. Optimum immunity was 
induced by two infections with 5000 oocysts per animal each, given in a 10 days interval. The 
oocyst production of a challenge infection administered after further 10 days was almost 
completely abolished. Histopathological investigations performed up to 72 h after challenge 
showed, that predominantly the development of first generation schizonts were affected in 
immune rats. 
Challenged animals showed significantly increased infiltrations with lymphocytes, plasma cells, 
macrophages, eosinophils and mast cells when compared with rats after primary infection. 
Immunohistological studies compared local tissue infiltrations in naive and immune rats over a 
period of 48 h after primary infection and challenge, respectively. There was no difference 
between the groups concerning CD45R+ cells, whereas significantly more CD3+ cells were found 
in the caecum wall of the immune rats. CD4+cells predominated in animals after primary infection, 
whereas CD8+ cells represented the predominant Τ cell subset in challenged rats. The proportion 
of γδ+ Τ cells did not differ between the groups, whereas challenged rats showed significantly 
increased numbers of αβ+ Τ cells in the caecum wall, when compared with animals after a primary 
35 
infection. These findings suggest that predominantly CD4^ cells may be involved in the immune 
response after primary infection, and that immunity to a challenge infection may be mediated by 
CD3+, CD8+ and αβ+ Τ cells. 
Development of effective in vitro methods for excystation of sporozoites (S. Kowalik et al.) 
In vitro studies with coccidia are sometimes hampered by a lack of suitable protocols for the 
isolation of viable sporozoites. Thus, in case of Eimeria separata, a parasite of the large intestine 
of rats, none of the techniques described for other coccidia was found sufficient. Therefore a 
method was developed particularly suitable for this parasite. The procedure uses conditions which 
resemble the in vivo environment. A first treatment of the oocysts in a 0.4 % pepsin/HCl solution 
alters the oocyst wall, which becomes thinner. The second treatment in a 0.4 % trypsin/0.75 % 
taurocholate medium breaks the oocyst wall and sporocysts release. A third incubation of the 
oocyst-sporocyst mixture in a trypsin-free medium with 0.75 % taurocholate and an additive of 
MgCli followed by a final incubation in medium RPMI with 1 % foetal calf serum yields an 
excystation of sporozoites up to 90 %. 
Phophocholine epitopes in Eimeria bovis (Β. Heise et al.) 
Phosphocholine (pc) epitopes are well known in parasitic helminths and seem to be involved in 
immunoregulative processes. In parasitic protozoa there is no information on this posttranslational 
modification. Studies with TEP15, a myeloma protein which specifically recognises PC showed 3 
reactive molecules of 66, 70 and 75 kDa in E. bovis merozoites I. PC epitopes are localised on the 
surface of merozoites and sporozoites in relative large amounts and can be removed by treatment 
with methanol or phospholipase C. Together with other data the results suggest that PC is linked 
to glycosphingolipids as they were described in Ascaris spp. Methanol treatment disclosed 
additional TEPC15-reactive material in an apical subpellicular, cap-like structure. Current 
experiment attempt to isolate PC-bearing molecules for fürther detailed characterisation. 
REPORTER 
Privatdozent Dr. Franz J. Conraths 
Direktor und Professor 
Institut für epidemiologische Diagnostik 
Bundesforschungsanstalt für Viruskrankheiten der Tiere 
Seestr. 55, D-16868 Wusterhausen 
1 Report on Vnth International Coccidiosis Conference/COST820 Annual Workshop 1997 
Together with Dr Ν. Smith, Professor Η. D. Chapman and Dr Anna Lundén I wrote a conference 
report which was published in Parasitology Today 14, 215-218. 
2 COST820 Annual Workshop 1998, Toledo, Spain 
I contributed to the general scientific planning of the conference, provided data about the 
economic impact of bovine neosporosis in Germany (presented as part of a European overview by 
Dr J. Wastling) and acted as a chairperson in one of the scientific sessions. 
36 
3 Management Committee (MC) 
As one of the German members, I attended two meetings of the MC held on 25 February, 1997, 
in Woking, United Kingdom, and on 22nd October 1998 in Toledo, Spain. Together with Dr 
Astrid M. Tenter, Dr Fiona Tomley, Professor B. Gottstein and Dr F. Spano I work on the design 
of networking activities in the field of coccidiosis research beyond COST820. 
4 Involvement in Working Group 4 "Toxoplasmosis, Sarcocystiosis, Neosporosis" 
As a result of the activities of Working Group 4,1 co-ordinated the preparation of a research 
proposal on diagnostic and epidemiological aspects of bovine neosporosis which was submitted to 
the FAIR Programme. 
5 Exchange of expertise and material 
As a consequence of scientific contacts and discussions at COST820 meetings, expertise and 
materials were exchanged with several scientists participating in the COST820 action. 
7.4. ITALY 
REPORTER: Dr. Furio Spano 
Istituto di Parassitologia, 
Università di Roma "La Sapienza", 
Piazzale A. Moro, 5, 
Box 6 Roma 62, 
00185 Rome, Italy 
Participants to the research: 
Furio Spano, Lorenza Putignani, Irene Ricci, Manlio Di Cristina 
Istituto di Parassitologia, Università di Roma "La Sapienza", Piazzale A. Moro, 5, 
Box 6 Roma 62, 00185 Rome, Italy. 
Andrea Crisanti 
Department of Biology, Alexander Fleming Building, Imperiai College, 
Imperiai College Road, London SW7 9AX, U.K. 
Progress report: 
a) Cloning of Cryptosporidium parvum proteins with adhesive properties. 
In our search for Cryptosporidium proteins potentially involved in the invasion process we have 
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recently cloned a C. parvum cDNA encoding a polypeptide, named sporozoite cysteine-rich protein 
(SCRP), possessing the following structural features: i) a leader peptide, ii) three thrombospondin-
like repeats, iii) one EGF-like domain and iv) a transmembrane sequence. SCRP is the second 
thrombospondin-related protein identified in C. parvum that adds to TRAP-Cl (Spano et al., Mol. 
Biochem. Parasitol. 92: 147-162, 1998), a micronemal protein recently cloned in our laboratory 
sharing structural similarity with EtplOO of.E. tenella and MIC2 of T. gondii. The SCRP gene is 
highly expressed in C. parvum sporozoites, where the protein seems to accumulate in the apical 
portion of the parasite. Work is in progress to establish the exact sub-cellular location of SCRP and 
assess its possible involvement in sporozoite gliding motility and/or host cell invasion. 
b) Analysis of genetic variation in Cryptosporidium parvum. 
Our interest in C. parvum has recently extended to the study of the parasite genetic variation. Most 
of the C. parvum typing studies carried out to date are based on the analysis of single 
polymorphisms. A multilocus approach has the potential to better define the structure of the C. 
parvum population and assess the degree of genetic isolation of the H (genotype 1) and C (genotype 
2) subpopulations. With this in mind we genotyped 28 C. parvum isolates of various host and 
geographical origin by simultaneously analysing up to five polymorphic loci belonging to at least 
three distinct linkage groups. Isolates were from Europe, North and South America and Australia. 
Seventeen isolates originated directly from humans, 3 were derived from humans and propagated in 
calves, and 8 were from various animals. Human isolates were both from sporadic cases and from 
documented outbreaks. Two isolates were derived from AIDS patients. Animal samples included 
the widely used Moredun and GCH1 isolates. The five polymorphic loci selected for this study have 
been shown to consist of at least two alleles differentially associated with animal or human C. 
parvum isolates. Four of the genetic markers were analysed by polymerase chain reaction-
restriction fragment length polymorphism (PCR-RFLP) assays and corresponded to the protein-
encoding genes Cryptosporidium Oocyst Wall Protein (COWP) (Spano et al., FEMS Microbiol. 
Letters 152: 209-217, 1997), polythreonine (polyT) (Carraway et al., Infect. Immun. 65: 3958-
3960, 1997), thrombospondin-related adhesive protein of Cryptosporidium-! (TRAP-Cl) (Spano 
et al., Mol. Biochem. Parásito! 92: 147-162, 1998) and ribonucleotide reductase (RNR) Rl 
subunit. The fifth polymorphism, residing within the internal transcribed spacer region 1 (ITS1) of 
the Type A ribosomal unit, was analysed by PCR employing genotype-specific primers (Carraway 
et al., Appi. Environ. Microbiol. 62: 712-716, 1996). Consistent with previous studies, isolates 
segregated into two groups, one comprising both human and animal isolates, the other only isolates 
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of human origin. No recombinant genotype was detected. This evidence, together with the broad 
geographical distribution of the multilocus genotypes identified, brings further support to the 
hypothesis that C. parvum reproduction is substantially clonal. 
c) Molecular characterization of novel S AGI-related Toxoplasma gondii antigens. 
The invasive stages of the apicomplexan parasite Toxoplasma gondii are known to express a set of 
surface antigens, known as the SAG proteins, sharing structural and functional characteristics. 
These molecules, which are anchored to the plasmamembrane via a GPI motif, are differentially 
expressed in sporozoites, tachyzoites and bradyzoites and are believed to play a role in the early 
steps of host cell invasion. The most extensively characterised among the SAG proteins are SAG1 
(p30), which is expressed exclusively in the tachyzoites and represents the immunodominant 
antigen during T. gondii infection (Burg et al., J. Immunol. 141: 3584-3591, 1988) and SAG3 
(p43), which is present in all invasive stages (Cesbron-Delauw et al., J. Biol. Chem. 269: 16217-
16222, 1994). These two molecules share approximately 40% amino acid identity and the presence 
of two amino acid repeats each containing 6 cysteine residues at conserved positions. T. gondii 
lines defective for either SAG1 or SAG3 have been shown to possess a reduced invasive activity. 
Recently, a series of novel T. gondii proteins sharing close structural similarity with S AGI and 
SAG3 have been identified: SRS1-4 and BSR4 by Boothroyd and co-workers (Hehl et al., Mol. 
Biochem. Parasito!. 89: 271-282, 1997) and SAG5 in our laboratory. 
A portion of the SAG5 gene was accidentally amplified from the genomic DNA of T. gondii (RH 
strain) employing unrelated primers. The PCR product 12G/16, encoding a 212 amino acid-long 
polypeptide showing a significant homology to both S AGI and SAG3, was used as a probe to 
screen a genomic T. gondii cosmid library. Southern blot analysis of the positive cosmid clones and 
of T. gondii genomic DNA employing the 12G/16 fragment as a probe yielded complex 
hybridisation patterns, suggesting the existence, in the genome of T. gondii, of a family of related 
genes. Extensive sequence analysis confirmed this hypothesis and revealed the presence of three 
tightly clustered genes encoding closely related proteins, denominated SAG5.1, SAG5.2 and 
SAG5.3. Al three polypeptides show the hallmarks of the family of S AGI-related molecules, being 
characterised by a leader peptide, 12 cysteine residues whose distribution suggests a tandem 
duplication of an ancestral 6-cysteine motif and a C-terminal GPI-anchoring signal. SAG5.2 and 
SAG5.3 are 367 amino acid-long and differ from each other at 8 amino acid positions (98% 
identity), while SAG5.1, which consists of 362 amino acids, is virtually identical to the other two 
SAG5 proteins only within the C-terminal region (positions 162-362). Notably, in the N-terminal 
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half of the molecule the degree of amino acid identity to SAG5.2/SAG5.3 drops to approximately 
40%, which represents the average homology shared by all members of the "SAG1" protein family. 
Northern blot and RT-PCR analysis of poly(A)+ RNA showed that all three SAG5 genes are 
expressed in tachyzoites. The transcriptional activity in the other invasive stages is under study. The 
Localization of the SAG5 proteins in T. gondii tachyzoites was investigated by 
immunofluorescence and immunoblot employing polyclonal antibodies raised against recombinant 
histidine-tagged fragments of SAG5.3 and SAG5.1 produced in E. coli and affinity purified by 
nickel chelate chromatography. SAG5.2 and SAG5.3 appear to be exposed on the parasite 
plasmamembrane, while the localisation of SAG5.1 will require fürther investigation. 
Publications 
• Spano, F., Putignani, L., Naitza, S., Puri, C , Wright, S. and Crisanti, A. Molecular cloning and 
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and Thompson, R.C Α . (1998). Molecular characterisation of'Cryptosporidium from various 
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3255-3259, 1998. 
• Widmer, G., Tchack, L., Spano, F. and Tzipori, S. A study of Cryptosporidium parvum 
genotypes and population structure. Memorias do Instituto Oswaldo Cruz 93: 685-686, 1998. 
• Naitza, S., Spano, F., Robson, K.H.J, and Andrea Crisanti. The thrombospondin related protein 
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COST820 Meetings 
• Participation to the annual COST820 general meeting: "Vaccines against animal coccidioses". 
Toledo, Spain, 22-25 October, 1998. 
• Organisation of the COST820/WG1-WG6 joint meeting: "Transfection and whole genome 
approaches to gene discovery and function: the way forward for vaccine research in 
coccidians?". Grottaferrata (Rome), Italy, 19-21 June, 1998. 
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Avian coccidiosis - Working Group 1 
PCR methods for species identification 
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A polymerase chain reaction (PCR) assay, based on the amplification of internal transcribed spacer 1 
(ITS1) regions of ribosomal DNA, was developed for the chicken coccidian species Eimeria maxima, E. 
mitis and E. praecox. Thus, in combination with our previous work (5), a complete set of ITS 1 based, 
species­specific primers for the detection and discrimination of all seven Eimeria species that infect the 
domestic fowl is now available. 
ITS1 primers for each of these seven species of Eimeria were further tested and evaluated in field 
samples. Additionally, they could be used as capture probes in a colormetric paper chromatography 
assay (PACHA). The addition of PACHA to the PCR assay provided a faster, more simplified 
alternative to the visualisation of PCR fragments by ethidium bromide staining and can be a useful 
approach in epidemiological studies (6­12). 
Alternatives to coccidiostats 
Non­chemotherapeutic means to control coccidiosis in broiler chickens have been studied in a 
series of experiments (13­14). In Sweden antimicrobial and growth promoting feed additives are 
not routinely used. Since some anticoccidials have antibacterial as well as anticoccidial effects, we 
have also studied how such substances affect the bacterial flora of the gut (2­3). 
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14. Waldenstedt, L. (1998). Coccidial and clostridial infections in broiler chickens - influence of 
diet composition, PhD thesis, Swedish University of Agricultural Sciences, Uppsala, Sweden. 
Acta Universitatis Agriculturae Sueciae, Agraria 88. ISBN 91-576-5536-7. 
Sarcocystiosis, toxoplasmosis and neosporosis - Working Group 4 
Serological surveys of Ν caninum infections 
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An ELISA based on N. caninum antigens incorporated into iscoms (immune stimulating 
complexes) has previously been developed (1-2). It has been used for serological studies ofN. 
caninum infections in dogs, cattle and water buffaloes. 
In a study comprising 80 dogs from the Czech and Slovak Republics, the sera were analysed for 
antibodies to N. caninum by the iscom ELISA and the indirect fluorescent antibody test (IFAT). 
One (1.3%) of the sera tested positive in both assays. Retrospective studies of the records of this 
dog revealed that it had shown clinical symptoms suggestive of N caninum-infecúon (7). 
Serum samples from 200 dairy cattle and 200 beef water buffaloes were collected in southern 
Vietnam during May to September 1995. The sera were analysed for antibodies to N. caninum by 
the iscom ELISA and IF AT and for antibodies to Toxoplasma gondii by the direct agglutination 
test. Significant levels of N. caninum antibodies were detected in 5.5% of the cattle sera and in 
1.5% of the water buffalo sera. 10.5% of the cattle sera and 3% of the water buffalo sera were 
found to contain T. gondii antibodies. Two of the cattle sera had both T. gondii and TV. caninum 
antibodies. The present communication is the first to report serological evidence of N. caninum 
infection in the water buffalo (5). 
In collaboration with scientists from Hungary, 97 sera from dairy cows that had aborted were 
analysed for antibodies to N caninum and other infectious agents known to cause bovine abortion. 
Antibodies to N caninum were found in 10% of the cows indicating that this parasite might be a 
cause of abortion in Hungarian cows (4). 
As part of a study comprising 1439 Norwegian dairy goats in 22 herds experiencing abortion 
problems, sera from 80 goats which had lost their foetuses and 25 goats with normal pregnancies 
were analysed for antibodies to N. caninum. Twenty three foetal brains were examined 
histologically and immunohistochemically for Af. caninum. No evidence ofN. caninum infection 
was found by any of the methods (3). 
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Oral M caninum infection in neonatal calves 
Out of 4 calves dosed orally soon after birth withN. caninum tachyzoites mixed with colostrum, 2 
became infected as shown by serological reactions and demonstration of N caninum in their brains 
by PCR (12-14). The data suggest that oral infection ofN. caninum via colostrum is a possible 
route of vertical transmission in newborn calves, in addition to transplacental infection. 
Experimental N caninum infection in pigs 
At the Danish Veterinary Laboratory, experimental infection of 6 pregnant gilts with the bovine N. 
caninum isolate Nc-SweBl was performed (6). A l gilts showed evidence of generalized infection, 
and, in one of them, transplacental transmission of the parasite to three foetuses was demonstrated. 
The study showed that N caninum readily establishes in the pig and has the potential to be 
transmitted transplacentally to the offspring of infected sows. 
Immunisation of mice against neosporosis 
The possibility of inducing protection against N caninum infection by immunisation, was 
investigated using a BALB/c mouse model. It was found that immunisation of mice with live 
parasites or parasite antigens either mixed with the saponin Quii A or incorporated into iscoms 
resulted in at least partial immunity against experimental neosporosis. In contrast, immunisation 
with parasite antigen without any adjuvant appeared to increase the susceptibility to infection (8-9). 
Sarcocystis species in water buffaloes in Vietnam 
Studies on Sarcocystis species of the water buffalo in Vietnam have been continuosly performed by 
a veterinary PhD student at at SWEPAR. Previously, three species of the water buffalo have been 
recognised, namely S. fusiformis, S. buffalonis and S. levinei.. During 1998, a paper describing a 
fourth bubaline species, S. dubeyi, was accepted for publication in the Journal of Parasitology, due 
out in January 1999. 
Recognition of a Sarcocystis species in otter (Lutra Intra) 
A paper describing the finding of large numbers of sarcocysts in the skeletal muscles of an otter in 
Sweden constitutes the first report of Sarcocystis infection in this species (15). The sarcocysts were 
0.3 - 2.3 mm long and 0.06 - 0.25 mm wide, and ultrastructurally they had a serrated surface 
without any visible projections. The otter, although mainly a predatory animal, may serve as 
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intermediate host for a Sarcocystis species that completes its life­cycle in a not yet identified 
carnivore, or it may in this case have acted as accidental host due to possible immunosuppression. 
Publications 
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using monoclonal antibodies. Parasite Immunology, 20, 73­80. 
2. Björkman, C. and Lundén, A (1998). Application of iscom antigen preparations in ELISAs for 
diagnosis of Neospora and Toxoplasma infections. International Journal for Parasitology, 28, 
187­193. 
3. Engeland, I.V., Waldeland, H., Andresen, 0., Løken, T., Björkman, C. and Bjerkås, I. (1998). 
Foetal loss in dairy goats: an epidemiological study in 22 herds. Small Ruminant Research, 30, 
37­48. 
4. Hornok, S., Näslund, K., Hajtos, I., Tanyi, J., Tekes, L., Varga, I., Uggla, A. and Björkman, C. 
(1998). Detection of antibodies to Neospora caninum in bovine postabortion blood samples 
from Hungary. Acta Veterinaria Hungarica, 46, 431­436. 
5. Huong, L.T.T., Ljungström, B.­L., Uggla, A. and Björkman, C. (1998). Prevalence of 
antibodies to Neospora caninum and Toxoplasma gondii in cattle and water buffaloes in 
southern Vietnam. Veterinary Parasitology, 75, 53­57. 
6. Jensen, L., Jensen, T.K., Lind, P., Henriksen, S.­A, Uggla, A. and Bille­Hansen, V. (1998). 
Experimental porcine neosporosis. Acta Pathologica, Microbiologica et Immunologica 
Scandinavica, 106, 475­482. 
7. Koudela, B., Svoboda, M., Björkman, C. and Uggla, Α. (1998). Neosporosis in dogs ­ the first 
case report in the Czech Republic. Veterinary Medicine ­ Czech, 43, 51­54. 
8. Lundén, Α., Alen, J.E., Buxton, D. and Wright, S. (1998). Immunisation of mice against 
neosporosis. COST 820 Annual Workshop, Toledo, Spain, p. 64. 
9. Lundén, Α., Alen, J.E., Buxton, D. and Wright, S. (1998). Immunisation of mice against 
neosporosis. International Veterinary Immunology Symposium, Ludhiana, Punjab, India, ρ 147. 
10. Lundén, Α., Marks, J., Maley, S.W. and Innes, EA. (1998). Cellular immune responses in 
cattle experimentally infected with Neospora caninum. Parasite Immunology, 20, 519­526. 
11. Marks, J., Lundén, Α., Harkins, D. and Innes, E A. (1998). Identification of Neospora antigens 
recognised by CD4+ Τ cells and immune sera from experimentally infected cattle. Parasite 
Immunology, 20, 303­309. 
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12. Uggla, A , Stenlund, S., Holmdahl, O.J.M., Jakubek, E.­B., Thebo, P., Kindahl, H. and 
Björkman, C. (1998). Neospora caninum: Is oral transmission a possible route of infection? 
Annual COST 820 Workshop, Toledo, Spain. 
13. Uggla, Α., Stenlund, S., Holmdahl, O. J. M., Jakubek, E.­B., Thebo, P., Kindahl, H. and 
Björkman, C. (1998). Oral Neospora caninum inoculation of neonatal calves. International 
Journal for Parasitology, 28, 1467­1472. 
14. Uggla, A , Stenlund, S., Holmdahl, O. JM., Jakubek, E.­B., Thebo, P., Kindahl, H., Schnitzler, 
B. E. and Björkman, C. (1998). PCR­based detection of Neospora caninum in newborn calves: 
galactogenic transmission as a possible route of infection. Proceedings of the 11th Japanese­
German Symposium on Protozoan Diseases, Chiba, Japan, p. 46. 
15. Wahlström, K., Nikkilä, T. and Uggla, Α. (1998). Sarcocystis species in skeletal muscle of 
otter (Lutra lutra). Parasitology, 118, 59­62. 
Immunology and cell biology ­ Working Group 6 
Molecular biology of T. gondii 
We have previously used an RNA display technique to identify genes that are down­regulated in an 
avirulent T.gondii mutant. One of these genes have now been characterised in detail. The gene 
encodes for a 36.2 kDa large surface protein that is expressed in tachyzoites (1). Sequence analysis 
suggests that this protein most likely carries a signal peptide that is of importance for its targetting 
to the surface, and Western blot data suggest that this signal peptide is cleaved off during 
maturation. Preliminary experiments with antibodies raised against a recombinant form of the 
protein localise the native protein to the apical end of the parasite. Studies are now underway to 
determine its importance for virulence. 
In collaboration with Dr. J. Wastling, University of Glasgow, UK, a number of T. gondii mutants 
overexpressing a cell­cycle dependent kinase have been constructed (2). On a short term scientific 
mission within the COST 820 framework, during the summer of 1998, Dr. Wastling visited 
SWEPAR where he studied the integration of novel genes into the genome of T. gondii. 
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1. Mattsson, J.G., Ljunggren, E., Bergström, K. and Soldati, D. (1998). Identification of a novel 
surface protein of Toxoplasma gondii using RNA display. Proceedings of the COST 820 
Annual Conference on Coccidiosis, Toledo, Spain. 
2. Wastling, J.M., Kinnaird, J.H. and Mattsson, J.G. (1998). Investigating the functional 
significance of Toxoplasma gondii cdc2-related kinases. Proceedings of the COST 820 
Meeting on Coccidiosis, Rome, Italy. 
7.6. SWITZERLAND 
REPORTERS: 
Research group members: A. Hemphill, S. Eperon, S. Sonda, N. Fuchs, H. Sager, B. Gottstein 
(Institute of Parasitology, University of Berne) 
Research on Neospora caninum and neosporosis: 1998 
Part 1. Identification and characterisation of cell surface-associated- and intracellular 
antigens in N. caninum tachyzoites 
Results based on a polyclonal anti-N. caninum antiserum: The approach used in our laboratory 
to identify possible parasite molecules involved in host cell entry was based on the rationale that 
these molecules must, at some stage, interact with membrane components. Thus, to identify 
membrane-interacting proteins ofN. caninum tachyzoites, purified tachyzoites were fractionated 
using the non-ionic detergent Triton-X-114. We were successful in the identification, 
characterisation and purification of three antigenically reactive bands of approximately 43, 36 and 
33 kDa, as described earlier. Nc-P36 exhibits a striking amino acid sequence similarity (76.3% 
similarity with 51.3% identities) to P30 (SAG1) the major T. gondii tachyzoite surface protein 1 
which has previously been shown to serve as attachment factor. The deduced amino acid sequence 
ofNc-P43 was also determined (Genbank accession No. U93870). Comparison of theNc-P43 
sequence with Toxoplasma surface antigens shows a high degree of similarity to the members of 
the family of S AGI-related antigens, with the highest similarity (44% identical amino acids) to the 
SAGl-related sequence 2 (SRS2) protein (GenBank accession No. AF012276). The degree of 
conservation is less than for the SAG1/Nc-P36 pair, but more careful analysis unambiguously 
shows the preservation of an overall architecture which is a hallmark for the members of this family 
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of GPI­anchored surface antigens. Al 12 cysteine residues in the mature proteins after cleavage of 
the putative N­terminal signal sequence can be aligned without introduction of significant gaps. 
Further biochemical evidence with regard to GPI­anchoring of Nc­P43 and Nc­P36 was provided 
in a collaboration with PD Dr. Peter Büttikofer's group at the Institute of Biochemistry and 
Molecular Biology of the Medical Faculty at the University of Bern by performing in vivo 
metabolic labelling ofN caninum tachyzoites using ^H­ethanolamine (which incorporates almost 
uniquely into GPI­anchors) and subsequent immunoprecipitation of respective proteins using 
specific antibodies. 
Part 2. Murine model for/V. caninum infections, immunology and the role of NO. 
A mouse model for N caninum infections was established in our laboratory. It is comprised of B­
cell­deficient antibody knock­out mice (C57BL/6 mice with a transgenic mutation in the 
transmembrane exon of the IgM μ chain gene; μΜΤ mice) and the corresponding parental strain 
C57BL/6. Wild type (wt) mice exhibited no symptoms upon an infective dose of 105 parasites / 
mouse, while the μΜΤ mice succumbed to lethal infection within 29­31 days p.i. PCR­analyses 
showed that more organs with a significantly higher infection and multifocal necrotic lesion 
intensity were parasitised in μΜΤ mice than in wt mice. In both wt and μΜΤ mice infected with 
live parasites, spleen cells stimulated with Nc­antigen produced high levels of IFN­γ and EL­10 in 
comparison to mice immunised with dead parasites. μΜΤ spleen cells produced less EL­10 than wt 
splenocytes, the phenomenon became more evident with increasing time of infection. No EL­4 
production was detected in either mouse strain. Infected mice produced higher amounts of EL­2 
than control mice inoculated with dead parasites, but no significant differences were seen between 
wt and μΜΤ mice. Splenocyte proliferation was actively suppressed by live N. caninum infection. 
Expression of inducible nitric oxide synthase (iNOS) was monitored on brain sections using an anti­
murine iNOS antibody detected by the peroxidase method. The sections were subsequently 
immunolabelled with an anti­AA. caninum antibody detected by the alkaline phosphatase method. In 
wt mice, parasite tachyzoites were found only at extremely low numbers in the brain and no iNOS 
could be detected in any brain cell. Conversely, in the brain of μΜΤ mice, multifocal lesions were 
seen: numerous parasites, often clustered, were present around a central necrotic lesion. In this 
heavily infected region and in the more peripheral region as well, numerous macrophage­like cells 
were iNOS­positive. Spleen cells obtained from mice infected for 10 and 24 days were in vitro 
cultivated during 72 h in presence of either crude extract antigen from N. caninum or from 
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Toxoplasma gondii or LPS. Cells from μΜΤ mice infected for 10 days produced nitric oxide (NO), 
whereas those from infected wt mice did not produce any NO. These results suggest that Ν 
caninum increases both expression of iNOS and production of NO in cells of brain and spleen. The 
lethal outcome ofN. caninum-mÍQCúon in B­cell deficient mice may be partially explained by an 
overproduction of NO. 
Part 3. Vaccination studies 
Two types of vaccination studies are currently being carried out, using the murine model 
established in our lab. In collaboration with Camilla Björkman's group in Uppsala, passive 
immunisation with anti­iVeasporø­ISCOMs mAbs in μΜΤ antibody knock­out mice is investigated, 
while active immunisation trials with recombinant Nc­P43 and Nc­P36 are performed using the 
parental C57BL/6 mouse strain. Planning of a third vaccination trial employing DNA vaccination of 
C57BL/10 mice (with cDNA corresponding to Nc­P43 and Nc­P36) is in progress. 
Part 4. Bovine neosporosis and epidemiology 
Neospora caninum has been recognised as one of the major protozoal abortion­inducing parasites 
in Swiss cattle. Diagnostic tools were initially validated upon experimental infection protocols. PCR 
was positive predominantly for the foetal brain and, additionally, for the abomasal and amniotic 
fluid of foetuses derived from experimentally infected heifers. The heifers seroconverted between 
day 10 to 17 p.i., foetuses remained serologically negative in all cases. By using these validated 
diagnostic methods, we have recently determined first prevalence data for the live­stock production 
in Switzerland. Thus, Neospora-DNA was detected by PCR in 24 brains (29%) from 83 bovine 
abortions, many of these brains were simultaneously characterised by histopathological findings 
typical for a protozoal, cerebral parasitosis. In another study we obtained first data on the 
Neospora- and 7bxop/asma­seroprevalence in Swiss cattle. We tested 1,689 sera obtained from 
113 dairy farms: The seroprevalence was 11.5% forAfeospora­SA­ELISA and 10.7% for 
7bxop/as/wa­P30­ELISA. From the same samples, 1.1%, less than statistically expected, were 
positive in both ELISAs. Within selected groups of beef cow­calf farms, the seroprevalence using 
the Neospora-SA-ELISA was 14% for dams and 15% for offspring calves. Seroprevalences 
determined by 7bxop/a5wa­P30­ELISA were 8% for dams and 3% for calves, respectively. None 
of the sera were double­positive by both ELISAs. In order to investigate the epidemiological 
situation in Switzerland further, a case­control­study covering six regions of Switzerland is 
presently performed. 
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7.7. UK 
REPORTER:Dr D. Buxton 
Pentlands Science Park, Bush Loan, by Edinburgh EH26 OPZ, Scotland, UK. 
Publications from the Moredun Research Institute, Pentlands Science Park, Bush Loan, by 
Edinburgh EH26 OPZ, Scotland, UK. 
Working Group 3 (Cryptosporidiosis and cyclosporosis). 
1. Spano F, Putignani 1, Naitza S, Puri C, Wright S E. Crisanti Α. (1998). Molecular cloning and 
expression analysis of a Cryptosporidium parvum gene encoding a new member of the 
thrombospondin family·. Molecular and Biochemical Parasitology: 92 147-162. 
2. Coop R L, Wright S E, Casemore D P. (1998). Cryptosporidiosis. Ch.45. 563-578. 
Zoonoses. Biology, Clinical Practice and Public Health Control. Eds. Palmer, Soulsby and 
Simpson. Oxford University Press. 
Working Group 4 (Sarcocystiosis, Toxoplasmosis and Neosporosis). 
Papers in refereed scientific journals. 
1. Buxton, D. (1998). Protozoan infections (Toxoplasma gondii, Neospora caninum and 
Sarcocystis spp.) in sheep and goats: recent advances. In Veterinary Research Ed M. Pepin, 
29,289-310. 
2. Osawa, T., Wastling, J., Maley, S., Buxton, D. and Innes, E A . (1998). A multiple antigen 
ELISA to detect Neospora-specific antibodies in bovine sera, bovine foetal fluids, ovine and 
caprine sera. Veterinary Parasitology. 79, 19-34. 
3. Buxton, D., Maley, S.W., Wright, S., Thomson, K.M., Rae, A G . and Innes, E A . (1998). The 
pathogenesis of experimental neosporosis in pregnant sheep. Journal of Comparative 
Pathology. 118, 267-279. 
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Buxton, D. (1998). Western blot analysis of the IgG responses of ruminants infected with 
Neospora caninum and Toxoplasma gondii. Journal of Comparative Pathology 119, 45­55. 
5. Gonzalez, L., Buxton, D., Atxaerandio, R., Aduriz, G , Maley, S., Marco, J.C., Cuervo, LA. 
(1999). Bovine abortion associated with Neospora caninum in Spain. Veterinary Record (in 
press). 
6. Björkman, C , Näslund, K., Stenlund, S., Maley, S.W., Buxton, D. and Uggla, Α. (1999). An 
IgG avidity ELISA for the estimation of recency in bovine Neospora caninum infection. 
Journal of Veterinary Diagnosis and Investigation (in press). 
7. Marks, J, Lundén, Α., Harkins, D. and Innes, E. (1998). Identification of Neospora antigens 
recognized by CD4+ Τ cells and immune sera from experimentally infected cattle. Parasite 
Immunology, 20, 303­309. 
8. Lundén, Α., Marks, J., Maley, S.W. and Innes, E A . (1998). Cellular immune responses in cattle 
experimentally infected with Neospora caninum. Parasite Immunology, 20, 519­526. 
9. Ferguson D Ρ J, Wright S E. (1998). An ultrastructural study of the host/parasite relationship of 
Toxoplasma gondii during enteric development in the small intestine of the cat. Electron 
Microscopy. Volume IV 335­336 
REPORTER: Dr J M Wastling 
In August 1998 a Short Term Scientific Mission funded under the COST 820 programme enabled 
Dr Jonathan Wastling of the University of Glasgow, United Kingdom, to spend a week at the 
laboratory of Dr Jens Mattsson of the Swedish National Veterinary Institute, Uppsala, Sweden. 
This collaboration arose directly as a result of the COST820 programme. The objectives of this 
visit were: 
1. To strengthen the collaborative link between the University of Glasgow, United Kingdom, and 
the Swedish National Veterinary Institute, Uppsala, Sweden, particularly in the area of research 
into cyclin­dependent kinases of Toxoplasma gondii. 
2. To enable the application of the technique of stable transformation of T.gondii to investigate the 
functional role of Toxoplasma CDKs. 
3. To investigate collaborative projects and funding opportunities that might arise from the 
collaboration between Glasgow University and the Swedish National Veterinary Institute. 
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4. For Dr Wastling to meet other members of the Swedish National Veterinary Institute as well as 
other academic members of Uppsala University. 
5. For Dr Wastling to present a seminar to the Swedish National Veterinary Institute on current 
research in Glasgow with the objective of highlighting areas of mutual interest between the two 
institutions, especially those topics relevant to the COST820 programme. 
The funds provided by the European Commission under the Short Term Scientific Mission enabled 
the above objectives to be fulfilled. A strong link encompassing a number of scientific projects has 
now been established between the two institutions. Future studies on the use of yeast­two hybrid 
technology for detecting molecules that interact with T.gondii cyclin­dependent kinases and on 
reverse genetic technologies for determining gene function were planned during the visit. This work 
is currently in progress in the respective laboratories. 
Attendance at two subsequent WG meetings in Rome and Toledo was also made possible by 
funding under the COST820 programme. These subsequent meetings were valuable in sustaining 
the outcomes of the Short Term Scientific Mission. 
Publication List 1998 
Working Group Rommel/Tenter, 
Tierärztliche Hochschule Hannover, Germany 
Papers 
• Carreno, RA., Schnitzler, Β.E., Jeffries, A.C., Tenter, A.M., Johnson, A.M., Baita, J.R.: 
Phylogenetic analysis of coccidia based on 18S rDNA sequence comparison indicates that 
Isospora is most closely related to Toxoplasma and Neospora. J. Euk. Microbiol. 45, 184­188, 
1998 
• Daugschies, Α., Rupp, U., Rommel, M.Blood clothing disorders during experimental 
sarcocystiosis in calves. Int. J. Parasitol. 28, 1187­1194, 1998 
• Daugschies, Α., Gäßlein, U., Rommel, M. Comparative efficacy of anticoccidials under the 
conditions of commercial broiler production and in battery trial. Vet. Parasitol. 76, 163­171, 
1998 
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Heckeroth, A.R., Tenter, A.M.: 
18S rDNA based PCR: The first test for in vivo diagnosis of acute sarcocystiosis in sheep. IXth 
International Congress of Parasitology, Makuhari Chiba, Japan, 24.-28.8.1998. In: Parasitology 
into the 21st Century, Parasitol. Int., 47, 233 
Heckeroth, A.R., Tenter, A.M.: 
Comparison of immunological and molecular methods for the diagnosis of infections with 
pathogenic Sarcocystis spp. in sheep. In: 11th Japanese-German Cooperative Sympsosium on 
Protozoan Diseases, Isehara, Japan, 29.-31.8.1998 
Mugridge, N.B., Morrison, D., Johnson, A.M., Votypka, J., Tenter, A.M.: 
Phylogeny of the family Sarcocystidae. In: Proc. Annual Scientific Meeting Australian Society for 
Parasitology, Melbourne, Australia, 27.9.-1.10.1998 
Tenter, A.M.: 
• Life cycles, taxonomy and genetic relationships of intestinal coccidia of pigs. In: Proc. COST 
820 "Vaccines against coccidiosis", Meeting Working Group 2, Weybridge, UK, 27.2.1998 
• Bedeutung von molekularen phylogenetischen Untersuchungen für die Klassifikation und 
Taxonomie von Kokzidien mit Oozysten vom Isospora-Typ. In: 18. Tagung der Deutschen 
Gesellschaft für Parasitologie, 24.-28.3.1998, Dresden, V 117 
• Epidemiological importance of animals in the transmission of Toxoplasma. IXth International 
Congress of Parasitology, Makuhari Chiba, Japan, 24.-28.8.1998. In: Parasitology into the 21st 
Century, Parasitol. Int., 47, 82 
• Impact of molecular phylogenetic analyses on classification and taxonomy of coccidia with 
isosporan-type oocysts. IXth International Congress of Parasitology, Makuhari Chiba, Japan, 
24.-28.8.1998. In: Parasitology into the 21st Century, Parasitol. Int., 47, 139 
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• Current knowledge on the epidemiology of infections with Toxoplasma. In: 11th Japanese-
German Cooperative Sympsosium on Protozoan Diseases, Isehara, Japan, 29.-31.8.1998 
• Epidemiology and economic impact of Sarcocystis species. In: Proc. COST 820 "Vaccines 
Against Coccidiosis", Annual Workshop, Toledo, Spain, 22.-25.10.1998 
Dr. med. vet.-Thesis 
Heckeroth, A. R.: 
Entwicklung einer PCR-Methode zum artspezifischen Nachweis von akuten Sarkozystiosen bei 
Schafen. Dissertation, Tierärztliche Hochschule Hannover, 1998 
8. COST 820 ANNUAL MEETING, TOLEDO, SPAIN 
This Workshop was organised superbly by Professor Luis Ortega-Mora and his colleagues, with help 
from Dr Astrid Tenter, for preparing the scientific programme and liasing with all delegates. 
Details of the programme are given in the Appendix, and copies of the Proceedings are available 
from Professor Luis Ortega-Mora. 
9. APPENDICES 
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COST 820 ANNUAL MEETING 
TOLEDO, SPAIN 
PROGRAMME 
Thursday, 22nd October 1998 
Arrival and accomodation at Beatriz Hotel 
15.00-18.30 Registration (Tavera Conference Room lobby) 
14.00 -16.30 COST-820 Management Committee Meeting (Castilla I Room) 
17.00 -18.00 OPENING LECTURE (Chairperson: M.W. Shirley) 
Invited expert: M. Tibayrenc 
Molecular epidemiology and evolutionary genetics of pathogens: the 
Leishmania case; comparison with other pathogens 
19.00 Wellcome reception (buffet) (Social Room) 
Friday, 23rd October 1998 
7.30 - 9.00 Breakfast (La Romana Cafeteria) 
RECOMBINANT ANTIGENS AND OTHER TOOLS FOR THE DEVELOPMENT OF MOLECULAR-
ENGINEERED VACCINES AGAINST COCCIDIAL PARASITES 
DNA Vaccines and Recombinant Antigens (Chairpersons: A.M. Tenter and B. Gottstein) 
9.00- 9.45 INVITED LECTURE: R.C. Kennedy and A.M. Watts 
DNA vaccination strategies and the induction of protective immunity 
9.45 - 10.00 D. Licois, K. Daveau, N. Cere, D. Rasscháert and F. Drouet-Viard 
First step in DNA vaccine against rabbit coccidiosis: expression library 
construction from Eimeria intestinalis sporozoites 
10.00 - 10.15 S. Sagodira. D. Buzoni-Gatel, S. Iochmann, M. Naciri and D. Bout 
Protection of neonates against cryptosporidiosis after genetic vaccination of 
dams 
10.15-10.45 INVITED LECTURE: A.Hemphill 
Antigen detection and characterization 
10.45 - 11.00 S. Eperon. N. Fuchs, S. Sonda, A. Hemphill and Β. Gottstein 
Vaccination of mice with recombinant proteins against Neospora caninum 
11.00 - 11.15 H. Vedel-Nielsen, L. Christiansen and E. Petersen 
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Use of recombinant SAG1 in a subunit vaccine against infection with 
Toxoplasma gondii in mice 
11.15­11.30 F. Petry and V. McDonald 
Further characterisation of recombinant antigens of Cryptosporidium parvum 
11.30 ­ 12.00 Coffee (Social Room) 
Identification of New Vaccine Candidates (Chairpersons: A. Hemphill and P. Pery) 
12.00­12.15 J.M. Bumstead and F.M. Tomlev 
Secretion of microneme proteins during invasion of Eimeria tenella 
12.15 ­12.30 P.J. Brown. K.J. Billington, J.M. Bumstead, J.D. Clark and F.M. Tomley 
A microneme protein of Eimeria tenella shows homology to the binding 
domains of factor XI and plasma pre-kallikrein 
12.30 ­12.45 A. Bonnin. J.F. Dubremetz, J. López, S. Robine, C. Chaponnier and G. Gabbiani 
Detection of microvillous cytoskeletal components in the parasitophorous 
vacuole wall of Cryptosporidium parvum 
12.45 ­ 13.00 F. Spano. I. Ricci, M. Di Cristina, C. Puri, L. Putignani and A. Crisanti 
The growing family of SAG-1 related antigens of Toxoplasma gondii: 
molecular characterization and expression analysis of the SAG-5 gene cluster 
13.00 ­13.15 S. Sonda. N. Fuchs, Β. Connolly, Ν. Muller and A. Hemphill (Switzerland) 
Molecular characterization of the Neospora caninum tachyzoite surface 
protein Nc-p36 
13.15­13.30 N. Fuchs. S. Sonda, Β. Gottstein and A. Hemphill 
Differential expression of cell surface -and dense granule- associated 
Neospora caninum proteins in tachyzoites and bradyzoites 
13.30­15.00 Lunch (Beatriz Restaurant) 
Adjuvants and Vectors (Chairpersons: D. Williams and F. Petry) 
15.00­15.30 INVITED LECTURE: K. Lövgren B engtsson 
Vaccine adjuvants 
15.30 ­ 15.45 F. Girard. P.Quéré, K. Lövgren, R. Mancanola and P. Péry 
Systemic immunoadjuvant activity of ISCOMs presentation for Eimeria 
recombinant HSP70 in chickens and protection against the parasite 
15.45 ­ 16.30 INVITED LECTURE: J.M. Escribano 
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Antigen delivery estrategies for mucosal vaccines 
16.30­ 16.45 A Vermeulen. D. Schaap, J. Dorrestein, G. Arts, N. Verhoeven, S. Vos, S. 
Steeghs, M. Cronenberg, C.v. Geffen and P. Sondermeyer 
Vector systems used to present Eimeria antigens to the immune system of the 
host 
16. 45­ 17.00 S.H.M. Jeurissen. E.M. Janse, M. Roos and L.J. Wiley 
The use of an apathogenic Eimeria as a parasitic vector 
17.00 ­ 17.30 Coffee (Social Room) 
Transfection (Chairpersons: A. Vermeulen and F. Spano) 
17.30 ­ 18.00 INVITED LECTURE: A Hehl 
Transfection in Toxoplasma gondii 
18.00 ­ 18.15 J.G. Mattsson E. Ljunggren, K. Bergström and D. Soldati 
Identification of a novel surface protein of Toxoplasma gondii using RNA 
display 
18.15­18.30 M. Soete. T. Meyer, D. Schlüter, D. Soldati 
Expression of the bradyzoite-specific surface antigen SAG-4 in the Ts-4 
vaccine strain of Toxoplasma gondii 
18.30 ­ 18.45 B. Gottstein, A. Hemphill and S. Eperon (Switzerland) 
μΜΤ knockout and wild-type mouse model for immunological studies in 
experimental neosporosis 
19.15 Dinner (Beatriz Restaurant) 
20.45 Guided Tour of Toledo (Assemble in the Hotel lobby) 
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Saturday, 24th October 1998 
7.30 - 9.00 Breakfast (La Romana Cafeteria) 
EPIDEMIOLOGY AND ECONOMIC IMPACT OF COCCDOIOSIS IN ANIMAL PRODUCTION 
Morning Scientific Session (Chairpersons: M. Rommel and J. Catchpole) 
9.00 - 9.15 B.E. Schnitzler. PL. Thebo, F.M. Tomley, A Uggla, M.W. Shirley 
PCR and PACHA as tools to investigate coccidian epidemiology 
9.15 - 9.30 F. Drouet-Viard. V. Veneziano, L. Rinaldi, G. Cringoli, D. Licois and P. Coudert 
Use of precocious lines in rabbit farms. Preliminary field surveys in France 
and Italy 
9.30 - 9.45 M. Giles. KA. Webster, J.A Green, J. Catchpole, C. Dawson, S. Pedraza-Diaz 
and J. McLauchlin 
Host specificity, pathogenesis and molecular classification of Cryptosporidium 
species 
9.45 - 10.00 S. Patel. J. McLauchlin, S. Pedraza-Diaz and D. Casemore 
Seroepidemiology and molecular characterisation of cryptosporidiosis 
10.00 -10.15 G. Pi Francesco. AR. D'Angelo, A Petiini and G. Savini 
Protozoal infections associated with abortion in Italian livestock 
10.15 - 10.30 H.C. Davison, A. Otter, N.P. French and A.J. Trees 
The epidemiology and significance of bovine neosporosis in England and 
Wales: interim results of a collaborative study 
10.30 - 10.45 A. Quintanilla-Gozalo, J.M. Pereira Bueno, E. Tabarés, EA. Innes, R. González-
Paniello and L.M. Ortega-Mora 
Seroprevalence of Neospora caninum infection in dairy and beef cattle in 
northern Spain 
10.45 - 11.00 J.M. Wastling. A. Schock, E.A. Innes and Y. Yamane 
Genetic polymorphisms in laboratory isolates of Neospora caninum 
11.00 -11.30 Coffee (Social Room) 
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Round Table (Chairperson: M.W. Shirley) 
11.30-11.50 R. B. Williams 
What is the cost of coccidiosis to the world's chicken production industry? 
11.50-12.10 LA. Stubbings and J. Catchpole 
Epidemiology and economic impact of coccidiosis in sheep and goats 
12.10 - 12.30 P.C. de Graaf. E. Vanopdenbosch and J.E. Peeters 
Introduction to the debate on the epidemiology and economic importance of 
Cryptosporidium spp. 
12.30-12.50 D. Buxton 
Epidemiology and economic impact of toxoplasmosis in animal production 
12.50-13.10 J.M. Wastling and E.A. Innes 
The economic impact of neosporosis 
13.10-13.30 A M. Tenter 
Epidemiology and economic impact of Sarcocystis species 
13.30 - 13.40 Overall Discussion 
13.40 -15.15 Lunch (Beatriz Restaurant) 
Afternoon Scientific Session (Chairpersons: F. Conraths and D. Buxton) 
15.15-15.30 M. Pakandl. F. S. Rénaux and F. Drouet-Viard 
Penetration of sporozoites of the rabbit coccidium Eimeria coecicola into the 
intestine of immune and naive rabbits 
15.30 - 15.45 C.A. Vergara-Castiblanco. S. Santos-Nuñez, F. Freire-Santos and E. Ares-Mazás 
Cryptosporidium parvum in two Colombian populations: immunoblot 
analysis of specific serum response (IgA, IgG and IgM) 
15.45 - 16.00 P. Lind. AM. Jensen, AM. Kjeldsen, H.C. Slotved, C. Björkman and A. Uggla 
Follow-up studies in Neospora caninum infected dairy herds using IgG-
subclass ELISAs 
16.00-16.15 J. Marks. I. Esteban-Redondo, A Lundén, S. Maley, A. McLean Tooke, T. 
Duggan and E. A. Innes 
Immunity to Neospora caninum 
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16.15 -16.30 CS. Guv. D.J.L. Williams, F. Guy, J.W. McGarry, K. MacEacheran, R. Smith, 
D.F. Kelly and AJ.Trees 
Immunological and clinical responses in cattle following experimental 
infection with Neospora caninum at different stages of gestation 
16.30 -16.45 T. Jäkel. J. Sangchai and Y. Khoprasert 
The role of immunological memory in Sarcocystis infection 
POSTER SESSION (Social Room) 
16.45-18.00 
1. A. Gawel. M. Mazurkiewicz and J. Jurowski 
Influence of selected chemoprophylaxis methods on immunity against coccidiosis in 
chickens 
2. F.Cernik and P. Bedrnik 
Eimeria tenella- monitoring of cross resistance between ionophorus anticoccidial drugs 
3. A. Ramisz. A. Balicka-Ramisz and B. Pilarczyk 
Epidemiological and economic impact of coccidiosis in cattle production 
4. F. Petry and JR. Harris 
Ultrastructural and molecular analysis of the extracellular stages of Cryptosporidium 
parvum 
5. S. Pedraza-Diaz. S. Patel and J. McLauchlin 
Molecular typing of Cryptosporidium from human water-borne outbreaks 
6. D. Champliaud, P. Gobet, M. Naciri, O. Vagner, J. Lopez, Y. Varga, G. Harly, R. Mancassola 
and A. Bonnin 
Failure to differentiate Cryptosporidium parvum from G meleagridis based on PCR 
amplification of eight DNA sequences 
7. F. Freire-Santos. C.A. Vergara-Castiblanco and E. Ares-Mazas 
An attempt of experimental infection by Cryptosporidium parvum in rainbow trout 
8. H. Abbassi, F. Coudert, Y. Chérel, J. Brugère-Picoux and M. Naciri 
Effect of pathogenic virus of Infectious Bursal Disease (IBD) on the pathogenicity of 
Cryptosporidium baileyi and the development of acquired immunity to parasite 
9. S. Hornok. Z. Széll, J. Nieuwenhuijs, M.G.B. Nieuwland, A.W.C. A. Cornelissen and I. Varga 
Immunogenicity of three oocyst extracts of Cryptosporidium baileyi in experimentally 
infected chickens 
10. S. Hornok. Z. Bitay, Z. Széll and I. Varga 
Assessment of maternal immunity to Cryptosporidium baileyi in chickens 
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11. A Lundén J.E. Allen, D. Buxton and S. Wright 
Immunisation of mice against neosporosis 
12. A. Schock. D. Buxton, J. Wastling, J. A. Spence, A. Rae, J. Yamane and J.C. Low 
Histopathological survey with special reference to Neospora caninum induced abortion 
and preliminary molecular biological characterisation of A. caninum isolates 
13. R. Atkinsons, P.AW. Harper, C. Ryce, D.A. Morrison and J.T. Ellis 
Investigations on the biological characteristics of two isolates of Neospora caninum 
14. S.Wright. C. Gortázar, D. Fernández de Luco and D. Buxton 
Seroepidemiology to Neospora antibody responses in red foxes (Vulpes vulpes) in Spain 
15 W. Wouda. C.J.M. Bartels, AR. Moen and Y.H. Schukken 
Case control study of Neospora caninum associated abortion in dairy herds in The 
Netherlands 
16. H. C. Slotved. L. Jensen and P. Lind 
Antibody responses in bovine fetal abortion due to neosporosis 
17. A Uggla, S. Stenlund. O.J.M. Holmdahl, E.B. Jakubek, P. Thebo, H. Kindahl and C. Björkman 
Neospora caninum: is oral transmission a possible route of infection? 
18. G. Jungersen. L. Jensen, U. Riber, P. Heegaard, E. Petersen and P. Lind 
Pathogenicity of selected Toxoplasma gondii isolates after intravenous inoculation in pigs 
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17.45 - 18.45 MEETING OF WORKING GROUP 3 (Chairpersons: D.C. de Graaf and A Bonnin) 
A vaccine against cryptosporidiosis: reality or fantasy ? 
- General introduction (D.C. de Graaf) 
- Is a vaccine necessary in veterinary medicine ? (D.C. de Graaf) 
- Is a vaccine necessary in human medicine ? (A. Bonnin) 
- The answers currently available (S. Sagodira) 
- Mechanisms of immune response to cryptosporidiosis relevant to 
vaccination (F. Petry) 
- Possible targets offered by the molecular biology (F. Spano) 
- Priorities for the future and conclusion (A. Bonnin) 
20.00 Conference Banquet (Conde de Orgaz Parador) 
(Assemble in the Hotel lobby) 
Sunday October 25th 
7.30-9.00 Breakfast (La Romana Cafeteria) 
9.0- Bus transfer from Beatriz Hotel to Madrid airport 
(Assemble in the Hotel lobby) 
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COST820 : Vaccines against Animal Coccidioses 
"Transfection and whole genome 
approaches to gene discovery and 
function: the way forward f or 
vaccine research in coccidians?" 
Joint meeting of Working Groups I and VI 
June 19 - 21, 1998 
Rome, Italy 
COST 
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INTRODUCTORY LECTURE 
Friday 19* June 
ROUGH GUIDE TO GENOMIC SEQUENCING : 
FROM DOLLARS SPENT TO BASE PAIRS COVERED. 
Daniel Lawson 
The Sanger Centre, Wellcome Trust Genome Campus, Hinxton, Cambridge CBIO ISA 
The past decade has seen the movement of sequencing technology from the laboratory bench to 
the factory floor. The majority of large scale (Mb's) sequencing is undertaken at a handful of genome 
centres specifically founded for this purpose. The scale of these centres has meant a reduction in the cost 
of sequencing, and has underpinned the successful completion of numerous bacterial genomes and the 
Yeast Saccharomyces cerevisiae. 
These triumphs have been achieved without a radical change in technology. Fluorescent 
labelling of Sanger dideoxy chain termination method remains the primary sequencing chemistry. The 
major changes in methodology have been an increase in the size of DNA fragment to be attacked; from 
small lambda clone (kb's), through cosmids (10's kb), BACs (100's kb) to entire chromosomes or 
bacterial genomes (Mb's). 
Recently, The Institute for Genomic Research (TIGR) and Perkin-Elmer announced an 
initiative which, in theory, revolutionalizes genomic sequencing. The arrival of capillary technology may 
hold the key to cheaper, raster sequencing. It re-opens old debates and at the least requires a reappraisal 
of what is the most cost effective strategy for genomic sequencing. 
SESSION ONE 
Saturday June 20*, 0900-1300. 
LESSONS LEARNT FROM LEISHMANIA 
AJ Ivens 
(Dept. of Biochemistry, Imperial College of Science, Technology and Medicine, Exhibition 
Road, London SW7 2AZ, UK.) 
As part of the UNDPAVorld Bank/WHO-TDR parasite genomes initiative, our laboratory has 
been involved in the construction of a physical map of the Leishmania major Friedlin reference strain. 
The map has been assembled by the combination of fingerprint analysis of a shuttle vector cosmid library 
and probe hybridisation. The integrated data obtained from the fingerprints and over 1000 probes have 
placed approximately 94% of the -33.6Mb genome into contigs representative of the 36 chromosomes. 
Sequencing tile sets have been identified, and a number of sequencing projects are underway within the 
Leishmania Genome Network. The data obtained from the Leishmania genome project have been 
analysed for possible functional significance, the output of which will be described. Data from the 
genome project are publicly available on the WWW at: http://www.ebi.ac.uk/parasites/leish.html 
HAPPY MAPPING OF CRYPTOSPORIDIUM PARVUM. 
Michael B. Piper, Alan T. Bankier and Paul H. Dear. 
(MRC Ixihoratory of Molecular Biology, Protein and Nucleic Acid Chemistry Division, Hills 
Road, Cambridge CB2 2QH, England.) 
HAPPY mapping is a fast and accurate method for the physical mapping of genomes Many 
parasite genomes are difficult to map by traditional methods due to their unusual biological 
characteristics, e.g. genomic regions with high AT contents can lead to instability of bacterial clones. 
HAPPY mapping is an entirely in-vitro method and hence mapping is unaffected by such biological 
phenomena. A HAPPY mapping panel is constructed by breaking genomic DNA at random and then 
taking samples, each containing less than one genomes worth of DNA, from this pool of random 
fragments. Breaks between closely linked markers are rare, and these markers tend to co-segregate on 
the same DNA fragments, and hence also co-segregate in the same samples. Breaks between widely 
spaced markers are more common and hence they co-segregate less frequently. The principle is similar 
to that used in genetic mapping, when recombination between closely linked markers during meiosis is 
rare. We have constructed a HAPPY map of the apicomplexan parasite Cryptosporidium pannim It 
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consists of over 130 STS (sequence tagged site) markers, which have been screened against a HAPPY 
mapping panel by nested PCR. They fall into 10 contigs. Cryptosporidium is believed to have 8 
chromosomes and a genome size of ~10.4Mb, meaning that there are only 2 gaps in the map and that on 
average there is a marker every 78kb. The map is expected to be accurate to about 30kb, and was 
constructed by a single person in under six months. In addition we have constructed a PAC (Ρ 1 artificial 
chromosome) library of Cryptosporidium with an average insert size of 38kb. The library is publicly 
available, and in conjunction with the map, should greatly facilitate genomic studies of this organism. 
ABOUT THE TINY NUCLEAR GENOME OF MICROSPORIDIA 
Christian Vivares 
(Universite Blaise Pascal, Aubieres, Fratice) 
Microsporidia, obligate intracellular parasites, with a wide host spectrum, represent a large 
group of pathogens of veterinary and medical importance mainly in ADDS patients. They can form a 
very small spore, contain 70S ribosomes and are devoid of mitochondria. 
The haploid genome size varies between 2.3 Mbp and 19.6 Mbp and the number of 
chromosomes between 8 and 16, according to species. Karyotype polymorphism has been shown in 
Eiwephalitozoon cuniculi. The variants discriminated on the basis of rDNA ITS structure may be 
heterogeneous as regard to the karyotype. 
The analysis of the E. cuniculi genome was performed through the systematic sequencing of 
the smallest chromosome (217 kbp) and the screening of a partial genomic library. The repetitive DNA 
comprises short micro­ and minisatellites and rDNA units dispersed over all the chromosomes. SSU and 
LSU rRNAs are very reduced as a result from the deletion of numerous variable regions. 
Currently, concerning chromosome I, a set of 30 randomly arranged contigs represents a total 
length of 180 kbp with 30 genes including 21 ORFs for known proteins and 9 ORFs with unknown 
function. Some intergenic regions are very short (DHFR,TS,SHMT contig) and the intron frequency 
very low. The sequence alignment of promoter regions suggests 2 boxes which may be involved in the 
initiation of transcription. A downstream box complementary to a part of the decoding region of the 
16S rRNA frequently occur and can play a role in traduction initiation. A typical polyadenylation signal 
is often present. The mitochondrial signature of an HSP70 gene supports that microsporida have 
secondarily lost mitochondria. 
With respect to proteins specifically associated to the major part of the invasive apparatus 
(polar tube), two different genes, close together on the chromosome VI, are of potential interest for 
diagnosis and therapeutics. 
TOWARDS A PHYSICAL MAP OF BRUGIA MALAYI : NEW INSIGHTS INTO THE 
BIOLOGY OF FILARIAL NEMA TODES 
D.B.Guiliano'. J. Daub', S.J. Jones2,and M.L.Blaxter' 
Í11.C.A.P.B. University of Edinburgh, West Mains Road Edinburgh EH9 3JT, UK. 'The 
Sanger Centre, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 ISA, UK) 
The Brugia malayi genome project is an international collaborative effort between seven 
laboratories funded by the WHO and MRC. The goal of this project is the identification of thousands of 
new Brugia genes and their placement on a medium resolution physical map. Over 14,000 ESTs have 
been sequenced from stage­specific B. malayi cDNA libraries. When grouped by sequence identity 
these 14,000 ESTs form over 5,000 clusters. A consensus sequence for each cluster has been generated 
from a multiple alignment of the constituent ESTs and this has been used in subsequent database 
analyses. 
The B. malayi physical map will be generated by hybridisation of several thousand Brugia 
genes identified during the EST sequencing phase of the project and BAC and YAC end probes selected 
using a sampling without replacement strategy. Generation of high quality genomic libraries has been 
complicated by AT bias (­70%) of Brugia genomic DNA and the presence of a bacterial endosymbiote 
which efficiently clones into cosmid and BAC vectors. However we are now entering into the 
preliminary mapping phase of the project with over two dozen Brugia genes mapped to our BAC filters 
and the initiation of several walking experiments. 
A single BAC containing the genomic copy of Bm­MIF­1 has been selected and is being 
sequenced at the Sanger Center. Construction of a physical map and the sequencing of a large piece of 
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Brugia genomic DNA will allow several important questions to be answered about nematode genomic 
organisation including the presence of opérons, transposons, and the possibility of synteny between 
Brugia and C. elegans. 
CHROMOSOME ANALYSIS AND DIPLOKARYON ULTRASTRUCTURE IN 
M1CROSPORIDIANPARASITE NOSEMA GRYUJ (M1CROSPORIDA: NOSEMATIDAE). 
Elena Nassonova'"2. Julia Sokolova2, Irma Issi2, Sergei Skarlato3 and Rolf Entzeroth1 
('-Institute of Zoology - Spezielle Zoologie, Technical University Dresden, Germany. '-All-
Russian Institute of Plant Protection, Russ. Acad. Agrie. Sci.. St. Petersburg, Russia. "-
Institute of Cytology, Russ. Acad. Sci., St. Petersburg, Russia.) 
The life cycle of Nosema grylli consists of three phases: infective, proliferative and 
sporogonial. The nuclear division, which occurs during the proliferative phase, involves a sequence of 
mitosis in the meronts and sporonts. The nuclear apparatus or "diplokaryon", consists of two closely 
adjacent nuclei, each of which is surrounded by a typical nuclear envelope. Diplokaryon is a very 
characteristic peculiarity of microsporidian intracellular stages, which allows them to be easily 
recognised in samples by different kinds of DNA-specific stains, e.g. by DAPI-staining. In 
dyplokaryotic nuclei of meronts and sporonts, closed intranuclear pleuromitosis was described. In this 
type of mitosis, the nuclear envelope stays intact; the entire mitotic apparatus is localized into the 
nucleus and the spindle is organised by special microtubule-organizing centres (MTOCs), so-called 
"centriolar plaques". In the course of mitosis chromosomes are weakly condensed and do not form a 
metaphase plate. Thus, the exact determination of the chromosome number by TEM is difficult. To 
obtain the detailed information on the chromosome content and basic genome organisation of M grylli, 
the transverse alternating field electrophoresis (TAFE) was used. 
By TAFE, using a program for DNA separation within a wide size range (50- lOOOkb), a set 
of chromosomal DNAs οΐΝ. grylli with the sizes 95-450kb was revealed. To separate numerous 
DNA molecules of similar sizes, a program with discrete increasing of pulse time was elaborated. It 
revealed 14 chromosomal bands ranging in size from 95 to 440kb. The total genome size of N. 
grylli, estimated on the basis of chromosomal DNA sizes, is about 3460kb. 
The method of chromosomal DNA purification from intracellular stages of N. grylli was 
adapted. The attempt to compare the molecular karyotype from spores and intracellular stages of N. 
grylli was done. There seems to be no difference between electrophoretical patterns of DNA from 
infective and proliferative stages of the Λ', grylli life cycle. 
Our data were compared to earlier reports on chromosomal DNAs from other species of 
the Nosema genus. The size of chromosomes of other species ranged from 139 to 1810 kb. The 
Nosema spp. from Orthoptera have the smallest genome sizes within the genus and have no 
chromosomal DNAs greater than lOOOkb. 
The variations of chromosome and genome sizes within Nosema spp. confirms the heterogenity 
of this genus, which has been discussed by Sprague, Issi and other authors (Sprague et al., 1992; Issi, 
1986). Recent studies on phylogenetic relationships among Nosema spp. based on ribosomal RNA 
sequence data confirmed that this genus is composed of several unrelated groups (Baker et al., 1994). 
ONGOING CONSTRUCTION OF AN RFLP LINKAGE MAP OF EIMERIA TENELLA: (USE 
OF RAPD-PCR AND AFLP MARKERS) 
M. W. Shirley 
Institute for Animal Health, Compton, Nr Newbury, Berks. RG20 7NN 
An RFLP linkage map is being constructed of the genome ofEimeria tenella. The map derives 
from analyses of the inheritance of polymorphic DNA markers in 22 cloned progeny of a genetic cross 
made between two parents characterised by complementary phenotypic traits. The map currently 
comprises just over 200 polymorphic markers, of which those defined by RAPD-PCR and, especially, 
AFLP are the most numerous. 
The results of an experimental cross which used parents with phenotypes of precocious 
development (attenuation) and resistance to arprinocid are providing insights into the behaviour of 
Eimeria chromosomes during meiosis and reveal an association between two different chromosomes and 
resistance to arprinocid or precocious development. 
Some findings include: 
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The extent of crossing-over between homologous chromosomes varies considerably within the 
karyotype and, for example, is substantially greater for chromosomes 1 and 2 than for chromosome 
chromosomes 9, 10 and 14. 
The frequency of DNA markers identified varies for the different chromosomes. For example, 
chromosomes 9, 11 and 14 are substantially over-represented in comparison to chromosome 10. 
Most chromosomes are characterised by a combination of polymorphic AFLP, RAPD-PCR and 
RFLP markers but, perhaps surprisingly, no AFLP markers have been identified for some 
chromosomes, including chromosome 14 which, at more than about 7 Mbp, is the largest in E. 
tenella. 
Linkage is inferred between arprinocid resistance and chromosome 1 and precocious development 
and (putative) chromosome 9. 
ESTABLISHMENT OF THE CRYPTOSPORIDIUM PARVUM KARYOTYPE 
S. Cacciò. R. Camilli, G. La Rosa, E. Pozio 
Laboratory of Parasitology, Istituto Superiore Sanità, Rome, Italy 
In several protozoa, including parasitic species, the chromatin is poorlycondensed during mitosis and 
distinct chromosomes can not be visualized. A breakthrough in the study of the genomes of parasites 
and of other lower eukaryotes was the development of the Pulsed Field Gel Electrophoresis 
CPFGE) technique, which allows for the separation of intact chromosomes. The use of PFGE has been 
instrumental for describing karyotypes, determining the ploidy status and genome size, investigating 
chromosomal polymorphisms and mapping of genes. So far, such studies have been conducted on 
important parasites such as Trypanosoma, Leishmania, Giardia, Plasmodium, Toxoplasma, Eimeria, 
Babesia and Theileria. We are interested in the study of the chromosome organization in the coccidian 
parasite Cryptosporidium parvum and our goal is the development of a physical map of the genome. So 
far, PFGE analysis of the C. parvum chromosomes revealed the presence of five bands in the 1-1.5 Mb 
range. However, it has been suggested that at least two of these bands are composed of multiple 
chromosomes very similar in size, which comigrate during the electrophoresis. This situation has 
hampered the determination of the chromosome number and size and also complicates the 
assigment of genes and of other DNA sequences to individual chromosomes. Since resolution of these 
bands into individual components is difficult to achieve, we have used restriction enzymes to cut 
chromosomes into fragments which can be more easily resolved by PFGE. Considering the AT-richness 
of the C. parvum genome, several restriction enzymes recognizing GC-rich motifs have been used. On 
the basis of these initial experiments. Noti and Sfil enzymes were selected for this study. The optimal 
separation of the Noti and Sfil restriction fragments in the low, intermediate and high molecular size 
range was obtained with three different PFG electrophoretic conditions. These experiments showed 
that the karyotype is comprised of eight chromosomes, ranging in size from approximately 0.95 to 1.45 
Mb; of the eight chromosomes, five were cut by the Sfil enzyme whereas only three were cut by the 
Noti enzyme, confirming the rarity of GC-rich motifs in the genome. The genome size of C parvum 
was estimated to be 9.6 Mb in size, a figure very close to that reported for Theileria parva and Babesia 
bovis (about 10 Mb), but quite different from that of two other coccidians, Toxoplasma gondii and 
Eimeria tenella, which have larger genomes (50-80 Mb). To confirm the identity of the chromosomes 
and of their restriction fragments, Southern blots of the PFGE gels were probed with a series of 20 
markers, representing 16 coding sequences, the ribosomal DNA, a pair of repetitive DNA sequences 
and a telomeric repeated sequence, (TTAGGG)n. All gene probes hybridized to individual 
chromosomes or to their restriction fragments, as expected form their single-copy nature, whereas 
hybridization with the ribosomal DNA probe revealed the presence of 5 copies that were scattered over 
four different chromosomes. Finally, all chromosomes and restriction fragment hybridized with a 
telomeric probe, indicating that no internal fragments were generated by either Noti or Sfil restriction. 
Recently, a general model of chromosome organization in parasites has been proposed. This model 
suggests that chromosomes are compartmentalized into conserved central domains and polymorphic 
chromosome ends. The central domain is highly transcribed and contains most of the structural genes, 
whereas the regions close to the telomeres contain few structural genes but several repetitive elements 
and have low transcriptional activity. The development of a physical map will help to clarify whether 
this particular organization is conserved in C. ¡xtnnim 
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SESSION TWO 
Saturday June 20*, 14.30-16.00 
GENE DISCOVERY AND GENETIC VARIA HON IN CRYPTOSPORIDIUM 
AND TOXOPLASMA. 
F. Spano*. L. Putignani^ I. Ricci', M. Di Cristina*, C. Purir, and A. Crisanti''·* 
* Istituto di Parassitologia e * Istituto di Istologia e Embriologia Generale. Università di 
Roma "La Sapienza", Rome, Italy; ' Imperial College, Department of Biology, London, U.K. 
The invasive stages of the apicomplexan parasite Toxoplasma gondii are known to express a set 
of surface antigens, known as the SAG proteins, sharing structural and functional characteristics. These 
molecules, which are anchored to the plasmamembrane via a GPI motif, are differentially expressed in 
sporozoites, tachyzoites and bradyzoites and are believed to play a role in the early steps of host cell 
invasion. The most extensively characterized among the SAG proteins are S AGI (p30), which is 
expressed exclusively in the tachyzoites and represents the immunodominant antigen during T. gondii 
infection (Burg et al., J. Immunol. 141: 3584-3591, 1988) and SAG3 (p43), which is present in all 
invasive stages (Cesbron-Delauw et al., J. Biol. Chem. 269: 16217-16222, 1994). These two molecules 
share approximately 40% amino acid identity and the presence of two amino acid repeats each 
containing 6 cysteine residues at conserved positions. T. gondii lines defective for either SAG1 or 
SAG3 have been shown to possess a reduced invasive activity. Recently, a series of novel T. gondii 
proteins sharing close structural similarity with SAG1 and SAG3 have been identified: SRS1-4 and 
BSR4 by Boothroyd and co-workers (Hehl et al.. Mol. Biochem. Parasitol. 89: 271-282, 1997) and 
SAG5 in our laboratory. 
A portion of the SAG5 gene was accidentally amplified from the genomic DNA of T. gondii 
(RH strain) employing unrelated primers. The PCR product 12G/16, encoding a 212 amino acid-long 
polypeptide showing a significant homology to both S AGI and SAG3, was used as a probe to screen a 
genomic T. gondii cosmid library. Southern blot analysis of the positive cosmidic clones and of T. 
gondii genomic DNA employing the 12G/16 fragment as a probe yielded complex hybridization 
patterns, suggesting the existence, in the genome of T. gondii, of a family of related genes. Extensive 
sequence analysis confirmed this hypothesis and revealed the presence of three tightly clustered genes 
encoding closely related proteins, denominated SAGS. 1, SAGS.2 and SAG5.3. All three polypeptides 
show the hallmarks of the family of S AGI-related molecules, being characterized by a leader peptide, 
12 cysteine residues whose distribution suggests a tandem duplication of an ancestral 6-cysteine motif 
and a C-terminal GPI-anchoring signal. SAG5.2 and SAG5.3 are 367 amino acid-long and differ from 
each other at 8 amino acid positions (98% identity), while SAG5.1, which consists of 362 amino acids, 
is virtually identical to the other two SAG5 proteins only within the C-terminal region (positions 162-
362). Notably, in the N-terminal half of the molecule the degree of amino acid identity to 
SAG5.2/SAG5.3 drops to approximately 40%, which represents the average homology shared by all 
members of the "SAGT protein family. Northern blot and RT-PCR analysis of poly(A)+ RNA showed 
that all three SAG5 genes are expressed in tachyzoites. The transcriptional activity in the other invasive 
stages is under study. The localization of the SAG5 proteins in T. gondii tachyzoites was investigated 
employing polyclonal and monoclonal antibodies raised against a recombinant histidine-tagged fragment 
of S AGS. 3 produced in E. coli and affinity purified by nickel chelate chromatography. In contrast with 
the other S AGI-related proteins, immunofluorescence analysis failed to show for SAG5 any significant 
staining of the tachyzoite plasmamembrane. Instead, anti-SAGS antibodies specifically decorated the 
apical end of the tachyzoites. This evidence was confirmed by immunoelectron microscopy experiments 
in which anti-SAG5 antibodies were shown to label the cytoplasmic side of the tachyzoite pellicle and 
electrondense structures possibly associated with the microtubular components of the apical complex. 
In our search for Cryptosporidium proteins potentially involved in the invasion process we have recently 
cloned a C. parvum incomplete cDNA encoding a polypeptide, named cysteine-rich sporozoite protein 
(CRSP), possessing adhesive amino acid motifs. CRSP is a novel thrombospondin-related protein that 
adds to TRAP-Cl, a micronemal protein recently cloned in our laboratory and sharing structural 
similarity to EtplOO of £ tenella and MIC2 of T. gondii. The CRSP gene is highly expressed in 
sporozoites. Work is in progress to clone the entire ORF encoding CRSP and to establish the exact sub­
cellular location of this molecule. 
Our interest in C. parvum has recently extended to the study of the parasite genetic variation. 
Most of the C. pan'um typing studies carried out to date are based on the analysis of single 
polymorphisms. A multilocus approach has the potential to better define the structure of the C. parvum 
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population and assess the degree of genetic isolation of the H and C subpopulations. With this in mind 
we genotyped 28 C. parvum isolates of various host and geographical origin by simultaneously analysing 
up to five polymorphic loci belonging to at least three distinct linkage groups. Isolates were from 
Europe, North and South America and Australia. Seventeen isolates originated directly from humans, 3 
were derived from humans and propagated in calves, and 8 were from various animals. Human isolates 
were both from sporadic cases and from documented outbreaks. Two isolates were derived from ADDS 
patients. Animal samples included the widely used Moredun and GCH1 isolates. The five polymorphic 
loci selected for this study have been shown to consist of at least two alleles differentially associated 
with animal or human C. parvum isolates. Four of the genetic markers were analysed by polymerase 
chain reaction­restriction fragment length polymorphism (PCR­RFLP) assays and corresponded to the 
protein­encoding genes Cryptosporidium Oocyst Wall Protein (COWP) (Spano et al., FEMS Microbiol. 
Letters 152: 209­217, 1997), polythreonine (polyT) (Carraway et al., Infect. Immun. 65: 3958­3960, 
1997), thrombospondin­related adhesive protein ofCryptosporidium-l (TRAP­C1) (Spano et al., Mol. 
Biochem. Parasitol. 92: 147­162, 1998) and ribonucleotide reductase (RNR) Rl subunit. The fifth 
polymorphism, residing within the internal transcribed spacer region 1 (ITS1) of the Type A ribosomal 
unit, was analysed by PCR employing genotype­specific primers (Carraway et al., Appi. Environ. 
Microbiol. 62: 712­716, 1996). Consistent with previous studies, isolates segregated into two groups, 
one comprising both human and animal isolates, the other only isolates of human origin. No recombinant 
genotype was detected. This evidence, together with the broad geographical distribution of the 
multilocus genotypes identified, brings further support to the hypothesis that C. parvum reproduction is 
substantially clonal. 
FIRST A TTEMPTS TO ISOLA TE RECOMBINANT CRYPTOSPORIDIUM Τ CELL 
ANHGENS. 
de Graaf P.C. ' . Hoff P.T.\ Petry, F.2 & Peeters J.E.' 
(* Veterinary atuí Agrochemical Research Centre, Groeselenberg 99, Β-1180 Brussels, 
Belgium. 3 Johannes Gutenberg Universität Mainz, Institut fur Medizinische Mikrobiologie 
und Hygiene, Augustusplatz/Hochhaus, D-55¡01 Mainz, Germany) 
When peripheral blood mononuclear cells from Cryptosporidium parvum infected neonatal 
calves are stimulated with crude Cryptosporidium oocyst extract they produce BFNy. Depletion of 
different T­cell subsets revealed that CD4+ Τ cells are involved. A low molecular weight (LM) oocyst­
derived antigen fraction that evoke this immuneresponse could be partially purified. This LM fraction 
consists of a simple protein pattern with bands below 50 kDa. However, efforts to identify· the 
antigen(s) that was/were responsible for the stimulation of IFNv production were hampered by the low 
quantities of antigen available. Therefore we have chosen to screen a Cryptosporidium cDNA library 
for recombinant antigens involved in this Τ cell response. In this presentation we present preliminary 
work done so far, showing the different strategic approaches that have been applied. 
UÏŒ, RECOMBINANT SALMONELLA AS CARRIER FOR EIMERIA AKTIGENS 
Dick Schaap'. Gerben Arts', Volker Spehr2, Yan Zheng­Xin2, Thomas F. Meyer' and Amo 
Vermeulen' 
f Intervet International, PO Box 31, 3830 AA Boxmeer, the Netherlands. 2 Max-Planck-
Instilute, Spemannstr. 34, 72076 Tubingen, Germœxy.) 
Eimeria species cause intestinal coccidiosis, an enteritis which is of significant economic loss in 
the poultry industry. At present, coccidiosis is mainly controlled by the use of antibiotics. However, the 
emergence of drug resistant Eimeria strains, requires the development of alternative methods of control. 
We are presently analysing various Eimeria antigens for their protective immunity in subunit vaccines. 
For this purpose live recombinant Salmonella strains are used, expressing Eimeria gene products. 
Attenuated Salmonella strains, expressing heterologous antigens, are known to induce an immune 
response against other parasites, like Plasmodium and Leishmania. However, expression of toxic gene 
products or overexpression of the foreign antigens limits the survival of these recombinant Salmonella in 
the host. To circumvent this problem, an expression system was developed and optimised, in which 
foreign antigen expression is dependent on the orientation of an invertible promoter. The invertible 
promoter will be either in the "ON" or "OFF" orientation, resulting in a mixed Salmonella population. 
"OFF" Salmonella will not transcribe heterologous proteins and "ON" Salmonella will transcribe them. 
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The subpopulation in the "ON" orientation will be overexpressing the heterologous proteins, and as a 
result will be inhibited in its growth. The "OFF" subpopulation is not growth inhibited, and shall 
maintain the population, from which also new "ON" Salmonella will be generated, each time that 
inversion takes place. 
We will present our expression system in Salmonella typhimurium. It utilises a genomically 
inserted T7 RNA polymerase driven by an invertible promoter. T7 RNA polymerase subsequently 
transcribes our heterologous antigens, located on an expression plasmid. Green fluorescent protein was 
initially expressed to show with FACS studies, that inversion indeed occurs. Furthermore, studies with 
broiler chickens will be presented to show the stability of our expression system ;/; vivo and to 
demonstrate the induced protection against coccidiosis. 
CHARA CTERISA ΉΟΝ OF TWO MAJOR SURFA CE PROTEINS OF NEOSPORA 
CANINUM TACHYZOITES 
Sabrina Sonda 
(Institute of Parasitology, University of Bern. Switzerland) 
Neospora caninum is structurally and biologically closely related to, but antigenically distinct 
from, Toxoplasma gotidii. N. caninum is an obligatory intracellular parasite, with two stages, namely 
tachyzoites and bradyzoites, being identified to date. Molecules associated with the surface and with 
secretory organelles are likely to participate in the host cell entry process, and they could influence the 
pathogenesis of neosporosis. Therefore, our investigations have aimed towards the identification and 
characterization of surface-associated proteins ofN. caninum tachyzoites. Two proteins namely Nc-p43 
and Nc-p36 have been identified and characterized. The cDNA coding for these two proteins has been 
sequenced. Nc-p36 is highly homologous to p30 (SAG1) from T. gondii, while Nc-p43 exhibits a lesser 
degree of similarity to Toxoplasma surface proteins. Recombinant proteins were expressed in E. coli. 
Immunogold electronmicroscopy using antibodies affinity-purified on these recombinant proteins 
showed that Nc-p36 is found exclusively on the surface of N. caninum tachyzoites, while epitopes 
reacting with anti-Nc-p43 antibodies were found on the surface and within the parasite dense granules. 
Most likely both proteins are anchored into the surface membrane via a GPI-anchor. Nc-p36 is 
expressed exclusively in the tachyzoite stage, while Nc-p43 can be detected in both tachyzoites and 
bradyzoites. Further studies will be aimed towards the functional characterization of these two surface 
proteins and their immunological significance during infection. 
IMMUNOLOGICAL PROPERTIES OF SOME SOL UBLE AND MEMBRANE BOUND 
MICROSPORIDIAN ANnGENS 
Julia Sokolova 
(All-Russian Institute of Plant Protection, Russ. Acad. Agrie. Sci., St. Petersburg, Russia) 
Microsporidia (phylum Microspora) (M) is the group of vast distributed (from Protozoa to 
Primates including Humans) intracellular parasitic protists, baring very primitive and very specialized 
features simultaneously. RNA and DNA sequences 
suggest they are probably the most ancient eukaryots. Information about structural, transport and 
regulatory proteins of M, as well as on their enzymes is scarce, though it may serve the basis for the 
understanding of M pathogenicity and indicate the possible sites of suppressive therapy. The 
experimental host-parasite system: Gryllus bimaculatus - Nosema grylli we are working with, has 
certain advantages to perform biochemical and immunological studies on parasite antigenes. The present 
study persuaded two main goals: (1) to examine diffèrent ways of antigen preparation 
and to evaluate their influence on the resulted poly- and monoclonal antibodies; (2) to identify and 
localize new proteins with the help of obtained antibodies by means of immunofluorescent assay 
analysis, immune electron microscopy and Western Blots. Besides two types of highly specific immune 
sera, the following monoclinal antibodies antibodies were obtained: (1) 1BF3 recognized a protein of 55 
kDa that is connected with the spore filament as it was clearly suggested by IEM and IF A; (2) 1BD9 
recognized the 25, 34, 43 kDa proteins associated with spore walls; (3) 1BB9 reacted with 36, 45, 65 
and 75 kDa proteins and gave weak fluorescence around spores; (4) 2BB3 recognized 44 and 55 kDa 
proteins; (5) 2BD4 - a single protein of 54 kDa. The obtained antibodies add to the existing 
microsporidian antibody bank and can be used for the further work of isolation, description and 
sequencing the microsporidian proteins to understand their functions. 
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TOOLS FOR THE GENETICMANIPULATIONOF TOXOPLASMA GONDII AND THEIR 
APPLICA ΉΟΝ TO STUDY HOST CELL IN\rASION. 
S. Brecht, Β. Frank, A Geiter, C. Hettmann, M. Reiss and D. Soldati. 
(Zentrum für Molekulare Biologie der Universität Heidelberg, Germany.) 
The random cDNA sequencing project for Toxoplasma.gondii has generated over 10,000 
ESTs resulting in an explosion of gene discovery. A significant number of sequences revealed 
homologies to genes phylogenetically restricted to the Apicomplexa which are potentially playing crucial 
role in the establishment of intracellular parasitism. The apicomplexan-specific proteins include apical 
antigens involved in recognition and adhesion of host cells, proteins associated with specific life cycle 
stages, and unique metabolic enzymes involved in energy production. 
However a genome sequence is useless as long as the function of a gene can not be tested. T. gondii is 
particularly well-suited to laboratory study and its accessibility to genetic manipulation provides the 
opportunity to explore many questions relevant to the biology and pathogenicity of this organism and its 
closest relatives. The repertoire of molecular genetic tools currently available offers great potentials and 
some limits to study the function of both non-essential and essential genes. We have applied some of 
these tools to study proteins potentially implicated in the process of invasion. 
Apicomplexan parasites rely on an unusual form of gliding motility for host cell invasion. The 
basic engine for gliding locomotion is the actin cytoskeleton and likely involves a myosin to generate the 
mechanochemical force along the actin filaments. We have cloned and characterised two T. gotviii 
myosins by a PCR screen of parasite genomic DNA. The two myosins, MyoA 93 kDa (recently 
described by Heintzelman and Schwartzman) and MyoD 91 kDa belong to a novel phylogenetic and 
structural class of myosins (XIV). To identify which myosin might be involved in invasion, we have first 
determined the subcellular localisation of MyoA and MyoD using epitope tagging of their coding 
sequences and stable transformation into tachyzoites. Whereas MyoD is more diffusely found at the 
periphery of the cell, the sharply defined plasma membrane localisation of MyoA makes it a good 
candidate as motor of the gliding motility. Moreover, a parasite transmembrane protein is necessary to 
associate tightly with the host cell surface and to transfer the mechanical force across the plasma 
membrane. The C-terminal domain shall be establishing directly or indirectly a connection with the actin 
cytoskeleton and inducing gliding motility. The Plasmodium berghei TRAP protein appears to fulfil 
this double function in malarial sporozoites. Mie 2 has been recently described as the homologue of 
TRAP in T. gondii, and was the only known protein bearing a transmembrane domain. We have cloned 
and characterised a novel T. gondii microneme protein which carries EGF-like domains as well as the 
conserved C-terminal domain, including the transmembrane region common to the family of TRAP 
proteins. Mie 4 coding sequence predicts a protein of 34 kDa which appears to be present as a dimer in 
the parasite. 
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THE CURRENT STATUS OF TRANSFECnON IN PLASMODIUM BERGHEI. 
T. de Koning­Ward 
(Department of Parasitology University of Leiden P.O. Box 9605 2300 RC Leiden The 
Netherlands.) 
Although genetic transfection in Plasmodium still requires further development, it is now 
possible using the currently available technology to express introduced transgenes in Plasmodium and 
disrupt malarial genes by site­specific homologous recombination. These recent advances in the 
transfection of Plasmodium provide not only a means to determine the necessity of specific malarial gene 
products but allow a more detailed analysis of many aspects of the parasite's cellular biology, including 
the mechanisms underlying drug resistance. In this presentation, we will describe the methods used to 
stably transfect the rodent malarial pathogen, P. berghei as well as the expression of the exogenous 
reporter, green fluorescent protein. We will also show the effect of disrupting two genes that are specific 
to the mosquito stage of the parasite's life cycle: (i) the S­type ribosomal RNA genes, and (ii) the Pbs21 
gene which encodes an ookinete surface protein that has been implicated as a potential transmission 
blocking vaccine candidate. The ability to complement these disrupted genes in trans to help elucidate 
the function of these gene products in P. berghei is not yet feasible due to the lack of another suitable 
selectable marker. In this report we will also discuss the approaches currently taken towards finding 
additional selectable markers in P. berghei and what further tools are required to fully exploit 
transfection technology in this parasite. 
TRANSIENT TRANSFECHON OF E. TENELLA AND HETEROLOGOUS EXPRESSION OF 
MICRONEME PROTEINS INT. GONDII 
Fiona Tomley, 
(Institute for Animal Health, Compton, Newbury, RG20 7NN UK) 
A transient transfection system was developed for Eimeria tenella, using ß­galactosidase (ßgal) 
as a reporter enzyme. Successfully expressed constructs contained transcriptional control sequences, 
derived from either the E. tenella microneme gene £ftnic­l or from the E. tenella actin gene, fused to 
the coding region oilacZ. Transfectants expressing ßgal were able to invade host cells and proceed 
through part of the life­cycle, forming schizonts from which merozoites were released. Some 
merozoites which arose from transfected sporozoites were also found to express ßgal. These results are 
encouraging for the development of a stable transfection system for E tenella, using ßgal as a reporter 
enzyme. 
Micronemes are secretory organelles which are conserved across the phylum Apicomplexa and which 
are critical for the early stages of host cell invasion by these parasites. Microneme proteins (mies) are expressed 
late during the process of oocyst sporulation and again during the maturation of intracelllular schizonts and are 
assembled into the micronemes by an, as yet, uncharacterised process. To help understand how mies reach their 
target organelle, we have expressed two E. tenella mies in the related coccidian Toxoplasma gondii, generating 
stable lines of T. gondii which express either £miic­l or Etnac-2 in addition to the normal complement of T. 
gondii mies.. Both proteins were expressed in T. gondii but whereas Etnuc-2 was targetted to the apical tip, 
the majority of Etmic-l was not. Further recombinants are now being generated to examine targetting signals in 
more detail. The successful expression of two E. tenella mies in T. gondii demonstrates the value of this 
heterologous system for experimental analysis of E tenella proteins. 
HOMOLOGOUS RECOMBINA ΠΟΝΑ Τ THE GRA2 LOCUS CA USES PARTIAL 
ATTENUAnONOF TOXOPLASMA VIRULENCE 
C. Mercier. D.K. Howe, D.G. Mordue, M. Lingnau and LD. Sibley 
(Washington University School of Medicine, Department of Molecular Microbiology, Saint-
Louis, MO, US.) 
Following invasion into the host cell. Toxoplasma gondii secretes a variety of proteins that 
modify the parasitophorous vacuole. Amongst them, the 28­kDa dense granule protein GRA2 is 
specifically targeted to the tubulo­vesicular network connected to the vacuolar membrane.To investigate 
the function of GRA2, a mutant T. gondii line was derived from the RH strain in which GRA2 was 
disrupted by replacement with the selectable marker Ble. The mutation does not affect the parasite 
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growth rate in vitro. However, the mutant was less virulent during acute infection in mice. In contrast to 
the wild­type strain which always leads to death in infected mice, 44?/o of infected mice survived acute 
infection with the knock­out line. Moreover, chronic infection was demonstrated by the presence of both 
parasites and cysts immunohistochemically detected in the brain of infected animals, six weeks post­
infection. Thus, absence of GRA2 partially attenuates the virulence of T. gondii during the acute phase 
of infection by the otherwise highly virulent RH strain. 
STRUCTURE TO FUNCHONANALYSIS OF THE ADHESIVE DOMAINS WITHIN TRAP 
(THROMBOSPONDIN RELA TED ADHESIVE PROTEIN) OF P. FACUPARUM 
Firman Ghouze and Andrea Crisanti. 
Department of Biology, Imperial College of Science, Technology mid Médecine 
Prince Consort Road, London, SW7 2BB 
The malaria parasite Plasmodium falciparum expresses specifically at the sporozoite stage the 
thrombospondin related adhesive protein (TRAP). An increasing amount of evidence indicates that this 
protein plays an important role in hepatocyte invasion. TRAP contains several highly conserved amino 
acid sequences. One amino acid motif based around the sequence WSPCSTVCGKGXRXR, known as 
region II, is also present in the circumsporozoite (CS) protein of different Plasmodium species and other 
unrelated adhesive proteins. Studies have demonstrated that this region confers to the proteins the ability 
to bind to sulphated glycoconjugates and to hepatocytes. TRAP also contains, at its amino terminal 
region, a sequence of approximately 200 amino acids known as the Α­domain. This domain is present in 
a number of integrins and mediates binding to various surface ligands. Additionally, TRAP off. 
falciparum contains a RGD motif which has been demonstrated to be essential in the interaction of 
several extracellular glycoproteins with members of the integrin superfamily. In this study we have 
analysed the structure to function relationship of these adhesive domains within the TRAP molecule. For 
this purpose we have generated, expressed and purified a series of TRAP constructs carrying a series of 
substitutions in specific amino acid residues. Furthermore a construct with a deletion spanning the 15 
amino acids of region Π, named TRAP 1.0R2­ was also generated. The binding activity of these 
constructs to both immobilised sulphatides and different tumour derived cell lines has been assessed. 
Data show that region II and the A domain but not the RGD motif play a role in binding. These findings 
further our understanding of the molecular interactions which occur during hepatocyte invasion. 
SPECIFIC TERMINAL DELEHONS CAN BE INDUCED ON PIASMODIUM BERGHEI 
CHROMOSOMES THROUGH TRANSFECTION TECHNIQUES. 
Marta Ponzi. Raffaella Scotti, Tomasino Pace. 
Laboratory of Cellular Biology, Istituto Superiore di Sanità, Rome, Italy 
Large subtelomeric rearrangements are often responsible for chromosome size polymorphisms 
often observed in Plasmodium. The instability of chromosome ends has been shown to be mostly 
associated with the loss of subtelomeric genes. Moreover, large deletions of terminal portions of 
chromosome 5 in P. berghei and chromosome 9 in P.falciparum correlate with the loss of 
gametocytogenesis in laboratory infections or in cultures. A linear vector containing a selectable marker 
and telomeric sequences was constructed and shown to be able to induce, in transfection experiments, 
specific chromosome deletions when provided with a short genomic region homologous to the target 
site. This new approach will allow to verify the phenotipic effect of controlled chromosome deletions 
and to study position effects exerted on functions located in the vicinity of the breakage point. 
COMPARISON OF THE HOST/PARASITE RELA nONSHIP IN THE ENTERIC AND 
EXOENTERIC FORblS OF TOXOPLASMA GONDII 
D.J.P. Ferguson 
Nuffield Department of Pathology, Oxford University, John Radcliffe Hospital, Oxford, UK. 
The host parasite relationship of Toxoplasma gondii during coccidian (asexual and sexual) 
development in cat and tachyzoite and bradyzoite the intermediate host was examined by electron 
microscopy and immunocytochemistry. T. gondii undergoes a unique form of asexual (endopolygony) 
and sexual development only within the enterocytes of the cat and no other species or cell type. 
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Ultrastructural examination of host parasite relationship shows that the enteric forms are located within 
a parasitophorous (PV) which is significantly different from that described for all other forms of the 
parasite. The various sexual and asexual stages are located within a tight fitting PV limited by thickened 
membrane with a laminated substructure. This membrane appear to be the result of the fusion of three 
unit membranes. A number of conical shaped indentations are located on the parasite side of the PV. 
There was no evidence of an intravacular network or the collecting of host cell mitochondria and rough 
endoplasmic reticulum around the PV which are characteristic of the tachyzoite PV. It Is possible that 
this unique host/parasite relationship and the coccidian devlopment of the parasite are interrelated. The 
biological nature of the PV formed in cat enterocytes is unclear but is appears to be triggered at the time 
of parasite penetration. 
The expression and location of the dense granule proteins (GRA 1­6 and NTPase) in the 
merozoite and during coccidian development of T. gondii in the small intestine of the cat (definitive 
host) has been examined by immuno­light and electron microscopy. This was compared with that of 
tachyzoites and bradyzoites present in the intermediate host. It was found that the merozoite contained 
the characteristic apical organelles plus a few large dense granules. By immunocytochemistry, these 
granules were negative for GRA proteins 1 to 6 in contrast to both tachyzoites and bradyzoites where 
dense granules were positive for all six proteins. The GRA proteins were associated with the 
parasitophorous vacuole (PV) during tachyzoite and bradyzoite development but were absent from the 
PV of the coccidian stages. However the dense granules were positive for NTPase which was similar to 
the tachyzoite but appears to be down regulated in the bradyzoite. The apparent release of the NTPase 
into the Ρ V was also similar to that described for the tachyzoite. This may reflect the relative metabolic 
activity of the various stages. This study shows that eof the GRA proteins has a similar stage specfic 
expression which is independant of NTPase expression. These observations are consistent with T. gondii 
having a different host parasite relationship in the enteric forms which does not involve the GRA 
proteins. 
T. gondii is a coccidian parasite with the cat as its definitive host but any warm blooded animal, 
including Man, can act as an intermediate host. In the intermediate host the parasite undergoes an acute 
phase where the tachyzoites reproduces rapidly followed by a chronic phase when the bradyzoites 
reproduce slowing giving rise to tissue cysts which are found predominantly in muscle and brain. These 
tissues cysts are believed to remain viable for long periods and can transmit the infection if eaten by 
other intermediate hosts or the cat. In the case of the cat, infection results in typical coccidian asexual 
and sexual development in the small intestine with the production of oocysts which are passed in cat 
faeces (Hutchison et al 1971, Frenkel and Dubey 1970). 
T. gondii is an obligate intracellular parasite and can only proliferate within nucleated cells. 
Therefore the interaction with the host cell is vital for parasite survival. The tachyzoite and bradyzoite 
are ubiquitous in the host species and cell type within which development can occur. In contrast, the 
coccidian development is restricted to single host species and cell type and to date no in vitro model 
exists. Due to the ease of obtaining parasites, the host/parasite relationship has been extensively studied 
in the tachyzoite. 
MICRONESIË SECREUON DURING INVASION EIMERIA 
J.M Bumstead and F.M. Tomley 
(Institute for Animal Health, Compton, Newbury, Berkshire, RG20 7NN). 
The invasion of in vitro cultured host cells by Eimeria tenella sporozoites involves the rapid 
relocalisation and secretion of microneme proteins. Microneme proteins are secreted from the apical 
end of the sporozoite and can be detected in the culture supernatant and also on the surface of host cells. 
Secretion is triggered by contact with cells and also by extracellular factors including serum and 
albumin. Microneme proteins can also be found in trails deposited by the sporozoite as it glides over the 
cell surface. If motility is inhibited with cytochalasins, secretion still occurs, but in this case microneme 
proteins are released apically and do not trail, presumably because the actin­myosin motor which is essential 
for motility does not engage. This suggests that microneme proteins may form a bridge between the motility 
motor, located in the sub­pellicular microfilaments and the surface of the host cell to which they bind via their 
many adhesive domains. 
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TO WARDS A FUNCTIONAL ANAL YSIS OF CYCLIN DEPENDENT PRO TEIN KINASES IN 
THEILERIA ANNULA TA. 
Jane H. Kinnaird. Mary Logan and Geoffrey Ingram 
(Dept of Veterinary Parasitology, University of Glasgow, Bearsden Road, Glasgow G61 10H. 
E-mail: J.Kinnaird%udcf.gla. ac.uk) 
Cyclin dependent kinases (CDKs) are highly conserved serine/threonine protein kinases which 
are intimately involved in regulating many essential cellular functions by phosphorylation of their target 
substrates. The activity of the kinase catalytic subunit is itself regulated by binding of a cyclin subunit 
and an inhibitor as well as by phosphorylation. Amongst the best characterised CDKs are those which 
are involved in regulating progression of the cell cycle although others have roles in cell cycle entry and 
in differentiation. In higher eukaryotes there is a large family of CDKs, whose activities are regulated by 
different cyclin partners. In lower eukaryotes there tend to be fewer CDKs, and notably in yeast, many 
elegant mutational studies have been carried out which demonstrate the essential role of these kinases. 
Amongst protozoan parasites, several genes encoding CDK related proteins have been isolated and none 
of these show the extremely high levels of conservation found in other eukaryotes. Two such genes have 
been characterised from Theileria annidata. The first, ThaCRK2 encodes a 34 kDa polypeptide which is 
most closely related to the CDK1/2 groups which regulate Gl­S and G2­M transitions of the cell cycle 
in other eukaryotes. ThaCRK2 RNA and protein are detectable in all dividing life cycle stages, which is 
consistent with a constitutive role in parasite division. Using a specific antiserum generated against 
recombinant ThaCRK2 we have shown that this protein localises to the cytoplasm in the macroschizont. 
In T. annulata the piroplasm stage does not show extensive multiplication but both Northern and 
Western blotting show a high levels of ThaCRK2 RNA and protein in comparison to signals obtained for 
other markers of nuclear division. This points to an additional role in the life cycle. The more recently 
isolated ThaCRK3 encodes a 45 kDa polypeptide with most significant homology to CDK7 which in 
combination with cyclin H is believed to activate some CDKs by phosphorylation. Although the 
relationship is not strong, a probable homologue, Pfrnrk, has been identified in Plasmodium falciparum. 
The RNA expression pattern of ThaCRK3 is distinct from ThaCRK2 in the different life cycle stages. 
ρ 13 is a small protein originally identified in yeast and which has homologues in other 
eukaryotes. It is found complexed with some CDKs and has been extensively used in their purification. 
Recombinant histidine tagged pl3 coupled to sepharose has been used to affinity purify kinases from 
native extracts of T. annulata piroplasms. At least two kinase activities have been identified in this way, 
one of which is attributable to ThaCRK2. Prior immunodepletion of ThaCRK2 showed that at least one 
other kinase activity remained which showed a bias towards α­casein as an in vitro substrate whereas 
extracts which were not depleted in ThaCRK2 showed more extensive phosphorylation of histone HI. 
These results confirm ThaCRK2 is active as a kinase in the piroplasm stage and also demonstrates that 
its substrate specificity is different from other kinases present in the extracts which can bind to yeast 
pl3. 
The ability to carry out Theileria transfection would greatly aid functional studies of these 
kinases in different life cycle stages. Preliminary studies have been carried out to establish transfection 
based on methods used for the intraerythrocytic stage oí Plasmodium spps. We have designed 
constructs using chloramphenicol acetyl transferase as a reporter linked to 5' and 3' regulatory regions 
of the T.annulata ß­tubulin gene. A construct has also been made again using a CAT reporter but under 
the control of the putative 5' and 3' regulatory regions of Tarns I, a gene encoding a 30 kDa merozoite 
surface polypeptide, whose transcription is up­regulated during differentiation to the merozoite. Various 
parameters of electroporation and use of different life cycle stages have not produced any conclusive 
evidence for parasite specific transient expression of the reporter. However the constructs based on the 
parasite ß­tubulin control sequences gave significant transient expression of CAT originating from the 
host cell, indicating that sequences within this particular parasite promotor region can be recognised and 
used by host proteins. Work is now proceeding, in collaboration with Roger Hall's group at York 
University, to develop a selectable marker for transfection using sporozoite and infected lymphocyte 
stages as the initial targets. Other methods of introducing DNA are also being investigated. 
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INJŒSUGATING THEFUNCnONAL SIGNIFICANCE OF TOXOPLASMA GONDII CDC2-
RELATED KINASES 
J.M. Wastling' , J.H. Kinnaird2 and J.G. Mattsson1 
f1 Institute of Biomedical & Life Sciences, Division of Infection & Immunity, Joseph Black 
Building, University of Glasgow, Glasgow G12 800, UK. ^Wellcome Unit for Molectdar 
Parasitology, University of Glasgow. 3 Department of Parasitology, National Veterinary 
Institute, Uppsala, Sweden.) 
Infection with Toxoplasma gondii is initially characterised by the rapid multiplication of 
tachyzoites followed by their differentiation into slowly-dividing bradyzoites and the formation of long-
lasting tissue cysts. The transformation of tachyzoites into bradyzoites involves a dramatic change in the 
rate of ceil division, implying a high degree of control over cell-cycle. Regulators of the Toxoplasma cell 
cycle have until recently received little attention. Cyclin-dependent kinases (CDKs), which include the 
cdc2 kinases, are evolutionary conserved molecules many of which regulate the eukaryotic cell cycle. 
cdc2 was first identified in yeast, where it regulates both the Gl-S and G2-M phase cell cycle 
transitions, then subsequently in a wide range of eukaryotes. Using consensus primers we have identified 
a number of T.gondii cDNA and genomic clones which show close homology to eukaryotic CDKs. For 
one of the clones (designated TgCRK2) we have obtained a full length genomic sequence which encodes 
a predicted polypeptide of 33kDa that is most similar to the cdc2 type of CDK (< 55%). However, the 
closest homologies are with a Theileria cdc2-related kinase, ThCRK2 (72% identity) and with PfPK5 
(72%), the CRK from Plasmodium falciparum most closely related to cdc2. TgCRK2 contains the 
characteristic PST ATRE motif, implicated in the binding of activating cyclins of A, B, D and E types to 
CDKs. Transcripts of TgCRK2 could be detected in T.gondii M3 strain bradyzoites using RT-PCR but 
appeared to be relatively more abundant in the rapidly dividing RH and S48 strain tachyzoites. Western 
blotting of Toxoplasma tachyzoites using an antiserum against the conserved PSTAJJRE region detected 
a molecule of 32-33 kDa, consistent with the predicted size of TgCRK2, but also suggested the 
presence of other related molecules. We are currently using a number of approaches to analyse the 
functional significance of Toxoplasma CDKs including transient and stable transfection of TgCRK2 
constructs in tachyzoites, homologous gene targeting, complementation and identification of the 
corresponding cyclin binding partners of Toxoplasma CDKs. 
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LIFE CYCLES, TAXONOMY AND GENETIC 
RELATIONSHIPS OF INTESTINAL COCCIDIA 
OF PIGS 
Astrid Tenter 
Institut rur Parasitologie, Hanover 
Keywords: Isospora, Toxoplasma, Neospora, Sarcocystis, 18S rDNA; PCR; phylogenetic analysis 
The phylogenetic relationships and taxonomie affinities of coccidia with isosporan-type 
oocysts have been unclear as overlapping characters, recently discovered life cycle features, and 
even recently discovered taxa, continue to be incorporated into biological classifications of the 
group. We determined the full 18S rRNA gene (rDNA) sequences of two mammalian Isospora 
spp., Isospora felis and Isospora suis, and a Sarcocystis spp. of a rattlesnake, and used these 
sequences for a phylogenetic analysis of the genus Isospora and the cyst-forming coccidia. 
Various alveolate 18S rDNA sequences were aligned and analyzed using maximum parsimony to 
obtain a phylogenetic hypothesis for the group. The two Isospora spp. were found to be most 
closely related to Toxoplasma gondii and Neospora caninum. This clade in turn formed the sister 
group to the Sarcocystis spp. included in the analysis. The results confirm that the genus 
Isospora does not belong to the family Eimeriidae, but should be classified together with the cyst-
forming coccidia in the family Sarcocystidae. Furthermore, there appear to be two lineages within 
the Sarcocystidae. One lineage comprises Isospora and the Toxoplasma!Neospora clade which 
share the characters of having a proliferative phase of development preceding gamogony in the 
definitive host and an exogenous phase of sporogony. The other lineage comprises the 
Sarcocystis spp. which have no proliferative phase in the definitive host and an endogenous phase 
of sporogony. A likely evolutionary scenario for heteroxeny in the group of coccidia with 
isosporan-type oocysts is that heteroxenous life cycles are derived features that have arisen 
independently in the different lineages, and that homoxenous Isospora spp. have retained the 
ancestral life cycle of the Isospora/'Toxoplasma/Neospora lineage. 
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OCCURRENCE OF ISOSPORA SUIS IN PIG 
BREEDING FARMS AND SPECIALIZED 
PIGLET REARING FARMS IN GERMANY 
Dr Arwid Daugschies 
Institut fur Parasitologie der Tieraztliche Hochschule Hannover, 
Bunteweg 17, D-30559 Hannover, Germany 
Key words:- Isospora, pig, prevalence, Germany 
The prevalence οι Isospora suis in breeding farms with 12 to 238 sows was investigated by fecal 
examination of litters in the 2nd, 3rd and 4th week after farrowing. 
Two farms specialized in pig rearing with conventional weaning (CW) at an age of 4 to 5 weeks, 
or segregated early weaning (SEW) at an age of up to 21 days were also examined immediately 
after stalling up, 2 weeks later and at the end of the rearing period. 
I. suis was diagnosed in all farms. 
The prevalence increased during the suckling period from 17 to 19 % in the 2nd week to almost 
40 % at the time of weaning. The cumulative prevalence in the litters was above 50 %. 
Diarrhoea was significantly associated with Isospora prevalence. 
In the farm managed according to the SEW system the prevalence decreased during rearing from 
37.5 % to 19.3 % and 4.1 % and the occurrence of diarrhoea decreased simultaneously from 
36.5 % to 11.0 % and 3.3 %. 
In the farm in which CW was practiced the Isospora prevalence ranged from 17.2 % to 21.9 % 
during the rearing period and diarrhoea was seen in about 34 % of the piglets at the first and 
second visit and decreased at the end of the rearing period to 5.7 %. 
Thus I. suis is a frequent endoparasite in piglet breeding farms irrespective of the size of the herd 
and infections are often associated with diarrhoea. 
Isospora also occurs in piglet rearing farms, at least at the beginning of the rearing period. 
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ISOSPORA SUIS IN SUCKLING PIGS -
THE ROLE OF HISTOPATHOLOGY IN THE 
DIAGNOSIS OF FIELD OUTBREAKS. 
Dr Robert Higgins, 
Veterinary Investigation Centre, 
Thirsk, UK 
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DIAGNOSIS can be based on several criteria 
1. Clinical signs 
2. Poor response to antibiotics 
3. Faecal examination for oocysts, 
parasite has a prepatency 5 days, patency 5-14 days 
4. Post-mortem examination 
This requires the sacrifice of LIVE pigs in the acute stage and examination 
(a) Impression smears of mucosa 
(b) Histology 
5. Prophylactic response to toltrazuril? 
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CLINICAL SIGNS 
Age range 6-15 days, peak 7-10 days 
Diarrhoea - yellow pasty initially, profuse white watery later 
Afebrile 
Usually continue to suckle 
Vomiting + 
Dehydration 
High morbidity 
Low mortality< 10% typically 
Poor response to antibiotics 
Weight loss ± scour 
Uneven growth rate in litter 
EPIDEMIOLOGICAL FEATURES 
1. Intensive indoor systems 
2. Sucklers only 
3. All parity litters 
4. Passive immunity ineffective 
5. Poor response to antibiotics 
6. Hygiene status ? 
7. Seasonality? submission bias 
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FAECAL EXAMINATION 
Glucose salt solution for flotation -fat content can cause technical problems 
Oocyst ID - hazy bodies at margins or 2 cell sporoblast stage 
Differential identification from Eimeria and Cryptosporidia oocysts 
There are several problems with faecal examinations 
For samples to be positive the infection must be at patent stage 
Multiple samples are often necessary from the same pig or from several pigs 
Correlation with gut damage and numbers of oocysts is unknown 
False Negatives may occur for several reasons 
Prepatency stage rather than patent stage 
There is thought to be a biphasic cycle of oocyst production, usually 9-11 days post 
infection, when no oocysts may be excreted 
Severe pathology will interfere with oocyst production 
Only 7% histologically confirmed pigs were oocyst excreters (Sandford 1983) 
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MUCOSAL SMEARS 
Technique 
1. Thin smear is essential. 
2. Scrape mucosa, compress between two slides, separate. 
3. Ar dry 
4. Stain with Giemsa or modified Wright (DifF-Quick). 
5. Meronts can be seen that are binucleate or multinucleate. 
Merozoites in pairs or multiples 
Assessment of technique 
1. Rapid, cheap, simple requires minimal laboratory equipment. 
2. Reasonable correlation with histology. But may be unnecessary duplication? 
3. May be more sensitive in severe cases? 
GROSS PATHOLOGY 
Non-specific lesions 
Thin walled intestines 
Excess liquid contents 
Mesenteric lymph nodes enlarged 
Necrotic enteritis ± fibrin cast 
No Haemorrhage 
HISTOLOGICAL DIAGNOSIS 
Rapid fixation after euthanasia is essential by simple immersion in 10% NBF/FS 
Sites - duodenum, jejunum*, ileum*, caecum, colon, 1-2 cm tubes 
* preferred sites 
Standard haematoxylin and eosin stain 
Lesions-. 
Special stains 
villous atrophy 
condensed villous cores 
enterocyte metaplasia 
microulceration ± 
reactive crypt hyperplasia Special stains 
Isospora suis asexual/sexual stages 
parasitiphorous vacuoles in enterocyte (not LP) 
necrotic enteritis ± secondary bacteria 
Jejunum, ileum mainly - rarely LI 
PAS, 
Giemsa - limited value 
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PATHOLOGY 
Neonatal challenge 
Age dependent effect - epithelial dynamics 
Field cases correlate best with 200,000 oocyst dose. 
Necrotic enteritis with 400,000 oocyst dose 
Biphasic damage has been shown experimentally 
4-6 days post infection see moderate villous atrophy, reactive CH. 
At 8-10 days post infection see severe necrosis and crypt damage. 
This can not be explained by reinfection. 
Is there a possible extra-intestinal stage returning to mucosa and causing damage? 
Parasite difficult to find in later stages 
Non-specific villous atrophy (early cases for diagnosis) 
Other organs - granulomatous lymphadenitis seen 
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HISTOLOGICAL DIAGNOSIS 
Advantages 
Comprehensive assessment of gut 
Direct visualization of parasite in situ 
Direct correlation with pathological change 
Differential diagnosis 
Disadvantages 
Expensive 
Requires laboratory facilities 
May be slow 
EXTRA-INTESTINAL STAGE ? 
Experimental evidence - need transmission studies 
Possible sites for stage- Reticulo-endothelial system, liver, spleen, lymph nodes 
Difficult to visualize - may need markers to identify? 
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DIFFERENTIAL DIAGNOSIS 
Clinical signs may be seen with several other conditions/infective agents 
ROTAVIRUS principally. 
Colibacillosis ETEC? - opportunistic 
Clostridium perfringens type C 
Salmonellosis - £ typhimurium 
Transmissible gastroenteritis TGE 
Porcine epidemic diarrhoea PED 
Adenovirus 
Cryptosporidia, C.parvum 
Strongyloides ransomi (not in UK) 
PRRS - immunosuppressive? 
Adverse environmental conditions will increase mortality 
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ECONOMIC EFFECTS 
Reduced growth rates 
Cost of treatment 
Increased susceptibility to other diseases both preweaning and postweaning 
SOURCE OF INFECTION 
ENIGMATIC 
SOW - minimal faecal excretion of I.suis, not via milk or transplacental 
Contaminated environment - previous litters in pen or other litters in house 
Appropriate disinfection/sanitisation to kill oocysts; most standard farm disinfectants will 
not kill oocysts 
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IDEAS ON CONTROL AND TREATMENT 
Dr Bill Smith 
Scottish Agricultural Colleges, 
Aberdeen, Scotland 
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SOME ASPECTS-LIFE CYCLE 
vo 
H 
Oocyst sporulation in 4 days 30°C 80-85% 
Sporulated oocyst ingestion 
*- Clinical disease 3-4 days 
► Shedding oocysts in faeces 
3-4 days after diarrhoea onset 
SPREAD OF DISEASE 
Ol 
Sow 
Environment/Food trough/Water bowl 
Flies 
Other vectors 
PREVENTION 
VO 
(Λ 
Sanitization 
Preventive Treatment 
Sow Faeces Removal Daily 
Shift Farrow 
SANITIZATION 
VD 
Flame Gun 
Oo-cide (Antee Int) 
Stalosan 
Biosuper 
ORAL DRUGS - Piglets 
CO 
Βaycox 
Midicel 
Sulphonamides 
Coccidiostats eg Deccox 
DRUGS IN FEED - Sow 
Deccox (Decoquinate) 
Monensin 
Amprolium 
Salocin 
REVIEW OF FIELD SURVEYS AND METHODS 
IN NORDIC COUNTRIES 
Dr Kirsten Larsen 
Bayer A/S 
Denmark 
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Translation of an article printed ¡n the Danish Veterinary Journal (Dansk 
Veterinær-tidsskrift) 1996, 79, 9, 1/5, pp. 387-392. 
Review of the literature, 1995 
Isospora suis. 
Porcine neonatal coccidiosis. 
by: cand. med. vet. Kirsten Larsen 
Bayer A/S 
Nørgaardsvej 32 
DK-2800 Lyngby 
DENMARK 
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Isospora suis. 
Porcine neonatal coccidiosis. 
By Kirsten Larsen 
Summary 
Neonatal coccidiosis caused by Isospora suis has been described in many different countries 
throughout the world. The life-cycle follows three phases: sporogony, excystation and an 
endogenous phase. It is discussed whether there is also an extra-intestinal phase. The typical clinical 
symptoms are diarrhoea in suckling pigs in the second week of life. The diarrhoea will typically be 
yellow and pasty, the morbidity rate is high, whereas mortality is often low. Herd conditions and 
management will be very significant factors in the spread of the disease. Routes of transmission are 
constantly being discussed, but the most likely is pig to pig transmission via contamination of the 
surroundings. Strong immunity develops after infection with I. suis. The diagnosis is made on the 
basis of the clinical symptoms and detection of oocysts or other development stages, either by 
means of a modified McMaster flotation technique, or by microscopic examination of a smear from 
the mucous membrane of the intestine. There are no highly suitable therapeutic agents or 
coccidiostatics on the market at present, which is why it is important to institute thorough hygiene 
measures. Sulpha preparations are used prophylactically by injecting the suckling pigs several times 
during the first week of life. A new product, toltrazuril (Baycox® 5% suspension), is under 
development. Toltrazuril has been shown to be especially effective in preventing coccidiosis in 
suckling pigs after a single oral dose of 20 mg/kg bodyweight. 
Introduction 
Diarrhoea in suckling piglets is a common disease in pig production in Denmark'. In particular, 
diarrhoea in the piglets' 2nd week of life does often occur. Most of these cases of diarrhoea are 
caused by the coccidia species Isospora suis. Thus Isospora suis was diagnosed in 20% of the 
faecal- or organ samples sent to the National Veterinary Laboratory in 1993 for parasitological 
examination. 
Coccidiosis in suckling pigs is also reported from abroad to a constantly increasing degree. 
This literature review updates the knowledge about Isospora suis: prevalence, life-cycle, 
pathogenesis, clinical symptoms, immunology, diagnosis and prevention and control. 
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Coccidia in pigs 
In all, identification of 13 species of Eimeria and 3 species οι Isospora2 has been reported in pigs. 
Many of these species are only known as the finding of oocysts in faeces, and some of these are 
probably not independent species. Some of the species found are thought to be only occasionally 
passing through the intestine 3. Only Isospora suis is considered to cause a pathological problem in 
pigs, although Eimeria species, in rare cases, can cause mild transient diarrhoea2. 
Isospora suis has been shown to cause the same clinical picture in wild boars 4 and miniature 
.5 swine 
Prevalence 
Nordic countries 
In a joint Scandinavian project concerning parasitic infections in pigs , several different Eimeria 
species as well as Isospora suis were detected. The Eimeria species were not determined. In the 
prevalence study there was found a great variation in the different Nordic countries (Fig. 1). The 
largest prevalence was observed in Iceland, while in Norway and Finland there was a very low 
occurrence of coccidia. The occurrence in Denmark and Sweden was more or less on the same level. 
One have to note that in Fig. 1 no differentiation is made between Isospora suis and Eimeria 
species. 
In 71% of the positive samples, identification of the species was successful (Fig. 2). Here, Isospora 
suis was confirmed in: 96% of the suckling piglets, 67% of the weaners, 57% of the prefatteners and 
in 40% of the fatteners respectively. 97% of the identified samples from the adult breeding animals 
were Eimeria spp. Isospora suis was only diagnosed in 3 pregnant sows and in 4 lactating sows, all 
from Iceland. 
■JLM, 
Ρ = Piglets, W = Weaners, SF = Small Fatteners (35-40 kg) LF = Large Fatteners (65-90 kg) 
G = Gilts, DS = Dry Sows LS = Lactating Sows, Β = Boars 
Fig. 1. Prevalence of Eimeria spp. and Isospora suis oocyst-count positive pigs in the Nordic 
countries in 1986-1988 (random herds)6. 
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Types of herds 
In this study6, the occurrence οι Isospora suis correlated strongly with the size of the herd. Only 
6.9% of the found positive samples from piglets were from herds with less than 50 sows, 21.5% 
from herds with 50­99 sows, and 34.3% from herds with more than 100 sows. 
The occurrence of Eimeria species from the breeding animals was positively correlated with access 
to outdoor sties. 
In Denmark it was also found that a high Isospora prevalence correlated strongly with a low 
weaning age, which may be explained by a rapid turnover of susceptible piglets in the farrowing 
pens. In addition, it was found that the SPF/MS system (declared Specific Pathogen Free) correlated 
with a low prevalence. 
In addition, in intensively farmed herds, coccidiosis is said to occur far more frequently in herds 
where the farrowing pens have solid or partially solid floors7. 
The results from the joint Nordic study correspond to other prevalence studies. In 1993, Nielsson et 
al.8 examined faecal samples from 34 Swedish sow herds. In the samples from the sows, they found 
that, Eimeria spp. were detected in 38.2% of the herds (17.9% of the sows examined), but Isospora 
suis was not detected in any of the herds. In the samples from the suckling piglets (1­4 weeks old), I. 
suis was detected in 25% of the herds, where there were problems with steatorrhoea (13% of the 
litters examined), and in 12.5% of the herds where no diarrhoea problems were recorded (8.3% of 
the litters examined). In another study8, Nielsson et al. detected oocysts in faeces from one lactating 
sow. However, the piglets of this sow were all negative for I. suis. 
ω o c 
D Eimeria spp. % 
■ Isospora suis % 
jS*ar^*ttTÌ1r\/* 
BA* 
Ρ = piglets, W = weaners, SF = small fatteners, LF = large fatteners BA = breeding animals 
(7 sows pos. for /. suis, all from Island) 
Fig. 2. Prevalence of the total Eimeria and Isospora suis oocyst­count in the Nordic countries in 
1986­19886. 
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Other countries 
Coccidiosis in piglets in the 2nd week of life is being described in many other countries. Apart from 
the Scandinavian countries, particularly USA and Canada10,1 ' are aware of the problems that 
Isospora suis can cause. From other overseas countries, /. suis coccidiosis has been described in 
Australia12 ' l 3 , l4, Brazil'3, Venezuela16 and China17. From the other countries in Europe, there have 
been only a few reports of the occurrence of coccidiosis in piglets, from, among others, 
is Czechoslovakia and Switzerland 19 
Seasonal variation 
Robinson and Morin" showed in 1982. that coccidiosis was a problem throughout the year, but that 
there were clear seasonal variations. The highest prevalence was found in July - September. This 
seasonal variation was not demonstrated in studies from Denmark" and in Australia14. 
Life-cycle 
Coccidia are protozoa, which are all obligatory parasites2. The classic coccidia belong to the family 
of Eimeriidae; this includes the genera Eimeria and Isospora. With just a few exceptions, they are 
parasites in the gastrointestinal tract. So far, 248 species of Isospora have been described" . 
The typical life-cycle for coccidia is in three phases: sporogony, excystation and endogenous 
development2,21·22. 
Sporogony 
Sporogony is the exogenous phase of the life-cycle. Oocysts are excreted with faeces, and 
sporulation to the infective stage takes place outside the host (see 111. 2). 
The sporulation is dependent on humidity, temperature and oxygen. The sporulation of Isospora 
suis oocysts is apparently inhibited by temperatures >40°C or <20°C. At optimum temperatures (30-
37°C), sporulation can take place in less than 16 hours8. 
When the / suis oocyst is sporulated, it contains two sporocysts, each with four sporozoites. This is 
different from the Eimeria species, where the sporulated oocysts contain four sporocysts, each with 
two sporozoites2-4 (111. 1). 
10pm 
111. 1. Sporulated oocysts from a: Eimeria suis, b: Eimeria debliecki, c: Eimeria polita, 
g: Isospora suis, (after Löwenstein and Kutzer, 1989)4. 
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Excystation 
Excystation is the process in which sporozoites are released from the sporocyst/oocyst. The release 
of sporocysts from the oocyst takes place with assistance from the gastric acid and in the presence of 
CO2" . Bile and pancreatic enzymes in the small intestine activate the sporozoites, which become 
mobile and cause the sporoblast/oocyst to burst. The sporozoites penetrate the villous epithelium, 
normally in the outermost 1/3 of the villi. The greatest concentration is seen in the middle part of 
the jejunum, but the ileum is also infected. In severe infections the colon can also be involved22. 
Endogenous development 
The endogenous development can be seen from 111. 2. In the cells of the intestinal epithelium, the 
meronts are formed by asexual reproduction, and a number of merozoites are produced. With the 
release of the merozoites, the cells of the intestinal epithelium are destroyed. The merozoites now 
invade new intestinal cells, and the asexual reproduction is repeated. According to Tubbs 198622, 
the process involves 3 asexual reproductions, whereas others believe that the number of asexual 
reproductions can vary21. 
The last asexual stage begins to form the sexual stages in the life-cycle, the macrogametes (female) 
and the microgametes (male). The microgamete fertilises the macrogamete, and the hereby 
produced zygote develops cell walls and becomes an oocyst. The oocyst is released into the lumen 
of the intestine, and is shed with-faeces. 
The pre-patent period fot Isospora suis is 5-7:days arid the patent time is from 5 up to 16 days23. 
Sporulated 
oocyst Two-celled 
stage 
Unsporulated 
oocyst 
III. 2. Isospora suis life-cycle in pigs'(after Lindsay and Blâgburn, 1994)21. 
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Extra-intestinal stages? 
In the case of Isospora species in dogs and cats, extra-intestinal stages occur in the tissue of the 
host. Instead of going through the normal life-cycle in the intestinal tract, some sporozoites and 
merozoites leave the intestine and invade extra-intestinal sites in the host. The mesenteric lymph 
nodes are most frequently infected, but other organs can also be involved. 
Whether such extra-intestinal stages occur with /. suis in pigs has not yet been clarified 22. 
Henriksen et al.24 showed in 1992, that piglets infected with low doses of I. suis oocysts (100 
oocysts) shed oocysts in a cyclical pattern with a periodicity of 5 days. Up to three periods were 
documented, separated by sub-patent periods. This discovery supports the hypothesis of extra­
intestinal stages for Isospora suis. 
Clinical symptoms 
Clinical coccidiosis is seen most frequently in 5-14 days old piglets, but can occur in piglets up to 
21 days old . The piglets develop diarrhoea, which initially is pasty, then becomes more 
liquid. The faeces are typically yellow and greasy/creamy, but can vary to brownish/greyish and be 
slightly frothy or watery. Typically, in the same herd there will be piglets with diarrhoea as well as 
piglets with normal faeces. From several places a typical picture has been described, where some 
piglets in the infected herd are constipated, with excretion of dry, pellet-like faeces ("sheep pellet 
faeces") 26, 27. This is thought to be pathognomic for neonatal coccidiosis. The diarrhoea lasts from a 
few days up to 5-6 days. In occasional cases the diarrhoea can last until weaning. The majority of 
affected piglets will continue to suckle, but become thin and possibly dehydrated. The morbidity is 
high, but the mortality is low to moderate. In a survey among Danish pig veterinary surgeons carried 
out in the spring of 19907, it was judged that slightly more than half of the litters in a herd typically 
were affected, and that, on average, slightly less than half of the piglets in affected litters developed 
diarrhoea. However, a significant variation from one herd to another were seen. In the same survey, 
the disease was judged to have only a slight influence on mortality, but to reduce growth by 15% on 
average. 
Pathogenesis 
The piglets become infected by absorbing sporulated oocysts. 
Route of transmission 
It is extremely rare for Isospora suis oocysts to be detected in the faeces of sows ' ' ' . One 
example from a study from USA9: From herds with a known history of Isospora coccidiosis in the 
piglets, no sows were found to be positive for Ζ suis; in herds without clinical coccidiosis, /. suis 
was isolated from one out of 249 sows. 
It must therefore be assumed that the piglets absorb oocysts that are present in the farrowing pen 
from the previous litter, or are brought in by the stall personnel, etc. Infected piglets shed 10-100 
thousand oocysts per gram of faeces, and since coccidia oocysts are very resistant to disinfectants, it 
is difficult to take precautions against the transfer of coccidiaoocysts from one litter to the next. 
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The significance of the infective dose 
The degree of clinical coccidiosis is to some degree dependent on the number of oocysts absorbed21' 
22, . Christensen and Henriksen investigated in 1994 which impact the infective dose of oocysts 
had on the clinical outbreak of coccidiosis in piglets23. With the infective doses of 3,000 to 50,000 
oocysts, clear clinical symptoms were seen from 5-7 days after infection. 8 out of 32 infected piglets 
died or were destroyed on account of severe clinical symptoms of coccidiosis. The shedding of 
oocysts from the infected piglets followed a cyclic pattern with 2 sequences with an interval of 
approx. 5 days. Between the periods, very low-grade oocyst shedding was observed. The greatest 
shedding of oocysts was found 6-8 days after infection. However, an infective dose as low as 100 
sporulated oocysts also caused clear shedding of oocysts and clinical manifestation of coccidiosis, 
although the highest oocyst shedding here was only recorded in the 2nd cycle 11-13 days after 
infection. In this group, a clear 3rd cycle was seen, with manifest peaks in the shedding of oocysts 
16-19 days after infection. 
Interactions with other pathogens 
Interactions between neonatal coccidiosis and other pathogens have been studied. 
Vitovec et al. studied the interaction between Isospora suis and rotavirus. 1-2 day-old piglets were 
experimentally infected orally with Isospora suis or rotavirus, either individually or with both 
agents, simultaneously or consecutively. After infection with I. suis alone, there was the typical 
picture with diarrhoea and biphasic shedding of oocysts. The changes in the intestine and the 
clinical symptoms were more severe after rotavirus infection alone than after I. suis infection alone. 
Synergistic effects of simultaneous infection with/, suis and rotavirus were manifest both clinically 
and pathologically, with watery, slightly yellowish diarrhoea and increased mortality as the result. 
In 1993, Driesen et al. studied the occurrence of I. suis, rotavirus and E. coli in faeces from 1054 
piglets with diarrhoea. The piglets were 5-30 days old, and came from 151 different herds in 
Australia. More than 90% of the cases of diarrhoea were in the age group of 6-15-day old piglets. In 
35.8% of the samples I. suis was found alone, in 10.7% /. suis was found together with E. coli, in 
6.7% / suis was found together with rotavirus, and in 0.6% of the samples I suis was found 
together with both rotavirus and E. coli. Rotavirus and E. coli were found alone or together in 8.6%, 
5.9% and 1.0% of the samples respectively. The study showed that by far the most frequent cause of 
diarrhoea in this age group was neonatal coccidiosis, and that mixed infections with E. coli and 
rotavirus were frequently seen. 
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Pathological changes 
On necropsy examination of piglets with coccidiosis, often only minor changes in the intestine are 
seen macroscopically 6 '9 '10 , m · 2 1 · 2 8 . In severe clinical cases a green/grey, adherent, fibrinonecrotic 
pseudomembrane covering the mucous membranes in the jejunum and ileum is seen. The stomach 
is mostly filled with mjlk coagula. 
Microscopically, villus atrophy, villus fusion, necrotic enteritis and hyperplasia of the crypt are 
seen. /. suis coccidia in different stages of development can be found in the cells of the intestinal 
epithelium in affected villi ' * ' ' . 
Immunity 
In general, infections with most species of coccidia will provide lifelong immunity29. This is also 
true for Isospora suis. Experiments have revealed a strong acquired resistance to re-infections . 
Age-related resistance to / suis has also been described : The piglets were infected experimentally 
with I. suis. Piglets that were 2-4 weeks old at the time of infection had less pronounced signs of the 
disease than piglets that were 2-3 days old. 
Attempts have been made to try to immunise the piglets via colostrum from the sows. Clinical 
trials32, in which sows late in pregnancy were fed faeces from piglets suffering from diarrhoea have 
indicated that such an autogenic vaccination can reduce the occurrence of diarrhoea in the offspring. 
This was especially true in herds in which neonatal coccidiosis was a problem. However, later 
controlled studies33 have showed, that it was impossible to transmit passive immunity to Isospora 
suis from the sows to the offspring. The piglets in the trial groups shed just as many oocysts as the 
piglets in the control groups. 
The type of immunity to coccidia [Eimeria species] is an intestinal immunity. It is very complex, 
and still only partly understood . The mechanism of immunity to Isospora suis has not so far been 
studied in depth. 
Diagnosis 
The diagnosis of Isospora suis-related diarrhoea in piglets is based on the history of the herd, 
clinical findings, necropsy examination findings and detection of I. suis development stages in the 
epithelium of the small intestine and/or the finding of I. suis oocysts in faeces 2'4'6'9'l8, '"22' ' -
In the acute phase of neonatal coccidiosis in a litter, it is not possible to detect oocysts in the 
faeces23,26. When the clinical symptoms of coccidiosis first appear, the I. suis oocysts still have to 
be developed. In these cases the diagnosis must be based on the finding of different development 
stages of I. suis in a smear from the small intestine or histopathological findings. 
A little later in the course of coccidioses, or where one is trying to make a diagnosis of the herd, 
faecal samples are valuable tools25,35. Here, it is important to remember that the shedding of oocysts 
varies greatly from one individual to another, and that shedding is intermittent in the individual 
piglet. 
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Henriksen et al.35 has drawn attention to the importance of the procedure when collecting faecal 
samples for examination for the presence of oocysts, and they have shown that the used examination 
method has great influence on the result36. The following procedure should be followed: 
I. Faecal samples must be taken from piglets aged 10-14 days, preferably from animals with 
diarrhoea. 
In a study from 1986-1998 carried out at the National Veterinary Serum Laboratory, 
Copenhagen20, 5398 faecal samples (primarily from animals with diarrhoea) were examined 
for coccidia. In the age group 8-14 days, 33.4% were positive. 
Lindsay (1989)25 mentions that samples from piglets with pasty faeces are more likely to 
contain large amounts of oocysts, compared with more watery faeces. 
2. The samples must be taken from at least 3-5 litters, from 3-5 pigs in each litter. The samples 
from the same litter can be collectedas one pooled sample. 
In the above-mentioned Danish study, a relatively marked correlation was found between the 
amount of samples investigated from a specific herd and the detection of coccidiosis in the 
herd. When 1-2 samples per herd were investigated, 32.3% of the herds were found to be 
infected with Isospora suis, with 3-5 samples per herd, 68.7% of the herds were positive, with 
6-10 samples, 75.7% were positive, and when >10 faecal samples were investigated 
simultaneously, 90.2% of the herd was found to be infected with Isospora suis. 
This is consistent with Lindsay's observations . He mentions that it is best to collect faecal 
samples from 10 litters where diarrhoea has been observed for 2-3 days. 
3. The examination of faecal samples must take place with a flotation test according to a 
modified McMaster technique. 
Henriksen et al.36 have shown for the Isospora suis oocysts' that, the ability to float, and the 
visual appearance in the microscope, depends on the flotation medium used. By comparing 
examining of the same faecal samples with the McMaster technique with a saturated NaCl 
solution (solution A) as the flotation medium, and the same NaCl solution with 500 g glucose 
per 1000 ml added (solution B), there was a marked difference: where solution Β was used, 
the found OPG (oocysts per gram of faeces) values were 6-7 times higher than in group where 
solution A was used, and the oocysts appeared much more clearly. 
4. If the litters are clinically affected, the shedding of oocysts will often be of the order of 
magnitude 104-I05 OPG (oocysts per gram of faeces). However, there may be great individual 
variation. 
Isospora suis. Porcine neonatal coccidiosis. 
I l l 
Prophylaxis and control 
Hygiene measures 
The best way of preventing coccidiosis in suckling pigs is by reducing the number of oocysts in the 
farrowing pen before each farrowing. The oocysts are sensitive to heat (>70°C)2, but apart from that 
they are very resistant to external influences. Tubbs (1987) states, that the sow should be washed 
with a mild disinfectant, and that the farrowing pen must be thoroughly cleaned mechanically, and 
disinfected, before each farrowing. The majority of general disinfectants are ineffective against 
oocysts. Chlorine or ammonia in a 50% solution is said to be the most effective . Cleaning with 
steam, high-pressure cleaning with warm water and direct heating with gas burners are also said to 
be effective. Thorough limewashing with a solution of slaked lime can replace the burning38. 
When the sow is installed in the farrowing pen, measures should be taken to reduce the risk of 
infection of the piglets: all faecal material should be removed daily, and care should be taken to 
prevent oocyst-containing faeces introduced from other pens. 
Coccidiostatics and therapy 
Since the primary source of infection is primarily piglets in the farrowing pens, it is pointless to treat 
the sows prophylactically against the shedding of oocysts. 
Several studies have been carried out in which the suckling pigs were treated prophylactically with 
various coccidiostatics. 
Doré and Morin39 from Canada have tested the active ingredient monensin in piglets which at 3 
days of age were infected experimentally with 50,000 sporulated oocysts of Isospora suis. The 
piglets were given monensin orally every other day in a dose of 15 mg/kg from 3 days of age. No 
difference with regard to clinical symptoms was found between the treated and untreated litters, and 
the treated piglets shed considerably more oocysts than untreated animals. The conclusion was that 
piglets should not be treated with monensin in order to prevent Isospora suis coccidiosis. 
Corresponding tests have been carried out with amprolium and furazolidone40. These coccidiostatics 
were given to piglets experimentally infected with Isospora suis oocysts as described above. 
Amprolium 9.6 % was given orally in a dose of 2 ml/piglet/day, starting on the day of infection. 
Furazolidone was given orally in a dose of 1 ml/piglet/day for 3 days from the day of infection, and 
thereafter 1 ml orally every other day for 6 days. All the treated piglets showed symptoms as in 
coccidiosis. A slight reduction in oocyst shedding was seen in piglets that were treated with 
amprolium; this was not observed in the group treated with furazolidone. 
Tests with halofuginone and lasalocid41, two coccidiostatics that are used in poultry feed, showed 
discouraging results. 
Newer coccidiostatics have also been tested for the prevention of Isospora suis coccidiosis in 
suckling pigs. Decox®(declazuril)42 given orally to the pigs (100 mg/kg b.w.) on the 3rd, 5th and 
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7th days of life, resulted in significantly better growth (days 3-21), lower mortality, and markedly 
lower oocyst shedding in treated pigs, compared with the placebo-group. 
Sulpha preparations have an effect on coccidia. They are used prophylactically by being injected 
several times within the piglet's first week of life. In Denmark, several sulpha preparations are 
registered for prophylactic treatment against coccidiosis. 
All the above-mentioned coccidia agents have either shown discouraging results in clinical trials, or 
are too time-consuming for use in practice. There is therefore a great need for more suitable 
products for the prevention of coccidiosis in suckling pigs. 
A relatively new coccidia agent, toltrazuril (Baycox ), has been developed by Bayer AG for the 
treatment of coccidiosis in poultry43. Toltrazuril has proved to be extremely effective against a wide 
range of Eimeria and Isospora species, without influencing the development of immunity44, 45. 
Tests of toltrazuril as a preventive agent against neonatal coccidiosis caused by Isospora suis have 
shown that one oral treatment with 20 mg toltrazuril (Baycox 5% suspension) per kg bodyweight to 
3-5 day-old piglets gives extremely satisfactory results 16 ,18 ,46 ,47 ,48 ,49 ,50 . Baycox in a 5% oral 
suspension is expected to be registered for pigs within the next few years. 
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TOPICS FOR DISCUSSION 
Janet Catchpole 
Central Veterinary Laboratory, Weybridge 
115 
What are the important questions we 
need to ask about coccidiosis in pigs? 
What is: 
♦ the role oí Isospora suis in pig health? 
♦ the role oí Eimeria species in pig health? 
♦ the inter­relationship with other pathogens? 
^1 
What are the important questions we 
need to ask about coccidiosis in pigs? 
♦ Are coccidia acting as 
­ primary pathogens? 
­ opportunists? 
­ precursors? 
♦ What is the route of transmission? 
­ from sow 
­ from other piglets 
­ environment/housing 
What are the important questions we 
need to ask about coccidiosis in pigs? 
What is:-
♦ Immunitity to Isospora and to Eimeriat 
♦ Influence of management systems on disease? 
♦ Life cycle 
­ particulary ideas about a possible extra­
intestinal stage of Isospora 
What are the important questions we 
need to ask about coccidiosis in pigs? 
£^> 
♦ Does Eimeria play a role in pig health at any 
stage in it's growth? 
♦ Do we need more information about the 
parasite or management system? 
♦ What about interactions with other disease 
pathogens? 
♦ Are coccidia important in their own right, are 
they opportunists or are they precursors to 
other problems? 
♦ Control strategies?? 
What are the important questions we 
need to ask about coccidiosis in pigs? 
♦ Are coccidia in pigs sufficently important to 
cause concern in the pig industry? 
to 
o ♦ Do we need more information about the 
parasite or pigs? 
♦ How do we get this information? 
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i. 
Vaccination of mice with recombinant proteins against Neospora caninum 
S. Eperon. N. Fuchs, S. Sonda, A. Hemphill and B. Gottstein 
Institute of Parasitology, University of Berne, Länggass-Str. 122, 3012 Berne, Switzerland. 
Neospora caninum is a coccidian parasite of considerable economic importance by causing abortion or 
stillbirth in cattle among other disorders in different animal species. We recently established an experimental 
mouse infection model which showed that wild type C57BL/6 mice injected i.p. with 105 living N. caninum 
tachyzoites were all N. caninum-posiïwe in their brain as tested by PCR analysis (at day 44 p.L). The present 
study included a vaccination trial to assess the putative protection by recombinant (ree) proteins from N. 
caninum against subsequent N. caninum challenge infection. The rec­proteins (Nc­p36, Nc­p43 and a mix of 
both) to be injected into mice were emulsified with the RIB! Adjuvant System (RAS) at 50 pg/ml, a crude 
extract of N. caninum (NC) was emulsified at a concentration of 250 pg/ml. Groups of wt C57BL/6 mice were 
inoculated i.p. with 200 μΙ of either RAS, rec­Nc­p36, rec­Nc­p43, the mix of rec­proteins or crude extract. A 
booster injection was repeated 14 days later. At this stage, parasite­specific IgG production in sera was con­
firmed by ELISA using NC crude antigen. Antibody concentrations were much higher in mice injected with 
either rec­Nc­p43 or crude extract than in mice injected with either Nc­p36 or the rec­protein mix. Seven days 
after booster injection, mice were infected with 2 χ 105 Ν. caninum tachyzoites and euthanised 15 d.p.L Blood 
was collected for antibody determination and brain, heart, liver and kidney for PCR­based N. caninum-DNA 
detection. All organs were PCR­negative in uninfected control groups. In infected control groups, 3/6 mice 
were positive in the brain and 1/6 in the liver. Mice injected with rec­Nc­p43 or crude extract before infection 
showed interesting results in that all organs were N. caninum-negaWve by PCR. Conversely, the brain of 2/3 
mice injected with rec­Ncp36 and the brain of 2/3 mice injected with the rec­protein mix was N. caninum-
positive, as well as the brains of non­immunized but Λ/eospora­infected control animals. These results suggest 
that vaccination with either ree Nc­p43 or N. caninum crude extract may induce protective immunity against 
subsequent N. caninum infection. A second vaccination trial is currently performed to elucidate the significance 
of our primary data. 
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Use of recombinant SAG1 in a subunit vaccine against infection with Toxoplasma 
gondii in mice 
H. Vedel-Nielsen, L Christiensen and E. Petersen 
Laboratory of Parasitology, Statens Seruminstitut, Artillerivej 5. DK-2300 Copenhagen, Denmark. 
It has been difficult to develop effective recombinant vaccines against protozoan infections. So far the 
most effective vaccine against infection with Toxoplasma gondii is a live, attenuated vaccine used in sheep. 
We have expressed the T. gondii surface antigen 1 (SAG1) in Escherichia coli and shown that antibodies 
induced by rSAG recognise native T. gondii. In another study, we found that mice immunised with rSAG1 in 
alum, induced partial protective immunity against infection with the lethal RH-strain, measured as an prolonged 
survival time. 
We have further developed the plasmid coding for the rSAGl into DNA vaccine, and will present data 
showing that mice immunised with the plasmid coding for the SAG1 induce antibodies which recognise native 
SAG1. 
Immunity against T. gondii is believed to be at least partially stage specific. We are in the process of 
developing an experimental vaccine containing both the SAG1 and the bradyzoite antigen 1 (SAG1), a bradyzoite 
specific antigen belonging to the HSP family. We hope that by using stage specific antigen we will be able to 
reduce the number of cysts after infection with a cyst forming strain. 
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The growing family of SAGl-related antigens of Toxoplasma gondii: Molecular 
characterization and expression analysis of the SAG5 gene cluster 
E Spano1. I. Ricci1, M. Di Cristina1, C. Puri2, L. Putignani1 and A. Crisanti1·3 
1 Istituto di Parassitologia e 2 Istituto di Istologia e Embriologia Generale, Università di Roma "La Sapienza", Rome, 
Italy; 3 Imperiai College, Department of Biology, London, UK. 
The invasive stages of the apicomplexan parasite Toxoplasma gondii are known to express a set of 
surface antigens, known as the SAG proteins, sharing structural and functional characteristics. Besides the 
extensively characterized SAG1 (p30) and SAG3 (p43) a series of novel Τ OOnd/'/'proteins sharing close 
structural similarity with SAG1 and SAG3 have been recently identified: SRS1-4 and BSR4 by Boothroyd and 
co-workers and SAG5 in our laboratory. A portion of the SAG5 gene was accidentally amplified from the 
genomic DNA of T. gondii (RH strain) employing unrelated primers. The PCR product 12G/16, encoding a 212 
amino acid-long polypeptide showing a significant homology to both SAG1 and SAG3, was used as a probe to 
screen a genomic T. gondii cosmid library. Southern blot analysis of the positive cosmidic clones and of T. 
gondii genomic DNA employing the 12G/16 fragment as a probe yielded complex hybridization patterns, 
suggesting the existence, in the genome of Τ gondii, of a family of related genes. Extensive sequence analysis 
confirmed this hypothesis and revealed the presence of three tightly clustered genes encoding closely related 
proteins, denominated SAG5.1, SAG5.2 and SAG5.3. All three polypeptides show the hallmarks of the family 
of SAG 1 -related molecules, being characterized by a leader peptide, 12 cysteine residues whose distribution 
suggests a tandem duplication of an ancestral 6-cysteine motif and a C-terminal GPI-anchoring signal. SAG5.2 
and SAG5.3 are 367 amino acid-long and differ from each other at 8 amino acid positions (98% identity), while 
SAG5.1, which consists of 362 amino acids, is virtually identical to the other two SAG5 proteins only within the 
C-terminal region (positions 162-362). Notably, in the N-terminal half of the molecule the degree of amino acid 
identity to SAG5.2/SAG5.3 drops to approximately 40%, which represents the average homology shared by all 
members of the "SAG1" protein family. Northern blot and RT-PCR analysis of poly(A)+ RNA showed that all 
three SAG5 genes are expressed in tachyzoites. The transcriptional activity in the other invasive stages is 
understudy. The localization of the SAG5 proteins in T.gondii tachyzoites was investigated employing polyclonal 
and monoclonal antibodies raised against a recombinant histidine-tagged fragment of SAG5.3 produced in E. 
coli and affinity purified by nickel chelate chromatography. In contrast with the other SAG 1-related proteins, 
immunofluorescence analysis failed to show for SAG5 any significant staining of the tachyzoite plasmamembrane. 
Instead, anti-SAG5 antibodies specifically decorated the apical end of the tachyzoites. This evidence was 
confirmed by immunoelectron microscopy experiments in which anti-SAG5 antibodies were shown to label the 
cytoplasmic side of the tachyzoite pellicle and electrondense structures possibly associated with the microtu-
bular components of the apical complex. Despite the evident structural similarity to the other SAG 1-related 
molecules, the unusual genomic organization of the SAG5 genes and the peculiar subcellular localization of 
the encoded proteins seem to indicate for the SAG5 proteins a distinct functional role, whose elucidation 
deserves further investigation. 
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Molecular characterisation of the Neospora caninum tachyzoite surface protein 
Nc-p36 
S. Sonda. N. Fuchs, Β. Connolly, Ν. Müller and A. Hemphill 
Institute of Parasitology, University of Bern, Switzerland. 
Neospora caninum is structurally and biologically closely related to, but antigenically distinct from, Toxo­
plasma gondii. These parasites are obligatory intracellular and molecules associated with the surface and with 
secretory organelles are likely to participate in the host cell entry process and therefore in the pathogenesis. A 
tachyzoite stage­specifically expressed surface protein of T.gondii \s SAG1 (p30) which has been shown to be 
involved in host cell attachment and invasion. Previously we have identified a cell surface­associated glycopro­
tein (Nc­p36) in N.caninum tachyzoites. The full length sequence of the cDNA coding for Nc­p36 was deter­
mined, and analysis of the deduced amino acid sequence demonstrated that Nc­p36 is closely related to 
SAG1. However these two proteins are antigenically distinct. 
Nc­p36 is encoded by a single copy gene which produces a transcript of 1.4 kb. Immunogold labeling of 
resin­embedded parasites using polyclonal antibodies affinity­purified on a recombinant Nc­p36 fusion protein 
expressed in Escherichia coli showed that this protein is located exclusively on the tachyzoite cell surface. 
5. 
Differential expression of cell surface- and dense granule-associated Neospora 
caninum proteins in tachyzoites and bradyzoites 
N. Fuchs. S. Sonda, Β. Gottstein and A. Hemphill 
Institute of Parasitology, University of Bern, Längass-Strasse 122, CH-3012 Berne, Switzerland 
Morphologically, the tachyzoites and the tissue cysts of Neospora caninum are difficult to distinguish from 
those of other cyst­forming apicomplexan parasites such as Toxoplasma gondii. Several stage­specific anti­
gens have been identified in T.gondii tachyzoites and bradyzoites, and respective antibodies are useful tools 
for discriminating between the two stages during tachyzoite­bradyzoite interconversion upon I gondii infec­
tions. While several cell surface­ and dense granule­associated proteins have been identified and characterized 
in N. caninum tachyzoites, little is known about antigenic components expressed in N. caninum bradyzoites. 
In this study, we describe the differential expression of the 2 N. caninum surface proteins Nc­p43 and Nc­p36 
and the dense granule protein Nc­p33 (NCDG1) within tachyzoites and bradyzoites of N. caninum by using 
protein­specific affinity purified polyclonal antibodies. Expression of the three proteins was assessed by immu­
nofluorescent staining of mouse brain sections containing either tachyzoites or bradyzoites (tissue cysts) of N. 
caninum. 
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6. 
Transfection in Toxoplasma gondii 
A.B. Hehl 
Dept. of Microbiology and Immunology, Stanford University School of Medicine. Stanford. CA 94305, USA 
Present address: Institute of Parasitology, University of Zürich, Winterthurerstrasse 266a, CH-8057 Zürich, 
Switzerland. 
Transfer and expression of foreign DNA in tachyzoites of the apicomplexan parasite Toxoplasma gondii 
was first described by Soldati and Boothroyd in 1993 (Science, 260:439­52). This tool complements several 
other features of Τ gondii, such as simple in vitro culture of tachyzoites, cyst formation in culture, and well 
defined classical genetics, making this protozoan a paradigm forstudies on intracellular parasitism. Over the 
last years, transfection has come to be used routinely in many laboratories working with Τ gondii, and conse­
quently a wide array of molecular genetic manipulations have been developed on the basis of the original 
protocol. In this paper we present a number of examples from our lab and others to illustrate both the power of 
transfection in various areas of basic Toxoplasma research and the potential for engineering apicomplexan 
parasites to fit specific needs. 
Linearized or circular vector DNA containing appropriate c/s­acting sequences is transfected into extra­
cellular tachyzoites by electroporation. Classical markers for selection, such as antibiotic resistance genes 
(Kim et al., Science 1993, 262: 911­4) or ß­Gal (Seeber & Boothroyd, Gene 1996, 22: 39­45), are used for 
most routine applications and yield stable transgenics at a frequency of up to 1%. Mutant alleles of the 
enzyme DHFR­TS that confer resistance to pyrimethamine increase this remarkably high frequency of 
transfection to about 5% (Donald & Roos, Proc. Natl. Acad. Sci., USA 1993, 90:11703­7). The non­essential 
purine salvage enzyme HXGPRT under the control of constitutive but also stage­specific promoter elements 
allows both selection for and against its expression by the drugs mycophenolic acid and 6­thioxanthine, 
respectively. Positive/negative selection has been used to screen for mutants deficient in differentiation and 
in promoter­trap experiments. Most recently, the addition of GFP to the arsenal of reporters has allowed in 
situ observation of protein trafficking, both inside live parasites and the parasitophorous vacuole (Striepen et 
al., Mol. Biochem. Parasitol. 1998, 92: 325­38). 
The power to control homologous vs. non­homologous integration of DNA makes transfection in T.gondii 
an extremely useful tool: Gene knock­outs by replacement insertion, which have been demonstrated for a 
number of genes (e.g. SAG1, ROP1, BAG1, HXGPRT), can be achieved with long contiguous genomic DNA 
from the target site flanking a selectable marker gene. Minimal homology regions in the transfected vector, on 
the other hand, lead to essentially random integration of linear tags or promoter­less reporter genes throughout 
the genome. This makes experimental approaches such as gene trapping or insertional mutagenesis with 
subsequent rescue of tagged loci highly efficient in this system. A shuttle vector containing a Toxoplasma 
origin of replication has been developed to be maintained as an episome under selection pressure. Such 
vectors have been used successfully to rescue mutants by complementation and will be essential for the 
convenient identification of genes responsible for a defined mutant phenotype or the analysis of lethal gene 
knock­outs. 
Sophisticated transfection techniques enable us to use T. gondii also as a model system to study the 
biological function of phylogenetically conserved proteins from related apicomplexans (e.g. AMA1 from Plas­
modia) which are less easily manipulated. Neospora caninum, which is closely related to T.gondiibui antigeni­
cally distinct, is now also amenable to transfection. N. caninum provides a convenient background to express 
and investigate selected surface antigens and organeilar proteins from T gondii without the need to introduce 
tags for detection. 
Efficient transfection protocols and the powerful selections that have been devised in this model parasite 
have expanded the realm of experimental possibilities greatly. As we learn more about the biological function 
of specific proteins and antigens in T. gondii and other apicomplexans, we have not only a ready tool to test 
our hypothesis but also the ability to tailor parasites to fit many of our experimental needs. 
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7. 
Identification of a novel surface protein of Toxoplasma gondii using RNA display 
J. G. Mattsson1. E. Ljunggren1, K. Bergström1 and D. Soldati2 
1Department of Parasitology, National Veterinary Institute, Box 7073, SE-750 07 Uppsala, Sweden; 
2ZMBH, University of Heidelberg, INF 282, DE-69 120 Heidelberg, Germany. 
A recently described mutant of the RH-strain of Toxoplasma gondii resistant to high doses of artemisinin 
has been shown to have lost its acute virulence. In order to investigate the genetic background to the observed 
phenotypes we have used an m RNA display strategy to compare expression changes between tachyzoites 
from the mutant and the parental RH-strain. Through this analysis we have isolated several short cDNA tags 
corresponding to genes whose expression has been modified in the mutant in comparison with the RH-strain. 
Northern blot analysis for one of these, RAP6, showed that it hybridised to 1.8 kb long mRNA whose expres-
sion has been significantly down regulated in the mutant. We then used an inverse PCR to obtain sequences 
outside the original RAP6 fragment. The extended sequence matched two clones from the expressed se-
quence tag (EST) dataset of T.gondii. The complete cDNA sequences from these two clones were determined 
and combined with the genomic sequences. The open reading frame of about 368 amino acids was shown to 
match a surface antigen from merozoites of Sarcocystis muris. The open reading frame also encode a hypo-
thetical N-terminal signal peptide sequence and a number of cysteine residues, reminiscent of the SAG-family 
of T.gondii. Using transfection techniques work is now on the way to further characterise the role of the RAP 6 
polypeptide. 
8. 
Expression of the bradyzoite-specific surface antigen SAG4 in the Ts-4 vaccine 
strain of Toxoplasma gondii 
M. Soête. T. Meyer*, D. Schlüter* and D. Soldati 
Zentrum für Molekulare Biologie Heidelberg, ZMBH, Germany. 
*lnstitut für Mikrobiologie und Hygiene, Mannheim, Universität Heidelberg, Germany. 
During infection with Toxoplasma gondii, the acute phase caused by the virulent stage tachyzoite is 
rapidly overcome by the onset of the immune response. Parasites develop into a chronic phase characterized 
by formation of cysts which persist during the life span of the host. In immunocompromized patients the re-
lapse of the cyst form is responsible for the pathogenesis of the disease. 
The temperature-sensitive mutant ts-4 of the T gondii RH strain fails to grow at 40 degrees C in vitro. 
This attenuated mutant which has been widely used to vaccinate mice against virulent T gondii strains, elicits 
strong preimmune defenses, dependent on gamma interferon, which are needed by mice to survive acute 
infection. Although this experimental vaccine protects animals from disease it does not prevent from infection 
and cyst formation. Information regarding the role of bradyzoite-specific antigens in immune protection is 
limited to date. To investigate the potential protective properties of the bradyzoite-specific surface antigen 
SAG4(P18), we have generated a recombinant ts-4 mutant expressing this surface protein in a constitutive 
fashion (ts-4/SAG4). In parallel we have produced and purified recombinant SAG4 protein from E. coli. 
Different combination of ts-4, ts-4/SAG4 and/or recombinant SAG4 protein have been used to immunize 
mice. Preliminary analyses show that the experimental vaccination elicits a strong antibody response and CTL 
proliferation against SAG4. The vaccinated mice will be challenged to other-wise lethal doses of cysts from the 
persistent Prugniaud strain to evaluate effectiveness of the SAG-4 based vaccines against chronic infection . 
128 
Α μΜΤ knockout and wi ld- type mouse model for immunological s tud ies in 
experimental neosporosis 
B. Gottstein. A.Hemphill and S. Eperon 
Institute of Parasitology, University of Berne, Länggass-Strasse 122, CH-3001 Berne, Switzerland. 
Neospora caninum has become an important veterinary pathogen as causative agent of neuromuscular 
disorders and abortion in different animals, especially cattle as tested in one of our studies (Gottstein et al., 
1998, Int. J. Parasitol., 28,679­691). We now established an experimental murine model for the study of host 
immunity. Thus, wild type C57BL/6 mice and B­cell deficient mice (transgenic mutation in the transmembrane 
exon of the IgM μ­chain gene; μΜΤ­mice) were infected i.p. with 105 living N. caninum tachyzoites. Mice were 
sacrificed at days 10,24 and 29­44 pi. Brain, heart, lung, liver, spleen, and kidney were collected for parasito­
logicai and pathological, spleen and serum for immunological investigations. Splenocytes were in vitro-sWmu-
lated with N. caninum- and T. gontf/Aantigens for assessing Τ cell proliferation and cytokine production. While 
wt mice were resistant to disease, μΜΤ mice died between days 29 ­ 44 pi. Histological examination of brain 
tissue from μΜΤ mice exhibited a high infection intensity with multifocal necrotic cerebral lesions, absent in 
brain of wt mice. Neospora antigen­stimulated splenocytes of both wt and μΜΤ mice infected with N. caninum 
showed a marked proliferative depression at day 10 pi. At day 24 pi, this immunosuppression was still main­
tained in μΜΤ mice whereas full immune responsiveness had been restored in wt mice. Stimulated splenocytes 
of infected μΜΤ mice secreted less IFN­yand less IL­10 than corresponding wt splenocytes. For IL­10, these 
differences markedly increased between days 10 and 24 pi. Consequently, the high susceptibility of μΜΤ 
mice appeared causatively associated to an impaired cellular response in addition to the humoral deficiency, 
finally resulting in a lethal outcome of infection. 
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IO . 
Protozoal infections associated with abortion in italian livestock 
G. Pi Francesco. A.R. D'Angelo, A. Petrini and G. Savini 
Istituto Zooprofilattico Sperimentale dell'Abruzzo e Molise "G. Caporale", 64100 Teramo, Italy. 
The significant role played by cyst-forming coccidian parasites in determining abortions, has been 
recently recognised in many part of the world. To assess the importance of foetal protozoan abortions 
in Italian livestock industry, 127 bovine, ovine and caprine foetuses, in which no bacteria, viruses or 
others have been isolated, were examined. From each foetus, sections of heart, liver, brain and kidney 
have been fixed and processed for histology and immunohistochemistry. According to the histological 
findings, 45.9% (17 out of 37) of the bovine foetuses had protozoon-like cysts, 37.5% (3/8) of goat 
foetuses were also found infected, whereas in only 14.6% (12/82) of ovine foetuses, cysts were present. 
Heart was the organ most commonly involved by the presence of the cysts. Histological lesions, 
characterised by non suppurative inflammation, were observed in 83.4% of foetuses and the liver was 
the organ most commonly involved. Immunohisto-chemical studies using antisera against Neospora 
caninum and Toxoplasma gondii, showed neydiife reactions also in those samples in which only histo-
logical lesions were observed. 
I I . 
The epidemiology and significance of bovine neosporosis in England and Wales: 
interim results of a collaborative study 
H.C. Davison1, A. Otter2·, N.R French2 and A.J. Trees1 
1Liverpool School of Tropical Medicine/Faculty of Veterinary Science, University of Liverpool; 
'Veterinary Investigation Centre, Carmarthen, U.K. 
In a project supported by the Ministry of Agriculture, Fisheries and Food, United Kingdom, and involving 
collaboration with the Veterinary Laboratories Agency, veterinary practitioners and dairy farmers, we are seek-
ing to determine the significance of bovine neosporosis in England and Wales and to elucidate its epidemiol-
ogy. Herd-and age-specific antibody prevalence data have been obtained from over 4,000 cattle in 16 herds by 
ELISA. Logistic regression analysis showed no difference between prevalence values in different age groups, 
consistent with vertical transmission being the major mode of transmission. On-farm studies of new-born 
calves sampled pre-colostrally have confirmed the extremely high efficiency of vertical transmission. In a 
randomised, case-control serological survey of aborting (n = 626) and normally calving (n = 416) cows, abort-
ing cattle were three times more likely to be Neospora antibody positive than non-aborting cows (p <0.0001 ) 
but the antibody prevalences to BVD virus, IBR virus and Leptospira hardjo were not higher in the aborting 
group. The antibody prevalence in normally calving cows was 5.7% (95% CI; 4,8). This is the first estimate of 
N. caninum seroprevalence using a random sample of dairy cattle in England and Wales, and these data 
provide a basis to estimate some economic costs associated with this infection. 
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1 1 . 
Seroprevalence of Neospora caninum infection in dairy and beef catt le in northern 
Spain 
A.Quintanilla­Gozalo1, J.Pereira­Bueno1, E.Tabarés2. E.A.Innes3, R.González­Paniello^nd LM. Ortega­Mora2 
1Dpto Sanidad Animal, Veterinary Faculty, University of León, 24007-León, Spain 
2Dpto Sanidad Animal, Veterinary Faculty, University of Madrid, 28040-Madrid, Spain 3Moredun Research Institute, 
International Research Centre, Pentland Science Park, Bush Loan, Penicuik, EH26 OPZ, Edinburgh, UK 
In recent years, neosporosis has been identified as a major cause of abortion in dairy and beef cattle. 
Although the disease has been described worl­wide there is a lack of information concerning the prevalence of 
this disease in different cattle production systems. 
The aim of this study was to investigate the seroprevalence of Neospora caninum infection in a represen­
tative area of beef and dairy cattle production in Spain. A cattle census provided by the Local Veterinary 
Service in 1996 showed an average population of 11,460 cattle distributed over 749 herds (498 beef and 251 
dairy herds). Cluster sampling was employed, in which herds constituted the initial sampling unit and two strata 
(dairy and beef herds) were considered. As there is little information concerning the prevalence of neosporosis 
in the different cattle producing systems the worst case was considered (50% prevalence). Using a 95% level 
of confidence and setting 5% (beef) and 5.4% (dairy) error limits, the desired sample size were 216 and 143 for 
beef and dairy herds, respectively. This sample size was distributed according to the proportional cattle herd 
number of the different municipalities in the area. Cattle herds were randomly selected using random number 
tables and contacted by the local Veterinary Service. On the basis of the formula n=[1­(1­CL)1/D][N­(D­1)/2], 
where n is the required sample size, CL is the confidence level (95%), D is the supposed number of infected 
cattle in each herd (23.4%) (Quintanilla­ Gózalo et al., 1996. IV Cong. Int. ANEMBE), and N is the herd size, 
nine animals (>1 year old) were randomly sampled in each herd to detect the presence of the infection. A herd 
was considered infected when at least one animal was seropositive. Sample sizes required to detect infection 
and estimate herd prevalence were calculated using the EPISCOPE computer program (Frankena et al., Vet. 
Ree, 126:573­576). In total, serum samples from 1121 dairy and 1712 beef animals were collected and tested 
for specific anü-N.caninum IgG using an ELISA test. Serum samples with optical densities equal to or higher 
than 0.40 were considered as positive (OSAWA et al., Vet. Parasitol. in press). 
Specific antibodies were detected in 55.1% (119/216) beef and 83.2% (119/143) dairy herds. Individual 
prevalences obtained were 17.9% (306/1712) for beef and 35.9% (402/1121 ) for dairy animals. Presence of N. 
caninum infection was higher in dairy than in beef herds and the association between infection and the cattle 
production system (dairy or beef) was statistically significant [χ2γ=29.21, p<0.001, OR=4.04 (2.35­6.99)]. 
Data concerning association with other epidemiological parameters such as herd size, herd management and 
herd location will be presented and discussed. 
This is the first estimate of N. caninum seroprevalence in dairy and beef cattle herds in Spain using a 
random and representative sample. Preliminary data show the widespread distribution of N. caninum infection 
and the influence of the production systems on the risk of acquiring this infection. This study may be of value to 
estimate the general prevalence of this disease in dairy and beef cattle in Spain and to calculate its economic 
repercussions. 
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Genetic polymorphism in laboratory isolates of Neospora caninum 
J. M .Wastling1 , A. Schock2 , E. A. Innes2 and I. Yamane3 
division of Infection & Immunity, Institute of Biomedical & Life Sciences, University of Glasgow, Glasgow, United 
Kingdom. G12 8QQ; 
2Moredun Research Institute, Edinburgh, United Kingdom; 
3National Insitute of Health, Laboratory of Epidemiology, Tsukuba, Ibaraki, Japan. 
The design of effective control measures against parasitic infections depends on a good under­
standing of the epidemiology of the parasite in question. Without this knowledge changes in management 
practice, vaccination or therapeutic intervention may make little impression on the economic impact of 
parasitic disease. Genetic typing which exploits DNA polymorphisms between different isolates of the 
same species is a valuable tool in determining the epidemiology of pathogenic microorganisms. Suitable 
genetic markers may be generated by a variety of techniques often depending on the extent to which 
genetic variation occurs within the target population. To date little is known about the genetic variation 
that occurs between different isolates of Neospora caninum, although ribosomal RNA sequencing sug­
gests that the isolates examined so far do form a single species (Marsh et al, J. Parasitology 1995, vol. 
84, pp. 530­535). In this study we have examined genetic variation occurring between a variety of N. 
caninum laboratory isolates maintained in tissue culture using random amplified polymorphic DNA analy­
sis (RAPD). The laboratory isolates analysed were from geographically distinct sites in Europe and Ja­
pan. Genetic polymorphisms identified in these laboratory isolates by RAPD analysis will now be used to 
generate DNA markers that will be evaluated on field samples. Such markers could be used to help 
answer questions such as (a) how genetically diverse are N. caninum field populations? (b) are different 
populations of N. caninum epidemiological^ related? (c) does vertical transmission contribute to the 
"clonality" of this parasite (d) are certain isolates associated with disease i.e. are there "virulent" and 
"avirulent" strains of N. caninum! 
IU­ . 
Follow-up studies in Neospora caninum infected dairy herds using IgG subclass 
ELISAs. 
P. Lind1. A.M. Jensen2, A.M. Kjeldsen2, H.­C. Slotved1, C. Björkman3 and A. Uggla3. 
1 Danish Veterinary Laboratory, Bülowsvej 27, DK-1790 Copenhagen V. Denmark. 
2The Danish Agricultural Advisory Centre, Udkaersvej 15, DK-8200 Aarhus N. Denmark. 
3 National Veterinary Institute and Swedish University of Agricultural Sciences, Box 7073, S-750 07 Uppsala, Sweden. 
The dynamics of Λ/eospora­specific serum antibodies during the life of the cow and the influence of 
pregnancy is still incompletely resolved. In a follow­up study on 4 Danish dairy herds with confirmed neosporosis, 
data from Iscom­ELISA on 285 cows with at least 2 bleedings with > 3 mo. interval were analyzed to study 
changes in an up to 1Vz years period. With an assay employing an lgG,­specific conjugate (Swedish National 
Veterinary Institute), 49% of the animals were consistently negative, while 41% were consistenly seropositive. 
Apparent seroconversions (7.7%) dominated over fluctuating responses (2.5%), which was also reflected in a 
moderately increased seroprevalence with cow age in the studied populations. Reasonably equipotent assays 
for lgG1 and lgG2 were established using monoclonal mouse conjugates from the same producer (Bethyl). The 
data from one of the investigated herds showed large variations between individual seropositive animals for 
the lgG/lgG2 OD­ratio, ranging from 0.23 to 4.3, with a trend towards a minimum around the time of parturition. 
Analysis of the data from all 4 study herds will be presented and discussed. 
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15. 
Immunity to Neospora caninum 
J. Marks. I. Esteban­Redondo, A. Lundén, S. Maley, A. McLean Tooke, T. Duggan and E.A. Innes 
Moredun Research Institute, International Research Centre, Pentlands Science Parí<, Bush Loan, Penicuik, Scotland. 
EH26 OPZ, UK. 
Neospora caninum is an intracellular coccidian parasite that causes abortion and congenital defects in cattle, 
dogs, horses and goats. The parasite is recognised as a major cause of infectious abortion and is linked to approxi­
mately 12­17% of bovine abortions in Scotland. Neospora can cause repeat abortion, but the rate of repeat abortion 
is estimated to be less than 5%. The only known route of natural infection is by congenital transmission. 
Cell mediated immune mechanisms, and in particular the Τ cell cytokine IFNy produced mainly by CD4+ 
T cells, are important in the development of protective immunity to Toxoplasma gondii, a closely related coccid­
ian parasite which causes abortion in sheep. Very little is known about the immune response to N. caninum, 
but it is likely that the production of IFNy is important in the prevention of repeat abortion. We have shown in 
previous studies that treatment of cells with recombinant IFNy significantly inhibits intracellular multiplication 
of N. caninum tachyzoites. 
In this study, calves experimentally inoculated with N. caninum NC1 strain tachyzoites developed a cell 
mediated immune response to infection. Peripheral blood mononuclear cells (PBM) from infected cattle prolif­
erated in vitro in response to Neospora whole antigen. CD4+ Τ cell lines generated from infected animals 
responded to a group of Neospora antigen fractions of molecular weight 30kDa and supernatants from the 
activated CD4+ Τ cells were found to contain high concentrations of IFNy. Pre­treatment of bovine fibroblasts 
with these supernatants inhibited the growth of N. caninum tachyzoites in vitro. These low molecular weight 
proteins may therefore be responsible for the induction of a potentially protective immune response. N. caninum 
tachyzoites were also cultured in alveolar macrophages from infected and control animals. Cells from the 
infected calves were able to suppress growth of the parasite in comparison to the growth of tachyzoites in cells 
from naive animals. 
A study of the immune response in congenially infected calves revealed that these animals also devel­
oped a cell mediated immune response to infection. PBM from these animals proliferated in response to a 
crude lysate of N. caninum NC1 tachyzoites in vitro and supernatant collected from proliferating cells also 
contained high concentrations of IFNy. 
While the nature of protective immunity to N. caninum is still unknown it is clear that IFNy plays an 
important role in the immune response to this parasite. A further understanding of the cell mediated immune 
response and the mechanisms involved will have a considerable impact on how to produce a potentially pro­
tective immune response. 
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16. 
Immunological and clinical responses in catt le following experimental infection 
with Neospora caninum at different stages of gestation 
Guv. CS., Williams, D.J.L., Guy, F, McGarry, J.W., MacEacheran, K., Smith R., Kelly, D. F. and Trees, A.J. 
Veterinary Parasitology, Liverpool School of Tropical Medicine / Faculty of Veterinary Science, Pembroke Place, 
Liverpool, L3 5QA, UK. 
The apicomplexan protozoan parasite, Neospora caninum, is a major cause of bovine abortion in 
many countries. Little is known about the immune response to Neospora in naturally or experimentally 
infected cattle, although as Neospora is closely related to Toxoplasma gondii, cell mediated immune 
responses are likely to be important. The aim of this study was to investigate the immunological, clinical 
and pathological responses in cattle experimentally infected with N. caninum at different times relative 
to gestation. Cattle were divided into three groups and infected with in vitro derived Ne (Liv) tachyzoites 
nine weeks prior to artificial insemination, ten weeks post­insemination or thirty weeks post­insemina­
tion. An increase in temperature was detected in 15/24 cattle 2­7 days after infection. Antibody levels 
increased and reached a peak at 4 weeks after infection. Peripheral blood mononuclear cells prolifer­
ated in response to parasite derived antigen by 8 days after infection and this was accompanied by 
secretion of high levels of ã interferon. The effect of infection on the viability of the foetuses will be 
presented. 
17. 
The role of immunological memory in Sarcocystis infection 
T. Jäkel1. J. Sangchai2 and Y. Khoprasert2 
division of Parasitology, Department of Zoology, University of Hohenheim, Emil Wolff Str. 34, 70599 Stuttgart, 
Germany; 
^Agricultural Zoology Research Group, Entomology and Zoology Division, Department of Agriculture, Bangkok 10900, 
Thailand. 
A hallmark of the immune response is memory, the ability to recall an earlier encounter with specific 
antigen. In a recent investigation Bunce and Bell (1997, J. Exp. Med., 185: 767­776) demonstrated that two 
isoforms of the CD45 molecule (CD45RCVC") define two types of CD4 memory Τ cells in the rat. Upon antigen 
encounter, naive CD45RC+ CD4 Τ cells rapidly switch to short­lived CD45RC" (memory) cells. If antigen does 
not persist, CD45RC" cells can revert within a week to longer­lived CD45RC+ memory cells which ensure that 
immunlogical memory endures. 
We investigated CD4 Τ cell memory in wild brown rats infected with Sarcocystis singaporensis. The 
underlying question was why natural infections (presumably following uptake of low numbers of sporocysts) 
apparently did not protect rats against acute sarcocystosis after challenge with high sporocyst doses (Jäkel et 
al. 1996, J. Parasitol., 82: 280­287). Rats were immunized with 10 or 1000 sporocysts or PBS (10 rats/group) 
16 days prior to challenge with 5 χ 105 sporocysts. Only animals immunized with 1000 sporocysts survived 
challenge. Flow cytometric analysis of spleen cells (anti­CD3, CD4, CD8, CD45RC) at the day of challenge 
revealed that only rats immunized with 1000 sporocysts showed a significantly higher number of CD8 Τ cells 
and CD45RC+ CD4 Τ cells (compared to PBS). Additionally, the Β cell response clearly mirrored the Τ cell 
results. In a set of repeated experiments, we used 100 sporocysts for immunization. Here, a majority of rats 
survived challenge. In contrast to the higher immunization dose, however, only numbers of CD45RC+ CD4 Τ 
cells were significantly increased in these rats at the day of challenge. 
These data indicate that formation of long­lived memory CD4 Τ cells in sufficient quantity may be crucial 
for protective immunity of rats against acute Sarcocystis infection. Adoptive transfer experiments are under­
way to further adress this question. 
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Epidemiology and economic impact of toxoplasmosis in animal production 
P. Buxton 
Moredun Research Institute, Pentland Science Park, by Edinburgh, EH26 OPZ, Scotland, UK. 
The apicomplexan parasite Toxoplasma gondii can infect most, if not all, warm-blooded vertebrates in 
which it has a two-stage life cycle (bradyzoites in tissue cysts and tachyzoites). In Felidae it can undergo a 
sexual life cycle and produce oocysts, which can survive on pasture, in food and in water for many months and 
constitute a source of infection for farm animals. It has its greatest impact in sheep in which, following a primary 
infection during pregnancy, it may cause fetal death and abortion. It can also cause abortion in goats and pigs 
but no significant disease is produced in cattle and horses. 
Sheep. Sheep are farmed in all 15 countries of the EU and in 1997 there were over 98 million of which 70.6 
million were recorded as being females of breeding age (Statistical Office of the European Commission - SOEC) 
of which three-quarters were located in the UK, Spain, Italy and France (1998, MLC European Handbook, 2,6-7, 
MLC, Milton Keynes). Toxoplasma abortion and fetal loss may occur wherever sheep are kept but precise figures 
of the losses do not exist. Perhaps the best estimates were made by Blewett and Trees (1987, British Veterinary 
Journal, 143,128-135) who concluded that the average incidence of clinical toxoplasmosis in the UK is between 
1 % and 2% per annum. This figure is an underestimate, as it does not include the loss of fetuses early in gestation 
that are resorbed so that the ewes present as cases of infertility. If the incidence of toxoplasmosis is assumed to 
be similar throughout the sheep rearing areas of the EU then in 1997 between 706,000 and 1.4 million lambs 
would have been lost (assuming an average lambing of one lamb per ewe). However this is a risky assumption 
and the incidence of clinical toxoplasmosis will probably vary from region to region. 
Because clinical toxoplasmosis occurs following primary infection during pregnancy its incidence is 
influenced by a) the number of susceptible sheep and b) the degree of contamination of food and water by 
viable oocysts, which itself is dependent both on the cat population and environmental conditions. A lower 
incidence than occurs in the UK will be recorded in a region if infection, seroconversion and immunity occur in 
a high proportion of sheep before they reach breeding age. This may occur if a) there is significant contamination 
of food and/or water with oocysts and/or b) environmental conditions favour their prolonged viability (relatively 
little dessication and frost). A lower incidence of clinical toxoplasmosis will be encountered in a region where 
viable oocysts are scarce. Thus few cats, extensive grazing practices, no supplementary feeding and relatively 
harsher weather conditions, with significant frosts and/or dessication, will lead to low infection rates. While 
there will be a relatively high proportion of susceptible pregnant sheep they will be exposed to minimal chal­
lenge by oocysts. 
Goats. The 12 million goats in the EU (SOEC) are as susceptible to toxoplasmosis as sheep and the 
incidence of clinical disease will be influenced in similar ways to those for sheep. Goats and sheep are also 
kept for milk production, particularly in Greece, France, Italy and Spain. Any cause of abortion may severely 
reduce herd and flock outputs. 
Pigs. There are an estimated 118.5 million pigs in the EU of which 12.8 million are females of breeding 
age (SOEC). The incidence of fetal losses due to toxoplasmosis is not known but it is likely to be less than that 
in sheep. However infection in pigs is relatively common (approximately 30% are seropositive)(Dubey and 
Beattie, 1988, Toxoplasmosis of Animals and Man, CRC, Boca Raton.) and likely to be more so in extensive 
outdoor management systems than in housed, minimal disease units. 
Toxoplasma gondii is also a zoonotic parasite that can cause serious illness in certain sections of the 
human population. As well as the suffering it causes there is a cost for the health services in the EU. Thus the 
cost of toxoplasmosis to EU (and non-EU) countries is considerable both in terms of inefficient animal produc­
tion and as a human pathogen often derived from ingested, infected meat. Only with more accurate data will it 
be possible to direct control measures effectively. 
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The economic impact of neosporosis 
^.M. Wastling and 2E.A. Innes 
1Division of Infection & Immunity, Institute of Biomedical & Life Sciences, University of Glasgow, Glasgow G12 8QQ; 
2Moredun Research Institute, Pentlands Science Park, Bush Loan, Penicuik, Midlothian EH26 OPZ, UK. 
Infection with Neospora caninum was first associated with bovine abortion about ten years ago and has 
since become recognised as an important reproductive disease of cattle with a world-wide distribution. Re­
cently the dog has been identified as a definitive host for this parasite, but vertical transmission is still thought 
to play a major role in the epidemiology of the disease in cattle. Just how important the disease is to the 
European economy has yet to be rigorously addressed, but this question requires urgent attention if appropri­
ate resources are to be allocated to minimise its impact. Recent advances in the diagnosis of infection, 
including serological tests (ELISA and IFAT), immunohistochemistry and PCR now provide the potential for 
more reliable diagnosis and hence quantification of the impact of neosporosis. Nevertheless, the implementation 
of appropriate standardised diagnostic procedures is probably still the single biggest obstacle in obtaining 
reliable estimates of the cost of this disease to the European farming industry. Some estimates of the economic 
cost of the disease have appeared in the literature, for example, the cost to the Californian dairy farming 
industry is thought to be approximately US$ 34.5 m each year. However, making an objective assessment of 
the economic impact of the disease that is robust enough to allow comparison between different countries, 
farming systems and economies is extremely difficult and simple translation of the assumptions made in one 
system may be inappropriate elsewhere. 
Although neosporosis affects both dairy and beef cattle, most of the data available is for dairy production 
where birth of a live calf and subsequent yearly milk yield are the principal economic outputs. For economic 
modelling to be meaningful, accurate information must be available on factors such as (a) the incidence of 
bovine abortion directly attributable to Neospora infection in relation to the total abortion rate (b) the cost of 
abortion both in terms of foetal loss and loss of milk production (c) the (sometimes hidden) cost of premature 
culling or re-sale of infected animals. The relative importance of neosporosis will also be dependent on the 
initial investment and expected profit on each animal as well as the prominence of other infectious agents, both 
of which may vary considerably in different agricultural systems. 
This paper will summarise current data obtained from The Netherlands, Switzerland, Australia, the United 
States, Spain, Holland, Sweden, Germany and the United Kingdom on the incidence and cost of bovine 
neosporosis. The aim of this paper will be (1 ) to provide a framework for discussion on the current estimates of 
the economic cost of bovine neosporosis (2) to review the quality of data available and identify where 
inadequacies in data or data collection exist (3) to compare methods used for computing economic impact 
with the aim of standardising best practice. 
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Epidemiology and economic impact of Sarcocystis species 
A. M. Tenter 
Institut für Parasitologie, Tierärztliche Hochschule Hannover, Bünteweg 17, D-30559 Hannover, Germany. 
The genus Sarcocystis comprises more than 120 species of heteroxenous cyst­forming coccidia with 
differences in life cycle and pathogenicity. About 30 of these species occur in livestock (Tenter, 1995, Int. J. 
Parasitol., 25:1311­1330). Knowledge on the epidemiology and relative importance of different Sarcocystis 
spp. has been impeded by the lack of sensitive and specific diagnostic methods for most of these species. 
However, Sarcocystis spp. can cause economic losses in the livestock industry in various ways. 
A primary infection with a high dose of sporocysts of a pathogenic Sarcocystis sp. can cause acute 
sarcocystiosis with high rates of mortality, in particular in sheep, goats and cattle. In pregnant animals, acute 
sarcocystiosis frequently results in foetal death, abortion or premature birth of the offspring. Chronic sarcocystiosis 
can result from the ingestion of a low dose of sporocysts of a pathogenic Sarcocystis sp. and can cause 
economic losses in the livestock industry due to reduced quality and quantity of meat, milk or wool in cattle, 
pigs, sheep and llamas. Additional economic losses are caused by infections with Sarcocystis spp. that are 
non­pathogenic, but form macroscopic cysts in muscles of cattle or sheep, which results in condemnation of 
whole carcasses or affected parts after slaughter. 
Sarcocystis spp. infecting ruminants appear to be the species of the highest economic importance. In 
some countries, infections with Sarcocystis spp. have been estimated to account for up to 25% of annual 
losses directly attributable to parasitic diseases in sheep, cattle and llamas. In this session we will attempt an 
estimation on the potential economic losses caused by these parasites in the EU. 
factors other than immunoglobulins are also transferred from C. baileyi infected hens to their progeny. A dot­
ELISA was developed to evaluate seroconversion of infected chickens which was 100% in both infected (IY 
and IC) groups. 
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Pathogenicity of selected Toxoplasma gondii isolates after intravenous 
inoculation in pigs 
G. Jungersen1, L Jensen1, U. Riber1, R Heegaard1, E. Petersen2 and R Und1 
1Danish Veterinary Laboratory, Bülowsvej 27, DK-1790 Copenhagen V, Denmark. 
2Statens Seruminstitut, Artillerivej 5, DK-2300 Copenhagen S, Denmark. 
The pathogenicity to 7 weeks old pigs of the human congenital Toxoplasma gondii strain "NED" (Dardé et 
al. 1992, Journal of Parasitology, 78: 786-794) and the porcine strain Ί19" (Work 1968, Acta Pathologica et 
Microbiologica Scandinavia, 73: 85-92) was compared to 3 danish T. gondii isolates recently isolated from a 
slaughter pig ("SVS P14"), a fox heart ("SVS Fox2") and a sheep abortion ("SVS 014"), respectively. Five 
groups of 5 pigs each were inoculated intravenously with 104 tachyzoites of the different isolates propagated in 
vero cell cultures. Additionally, one group of 5 pigs was inoculated intravenously with 106 tachyzoites of the 119 
strain. Eight pigs were included as PBS sham infected controls. Pigs inoculated with 10" tachyzoites of NED, 
119, P14 and Fox2 experienced a short-lived rise in body temperature from day 6-8 post inoculation (p.i.) 
without any apparent illness or inappétence, whereas control pigs and pigs inoculated with the 014 isolate had 
normal body temperature. Pigs inoculated with 106 tachyzoites of the 119 strain showed variable degrees of 
clinical illness and recurrent episodes of fever 4-17 p.i. Differential leucocyte count on peripheral blood re-
vealed a significant lymphocytopenia on day 6 p.i. for all pigs except the 014 inoculated group. All T. gondii 
inoculated pigs seroconverted (ELISA) 14 to 17 days p.i., and significant differences in level of antibody re-
sponses between groups were observed. At the time of abstract submission the following analyses were still in 
progress: T. gondii specific PCR on Ficoll purified blood mononuclear cells. Haptoglobin and alkaline phos-
phatase activity in serum. Lymphocyte subsets and capacity of oxidative burst in phagocytic cells of peripheral 
blood leucocytes from the pigs inoculated with 10" or 106 tachyzoites of the 119 strain. In conclusion the 
preliminary results indicate clear differences in pathogenicity of the selected isolates of T. gondii when inocu-
lated intravenously in young pigs. 
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Histopathological survey with special reference to Neospora caninum induced 
abortion and preliminary molecular characterisation of the Neospora isolates 
A. Schock1. D. Buxton1, J. Wastling2, J.A. Spence1, A.Rae1, J. Yamane3 and J.C. Low4 
1. Moredun Research Institute, Pentland Science Park, Bush Loan, Penicuik, Midlothian BH26 OPZ, UK. 
2. Glasgow University, Institute for Infection and Immunity, Glasgow G12 800, UK. 
3. Laboratory of Epidemiology, Institute of Animal Health, 3-1-1 Kannodai, Tsukuba Shi, Ibaraki, 305 Japan. 
4. Scottish Agricultural College Veterinary Science Division, Bush State, Penicuik, Midlothian EH26 OQE, UK. 
Neosporosis is a reproductive disease in cattle caused by the protozoan Neospora caninum characterised 
by abortion. The predominant histopathological changes observed in the aborted foetus include multifocal, 
necrotising, non suppurative encephalitis, however very little is known about the parasite and the pathogenesis 
of the disease. 
Between November 1996 and November 1997, brains, selected foetal viscera and sera from over 500 
aborted bovine foetuses, stillbirths and non viable neonates were examined to investigate the prevalence of 
bovine neosporosis in Scotland. Histopathological changes could be found in 42% of 374 cases examined and 
3.7% showed changes indicative of neosporosis. Of the cases of suspected neosporosis, three were positive 
by immunohistochemistry showing a small number of tachyzoites associated with a glial response. Of the 464 
foetal serum samples examined for IgG, 10.1% were seropositive for N. caninum antigen. Of these, 12.8% 
showed changes supporting the diagnosis of neosporosis whereas 2.7% of the seronegative cases showed 
the comparable type of changes. This might be due to the lack of detection of IgM. From the brains of a number 
of selected cases (86), amplification of DNA specific for N. caninum by PCR was attempted. In 12 cases, the 
presence of this DNA was demonstrated. Three of those showed changes consistent with the histopathological 
diagnosis of neosporosis and six cases were seropositive for N. caninum. To establish typing mechanisms to 
differentiate these DNA isolates from the field, a number of cell culture isolates from around the world were 
characterised by RADP analysis. Preliminary data from this characterisation will be presented. The markers 
established through this technique will than be applied for the characterisation of these field samples. In con-
clusion, the survey confirms the presence of N. caninum infection in Scotland and raises the need to further 
characterise the parasite by establishing possible strain differences. 
*The authors would like to thank the help of all the laboratories of SACVS, Mrs A. Baird and Mrs V Forbes 
in generating the material. 
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Case control study of Neospora caninum associated abortion storms in dairy 
herds in The Netherlands 
W. Wouda^C. J. M. Bartels,2 A. R. Moe^and Y. H. Schukken2 
animal Health Service, P. 0. Box 361, 9200 AJ Drachten, The Netherlands, 
department of Herd Health and Reproduction, Utrecht University, The Nethertands.. 
A case control study design was used to analyze Neospora caninum-associated abortion storms in 50 
dairy herds during 1995-1997. The duration of the abortion storms ranged from 6 to 65 days (mean 41.5 days) 
and the cumulative proportion of aborting cows ranged from 0.11 to 0.57 (mean 0.26) of the cows at risk. Most 
abortion storms occurred during summer and early autumn. Prevalence of antibodies to N. caninum in 50 case 
herds (range 17 to 87%, mean 51.5%) was significantly higher than that in 100 control herds (range 0 to 53%, 
mean 13.9%). In general, seropositive animals were equally distributed in all age groups, which suggests that 
the infection had been perpetuated by vertical transmission and that the abortion storms had been induced by 
factors causing recrudescence of chronic infection rather than being the result of a recent introduction. How-
ever, the high seroprevalence levels found indicate that horizontal transmission had taken place at some time 
point. 
An analysis of herd level risk factors for N. caninum-associated abortion storms was done by conditional 
logistic regression using a three-steps procedure. The analysis revealed that presence of dogs and presence 
of poultry on the farm were significant risk factors, suggesting involvement of these animals in the transmission 
of N. caninum infection to cattle. Another risk factor was feeding of moldy corn silage during summer. This is 
considered to be a factor which may induce recrudescence of a latent N. caninum infection by mycotoxins 
causing immune suppression. 
In conclusion, our results provide further evidence that both vertical and horizontal transmission play a 
role in the epidemiology of bovine neosporosis. Dogs and poultry may be involved in the introduction of the 
infection into a herd. Such infection may be perpetuated by vertical transmission without clinical signs until 
,factors causing immune suppression induce reactivation of the infection which may lead to abortions. 
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Antibody responses in bovine fe ta l abortion due to neosporosis 
H.­C. Slotved. L Jensen and R Lind 
Danish Veterinary Laboratory, Bülowsvej 27, DK-1790 Copenhagen V, Denmark. 
The study was carried out to evaluate the efficacy of fetal serology in the diagnosis of bovine neosporosis 
abortion. Pleural fluid from 15 fetuses of cows with confirmed neosporosis (group A), 9 fetuses with confirmed 
Bovine Viral Diarrhea (BVD) (group B) and 11 aborted fetuses without demonstrable infection (group C) were 
examined by Rocket Immunoelectrophoresis (fluid dilution 1:10), Mancini technique (fluid dilution 1:1 ­1:15), 
Immunofluorescence test (IFAT) (twofold dilution from 1:10) and Iscom-ELISA (fluid dilution 1:40). 
The albumin concentration measured by the Rocket Immunoelectrophoresis was not significantly 
different in group A compared to both group Β and C. Group Β was significantly different from group C. 
Levels of total IgG from 0.02% to 11.0% of adult serum measured by the Mancini technique was found in 
all fetuses from group A and 7 fetuses in group B, with no significant difference between levels in the two 
groups. Only one fetus in group C had a detectable level of IgG. All fetuses in group A gave a specific IgG 
response (titer 20) against N. caninum using the IFAT­technique, while no positive responses were found 
in group Β and C. The results from specific lgG1 by Iscom­ELISA showed only one false negative result 
in group A, with no reactions in group Β and group C, using an lgG1 cut­off OD­value at 0.08 (the mean 
response of group Β + 2 χ SD). The lgG2 results with a cut­off OD­value of 0.09 showed 3 false negative 
results in group A, but no reaction in group Β and C. The lgG1 and lgG2 response in group A was 
correlated according to the Spearman test (r = 0.6571). With increasing age of the fetuses, there ap­
peared to be an increase in the amount of total IgG, specific IgG and specific lgG1, although this could 
not be confirmed statistically. 
On the basis of the obtained results it was concluded that the IFAT­method at a cut­off titer of 20, had 
a 100% success rate for detecting neosporosis in fetal fluid. The Iscom­ELISA also showed promising 
results. 
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Neospora caninum: Is oral transmission a possible route of infection? 
A. Uggla, S. Stenlund. O.J.M. Holmdahl, E.B. Jakubek, R Thebo, H. Kindahl, and C. Björkman. 
National Veterinary Institute and Swedish University of Agricultural Sciences, SE-75007 Uppsala, Sweden. 
Neospora caninum is a cyst-forming coccidian parasite with a canine definitive host and different mam-
mals as possible intermediate hosts. In cattle the major route of transmission is considered to be transplacen-
tal. External sources of infection has been evident in some reported outbreaks, but there has been no evidence 
as yet of transmission by oral ingestion of parasites in milk. The closely related organism Toxoplasma gondii 
has been transmitted experimentally via milk in mice. The aim of this study was to investigate the potential on 
N. caninum tachyzoites to infect neonatal calves when given orally with colostrum (Int. J. Parasitol. 1998, 
28,1467-1472). 
Four full-term calves, seronegative to N. caninum and born from seronegative dams, were fed colostrum 
with added N. caninum tachyzoites of the Nc-SweB1 isolate in their first feed. Two of the calves were fed via 
gastric tubes, and the other two by feeding bottles. Weekly blood samples for N. caninum serology were 
collected. After 15 weeks the calves were euthanised, autopsies were performed, sections of CNS were sub-
jected to immunohistochemical labelling and re-isolation of the parasite was attempted. In addition PCR was 
performed on selected parts of CNS. 
The two calves inoculated via gastric tubes remained seronegative throughout the observation period, 
while there was a marked rise in N. caninum antibody levels at 4-5 weeks p.i. in serum from the two calves 
inoculated by feeding bottles. The high level was maintained until the termination of the study. No pathological 
lesions were found, and no parasites were detected by immunohistochemistry or in the cell cultures. N. caninum 
DNA was, however, repeatedly demonstrated in one sample each (hippocampus) from the brains of the two 
bottle-inoculated calves. 
These results provide evidence that galactogenic transmission of N. caninum is possible in neonatal 
calves. Which implications the possibility of galactogenic transmission has for the epidemiology of N. caninum 
in cattle have yet to be determined. 
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Seroepidemiology of Neospora antibody responses in red foxes (Vulpes vulpes) 
in Spain 
S. Wright1, C. Gortázar2, D. Fernandez de Luco 3 and D. Buxton 1 
1 Moredun Research Institute, IRC, Pentland Science Park, Bush Loan, Penicuik, Midlothian, EH26 OPZ, UK 
2Ebronatura S.L., Miguel Servet 69, E-50.013, Zaragoza, Spain. 
3 Departamento de Patologia Animal, Facultad de Veterinaria, Universidad de Zaragoza, c/Miguel Servet 177, 50013 
Zaragoza, Spain. 
The recent discovery that the dog is a definitive host for Neospora caninum (McAllister et al., 1998, 
Int. J. Parasitol., 28: 1473-1478) highlights the potential importance of canids in the transmission of 
neosporosis. Serological surveys of wild canids have revealed that a significant proportion develop an 
antibody response to this parasite, though the numbers are markedly less than those which have been 
infected by the related parasite Toxoplasma gondii, implying that potential sources of N.caninum infection 
are limited. 
Archived sera collected in the central Ebro valley region of Spain from foxes culled over a 4 year period 
were analysed for antibodies to N.caninum and T. gondii using an immunofluorescent antibody test, represent-
ing a total of 61 animals. 
The cut off titre selected to represent seropositivity for N.caninum in canids varies between research 
groups, but if set at 1/256,8.2% of the foxes were seropositive for Neospora, contrasting with 62% seroposi-
tivity for Toxoplasma. Using the 1/50 titre also commonly quoted, infection rates were increased to 21% for 
Neospora and 77% for Toxoplasma. These figures relate closely to other surveys of canids, including red foxes 
in Belgium (Buxton et al., 1997, Vet. Ree., 141:308-309), coyotes in the USAÜJndsay et al., 1996, J. Parasitol., 
82:657-659) and domestic dogs in the UK (Trees et al., 1993, Vet. Ree., 132:125-126). The potential role that 
foxes play in the epidemiology of neosporosis requires further study. 
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Immunisation of mice against neosporosis 
A. Lundén1. J. E. Allen2, D. Buxton3 and S. Wright3 
1 Department of Veterinary Microbiology, Section of Parasitology, Swedish University of Agricultural Sciences, P.O.Box 
7073, S-750 07 Uppsala, Sweden. 
2 Institute of Cell, Animal and population Biology, University of Edinburgh, West Mains Road, Edinburgh, EH9 3JT, 
Scotland, UK. 
3 Moredun Research Institute, Pentlands Science Park, Bush Loan, Penicuik, Midlothian, EH 26 OPZ Scotland, UK. 
Neospora caninum can infect a wide range of animal species and has during recent years been identified 
as a major cause of bovine abortion in many countries around the world. The aim of the work presented was to 
investigate the possibility of inducing protection against N. caninum infection by immunisation, using a BALB/ 
c mouse model. 
Groups of ten mice were immunised with a sublethal dose of live N. caninum tachyzoites of the NC­1 
isolate or with one of three different antigen preparations: 1) N. caninum antigens incorporated into immune 
stimulating complexes (¡scorns); 2) N. caninum lysate mixed with Quii A; 3) N. caninum lysate in PBS. Control 
mice were given Quii A only. A second immunisation was undertaken after 6 weeks. Two weeks thereafter all 
mice were inoculated with 2.5 χ 106 Ν. caninum tachyzoites. 
Symptoms of acute infection were seen in all mice from day 4 post infection (p.i.). While the non­immunised 
controls remained ill until the end of the experiment, all mice immunised with live parasites or parasite lysate in 
Quii A recovered after 4 ­ 5 days. Of 9 mice immunised with N. caninum ¡scorns 7 recovered while 2 died at 
days 10 and 21 p.i. Most severely affected were the mice immunised with parasite lysate only. All of them died 
within 28 days p.i. 
The N. caninum specific antibody responses (lgG1 & lgG2a) and cytokine production (IFN­γ & IL­5) of 
splenocytes after in vitro stimulation with parasite antigen will be presented. 
Conclusion: Immunisation of mice with live parasites or parasite antigens either mixed with Quii A or 
incorporated into ¡scorns resulted in at least partial immunity against experimental neosporosis. In con­
trast, immunisation with parasite antigen without any adjuvant appeared to increase the susceptibility to 
infection. 
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Investigations on the biological character ist ics of two isolates of Neospora 
caninum 
R. Atkinson1, R A.W. Harper2, C. Ryce1, D. A. Morrison1 and J. T. Ellis1 
Molecular Parasitology Unit, Department of Cell & Molecular Biology, University of Technology, Sydney, Westboume 
Street, Gore Hill, NSW 2065, Australia. 
2Grafton Agricultural Research & Advisory Station (NSW Agriculture), Grafton, NSW 2460, Australia. 
The development of recombinant vaccines against Neospora caninum and neosporosis requires the 
development of suitable animal models and the in-vivo testing of recombinant antigens or live, attenuated 
organisms as vaccines. In recent years, mouse models for central nervous system (CNS) infections, transpla-
cental transmission and foetal loss have been reported for N. caninum. The studies described here compared 
the biological properties of a bovine (NC-SweB1) and a canine (NC-Liverpool) isolate of N. caninum in a 
mouse model. 
Infection of in-bred Balb/C mice demonstrated marked differences in pathogenicity between the 
isolates. NC-Liverpool induced severe clinical signs of neosporosis in mice including discoordinated 
movement, hindlimb paralysis and coat ruffling with severe weight loss. In contrast NC-SweB1 induced 
similar but less severe symptoms in a much smaller proportion of mice over the same time period. NC-
Liverpool infection resulted in intense inflammatory infiltrates and highly necrotic lesions in the brain 
whereas NC-SweB1 induced a milder meningoencephalitis. Passage in cell-culture over a period of 14 
months did not affect the pathogenicity of NC-Liverpool. Immunoblots showed antibodies to N. caninum 
appeared earlier in mice inoculated with NC-Liverpool than with NC-SweB1. Thus the evidence provided 
indicates that NC-Liverpool and NC-SweB1 differ in their biological properties. In particular NC-SweB1 
appears remarkably attenuated in its ability to induce a marked pathologic response in the mouse model. 
Therefore we investigated whether infection by NC-SweB1 would protect mice against a lethal challenge 
of NC-Liverpool. Infection of mice with NC-SweB1 induced a significant level of partial protection against 
a lethal dose of NC-Liverpool as judged by prolonged survival of mice, reduction in weight loss and brain 
histopathology. 
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European Commission 
EUR 19223 — COST 820 — Vaccines against animal coccidioses — Annual report 1998 
Edited by Martin Shirley and Françoise Coudert 
Luxembourg: Office for Official Publications of the European Communities 
1999 — 145 pp. — 21 χ 29.7 cm 
ISBN 92­828­7713­2 
Price (excluding VAT) in Luxembourg: EUR 22 
COST Action 820 began formally in July 1994 following the signing of a memorandum of understanding 
by at least seven countries. The main objectives are: 
• the evaluation of new vaccination strategies; 
• the development of new vaccines, with the emphasis on recombinant vaccines; 
• the study of innovative ways for vaccine production; 
• the preparation of recommendations for industrial production and efficacy and safety evaluations of 
vaccines; 
• the development of biomathematical models for evaluating the potential impact of immunisations on 
the epidemiology of infections with coccidia. 
For these objectives, it was anticipated that high priority will be given to three areas loosely defined as 
the following. 
Basic studies: to include aspects of the molecular biology and immunology of the coccidial parasites 
that have potential relevance for vaccine development. Such studies might include the development of 
strategies to identify protective antigens, the isolation and characterisation of antigens and fundamen­
tal molecular analyses of the parasites, etc. 
Intermediate studies: to include evaluations of eucaryotlc expression systems to produce modified 
parasite proteins, investigations of the abilities of different viral and bacterial vectors to present antigens 
In different sites, examinations of different adjuvants and the initial small­scale evaluation of potential 
vaccine candidates. 
Vaccination: to include the more practical aspects of vaccinations and larger scale trials of any out­
standing recombinant vaccine candidates as will be required. 
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